id	sid	tid	token	lemma	pos
cuesj-1229	1	1	tx_1	tx_1	PROPN
cuesj-1229	1	2	~	~	X
cuesj-1229	1	3	abs	ab	NOUN
cuesj-1229	1	4	:	:	PUNCT
cuesj-1229	1	5	at	at	ADP
cuesj-1229	1	6	/	/	SYM
cuesj-1229	1	7	add	add	VERB
cuesj-1229	1	8	:	:	PUNCT
cuesj-1229	1	9	tx_2	tx_2	PROPN
cuesj-1229	1	10	~	~	NOUN
cuesj-1229	1	11	abs	ab	NOUN
cuesj-1229	1	12	:	:	PUNCT
cuesj-1229	1	13	at	at	ADP
cuesj-1229	1	14	26	26	NUM
cuesj-1229	1	15	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1229	1	16	cuesj	cuesj	ADJ
cuesj-1229	1	17	2024	2024	NUM
cuesj-1229	1	18	,	,	PUNCT
cuesj-1229	1	19	8	8	NUM
cuesj-1229	1	20	(	(	PUNCT
cuesj-1229	1	21	2	2	NUM
cuesj-1229	1	22	):	):	PUNCT
cuesj-1229	1	23	26	26	NUM
cuesj-1229	1	24	-	-	SYM
cuesj-1229	1	25	30	30	NUM
cuesj-1229	1	26	research	research	NOUN
cuesj-1229	1	27	article	article	NOUN
cuesj-1229	1	28	epidemiological	epidemiological	ADJ
cuesj-1229	1	29	insights	insight	NOUN
cuesj-1229	1	30	into	into	ADP
cuesj-1229	1	31	torch	torch	NOUN
cuesj-1229	1	32	infections	infection	NOUN
cuesj-1229	1	33	in	in	ADP
cuesj-1229	1	34	the	the	DET
cuesj-1229	1	35	population	population	NOUN
cuesj-1229	1	36	of	of	ADP
cuesj-1229	1	37	erbil	erbil	PROPN
cuesj-1229	1	38	city	city	PROPN
cuesj-1229	1	39	ameena	ameena	PROPN
cuesj-1229	1	40	s.	s.	PROPN
cuesj-1229	1	41	m.	m.	PROPN
cuesj-1229	1	42	juma1	juma1	PROPN
cuesj-1229	1	43	,	,	PUNCT
cuesj-1229	1	44	kamgar	kamgar	NOUN
cuesj-1229	1	45	a.	a.	NOUN
cuesj-1229	1	46	rasul2	rasul2	PROPN
cuesj-1229	1	47	,	,	PUNCT
cuesj-1229	1	48	muhsin	muhsin	PROPN
cuesj-1229	1	49	h.	h.	PROPN
cuesj-1229	2	1	ubeid1	ubeid1	PROPN
cuesj-1229	2	2	,	,	PUNCT
cuesj-1229	2	3	shakir	shakir	PROPN
cuesj-1229	2	4	m.	m.	PROPN
cuesj-1229	2	5	al	al	PROPN
cuesj-1229	2	6	-	-	PUNCT
cuesj-1229	2	7	awqati3	awqati3	PROPN
cuesj-1229	2	8	,	,	PUNCT
cuesj-1229	2	9	tanya	tanya	PROPN
cuesj-1229	2	10	s.	s.	PROPN
cuesj-1229	2	11	salih4	salih4	PROPN
cuesj-1229	2	12	,	,	PUNCT
cuesj-1229	2	13	muhamed	muhamed	PROPN
cuesj-1229	2	14	aydin	aydin	NOUN
cuesj-1229	2	15	abbas5	abbas5	NOUN
cuesj-1229	2	16	1department	1department	NUM
cuesj-1229	2	17	of	of	ADP
cuesj-1229	2	18	medical	medical	ADJ
cuesj-1229	2	19	microbiology	microbiology	NOUN
cuesj-1229	2	20	,	,	PUNCT
cuesj-1229	2	21	college	college	NOUN
cuesj-1229	2	22	of	of	ADP
cuesj-1229	2	23	science	science	NOUN
cuesj-1229	2	24	,	,	PUNCT
cuesj-1229	2	25	cihan	cihan	VERB
cuesj-1229	2	26	university	university	NOUN
cuesj-1229	2	27	-	-	PUNCT
cuesj-1229	2	28	erbil	erbil	PROPN
cuesj-1229	2	29	,	,	PUNCT
cuesj-1229	2	30	kurdistan	kurdistan	PROPN
cuesj-1229	2	31	region	region	NOUN
cuesj-1229	2	32	,	,	PUNCT
cuesj-1229	2	33	iraq	iraq	PROPN
cuesj-1229	2	34	,	,	PUNCT
cuesj-1229	2	35	2department	2department	NUM
cuesj-1229	2	36	of	of	ADP
cuesj-1229	2	37	medical	medical	ADJ
cuesj-1229	2	38	microbiology	microbiology	NOUN
cuesj-1229	2	39	,	,	PUNCT
cuesj-1229	2	40	college	college	NOUN
cuesj-1229	2	41	of	of	ADP
cuesj-1229	2	42	medicine	medicine	NOUN
cuesj-1229	2	43	,	,	PUNCT
cuesj-1229	2	44	hawler	hawler	PROPN
cuesj-1229	2	45	medical	medical	PROPN
cuesj-1229	2	46	university	university	PROPN
cuesj-1229	2	47	,	,	PUNCT
cuesj-1229	2	48	erbil	erbil	PROPN
cuesj-1229	2	49	,	,	PUNCT
cuesj-1229	2	50	kurdistan	kurdistan	PROPN
cuesj-1229	2	51	region	region	NOUN
cuesj-1229	2	52	,	,	PUNCT
cuesj-1229	2	53	iraq	iraq	PROPN
cuesj-1229	2	54	,	,	PUNCT
cuesj-1229	2	55	3department	3department	NUM
cuesj-1229	2	56	of	of	ADP
cuesj-1229	2	57	anesthesia	anesthesia	PROPN
cuesj-1229	2	58	technologies	technology	NOUN
cuesj-1229	2	59	,	,	PUNCT
cuesj-1229	2	60	college	college	NOUN
cuesj-1229	2	61	of	of	ADP
cuesj-1229	2	62	science	science	NOUN
cuesj-1229	2	63	,	,	PUNCT
cuesj-1229	2	64	cihan	cihan	VERB
cuesj-1229	2	65	university	university	NOUN
cuesj-1229	2	66	-	-	PUNCT
cuesj-1229	2	67	erbil	erbil	PROPN
cuesj-1229	2	68	,	,	PUNCT
cuesj-1229	2	69	kurdistan	kurdistan	PROPN
cuesj-1229	2	70	region	region	NOUN
cuesj-1229	2	71	,	,	PUNCT
cuesj-1229	2	72	iraq	iraq	PROPN
cuesj-1229	2	73	,	,	PUNCT
cuesj-1229	2	74	4department	4department	NUM
cuesj-1229	2	75	of	of	ADP
cuesj-1229	2	76	physiotherapy	physiotherapy	NOUN
cuesj-1229	2	77	,	,	PUNCT
cuesj-1229	2	78	college	college	NOUN
cuesj-1229	2	79	of	of	ADP
cuesj-1229	2	80	health	health	PROPN
cuesj-1229	2	81	technology	technology	NOUN
cuesj-1229	2	82	,	,	PUNCT
cuesj-1229	2	83	cihan	cihan	VERB
cuesj-1229	2	84	university	university	NOUN
cuesj-1229	2	85	-	-	PUNCT
cuesj-1229	2	86	erbil	erbil	PROPN
cuesj-1229	2	87	,	,	PUNCT
cuesj-1229	2	88	kurdistan	kurdistan	PROPN
cuesj-1229	2	89	region	region	NOUN
cuesj-1229	2	90	,	,	PUNCT
cuesj-1229	2	91	iraq	iraq	PROPN
cuesj-1229	2	92	,	,	PUNCT
cuesj-1229	2	93	5college	5college	PROPN
cuesj-1229	2	94	of	of	ADP
cuesj-1229	2	95	pharmacy	pharmacy	NOUN
cuesj-1229	2	96	,	,	PUNCT
cuesj-1229	2	97	cihan	cihan	VERB
cuesj-1229	2	98	university	university	NOUN
cuesj-1229	2	99	-	-	PUNCT
cuesj-1229	2	100	erbil	erbil	PROPN
cuesj-1229	2	101	,	,	PUNCT
cuesj-1229	2	102	kurdistan	kurdistan	ADJ
cuesj-1229	2	103	region	region	NOUN
cuesj-1229	2	104	,	,	PUNCT
cuesj-1229	2	105	iraq	iraq	PROPN
cuesj-1229	2	106	abstract	abstract	VERB
cuesj-1229	2	107	a	a	DET
cuesj-1229	2	108	seroepidemiological	seroepidemiological	ADJ
cuesj-1229	2	109	study	study	NOUN
cuesj-1229	2	110	of	of	ADP
cuesj-1229	2	111	the	the	DET
cuesj-1229	2	112	torch	torch	NOUN
cuesj-1229	2	113	panel	panel	NOUN
cuesj-1229	2	114	was	be	AUX
cuesj-1229	2	115	conducted	conduct	VERB
cuesj-1229	2	116	on	on	ADP
cuesj-1229	2	117	inhabitants	inhabitant	NOUN
cuesj-1229	2	118	of	of	ADP
cuesj-1229	2	119	erbil	erbil	PROPN
cuesj-1229	2	120	city	city	PROPN
cuesj-1229	2	121	to	to	PART
cuesj-1229	2	122	provide	provide	VERB
cuesj-1229	2	123	updated	update	VERB
cuesj-1229	2	124	baseline	baseline	NOUN
cuesj-1229	2	125	data	datum	NOUN
cuesj-1229	2	126	on	on	ADP
cuesj-1229	2	127	torch	torch	NOUN
cuesj-1229	2	128	prevalence	prevalence	NOUN
cuesj-1229	2	129	.	.	PUNCT
cuesj-1229	3	1	508	508	NUM
cuesj-1229	3	2	individuals	individual	NOUN
cuesj-1229	3	3	were	be	AUX
cuesj-1229	3	4	included	include	VERB
cuesj-1229	3	5	in	in	ADP
cuesj-1229	3	6	this	this	DET
cuesj-1229	3	7	study	study	NOUN
cuesj-1229	3	8	.	.	PUNCT
cuesj-1229	4	1	218	218	NUM
cuesj-1229	4	2	 	 	SPACE
cuesj-1229	4	3	(	(	PUNCT
cuesj-1229	4	4	42.91	42.91	NUM
cuesj-1229	4	5	%	%	NOUN
cuesj-1229	4	6	)	)	PUNCT
cuesj-1229	4	7	were	be	AUX
cuesj-1229	4	8	females	female	NOUN
cuesj-1229	4	9	and	and	CCONJ
cuesj-1229	4	10	290	290	NUM
cuesj-1229	4	11	 	 	SPACE
cuesj-1229	4	12	(	(	PUNCT
cuesj-1229	4	13	57.09	57.09	NUM
cuesj-1229	4	14	%	%	NOUN
cuesj-1229	4	15	)	)	PUNCT
cuesj-1229	4	16	were	be	AUX
cuesj-1229	4	17	males	male	NOUN
cuesj-1229	4	18	.	.	PUNCT
cuesj-1229	5	1	their	their	PRON
cuesj-1229	5	2	ages	age	NOUN
cuesj-1229	5	3	ranged	range	VERB
cuesj-1229	5	4	from	from	ADP
cuesj-1229	5	5	13	13	NUM
cuesj-1229	5	6	to	to	ADP
cuesj-1229	5	7	63	63	NUM
cuesj-1229	5	8	 	 	SPACE
cuesj-1229	5	9	years	year	NOUN
cuesj-1229	5	10	,	,	PUNCT
cuesj-1229	5	11	the	the	DET
cuesj-1229	5	12	majority	majority	NOUN
cuesj-1229	5	13	being	be	AUX
cuesj-1229	5	14	within	within	ADP
cuesj-1229	5	15	the	the	DET
cuesj-1229	5	16	age	age	NOUN
cuesj-1229	5	17	group	group	NOUN
cuesj-1229	5	18	(	(	PUNCT
cuesj-1229	5	19	21–30	21–30	NOUN
cuesj-1229	5	20	 	 	SPACE
cuesj-1229	5	21	years	year	NOUN
cuesj-1229	5	22	)	)	PUNCT
cuesj-1229	5	23	,	,	PUNCT
cuesj-1229	5	24	162	162	NUM
cuesj-1229	5	25	 	 	SPACE
cuesj-1229	5	26	(	(	PUNCT
cuesj-1229	5	27	31.89	31.89	NUM
cuesj-1229	5	28	%	%	NOUN
cuesj-1229	5	29	)	)	PUNCT
cuesj-1229	6	1	(	(	PUNCT
cuesj-1229	6	2	p	p	X
cuesj-1229	6	3	<	<	X
cuesj-1229	6	4	0.05	0.05	NUM
cuesj-1229	6	5	)	)	PUNCT
cuesj-1229	6	6	.	.	PUNCT
cuesj-1229	7	1	20	20	NUM
cuesj-1229	7	2	individuals	individual	NOUN
cuesj-1229	7	3	(	(	PUNCT
cuesj-1229	7	4	3.94	3.94	NUM
cuesj-1229	7	5	%	%	NOUN
cuesj-1229	7	6	)	)	PUNCT
cuesj-1229	7	7	tested	test	VERB
cuesj-1229	7	8	positive	positive	ADJ
cuesj-1229	7	9	for	for	ADP
cuesj-1229	7	10	anti	anti	ADJ
cuesj-1229	7	11	-	-	ADJ
cuesj-1229	7	12	toxoplasma	toxoplasma	ADJ
cuesj-1229	7	13	gondii	gondii	NOUN
cuesj-1229	7	14	(	(	PUNCT
cuesj-1229	7	15	tox	tox	NOUN
cuesj-1229	7	16	)	)	PUNCT
cuesj-1229	7	17	immunoglobulin	immunoglobulin	NOUN
cuesj-1229	7	18	g	g	PROPN
cuesj-1229	7	19	(	(	PUNCT
cuesj-1229	7	20	igg	igg	PROPN
cuesj-1229	7	21	)	)	PUNCT
cuesj-1229	7	22	antibodies	antibodie	VERB
cuesj-1229	7	23	.	.	PUNCT
cuesj-1229	8	1	one	one	NUM
cuesj-1229	8	2	of	of	ADP
cuesj-1229	8	3	the	the	DET
cuesj-1229	8	4	20	20	NUM
cuesj-1229	8	5	 	 	SPACE
cuesj-1229	8	6	(	(	PUNCT
cuesj-1229	8	7	5	5	NUM
cuesj-1229	8	8	%	%	NOUN
cuesj-1229	8	9	)	)	PUNCT
cuesj-1229	8	10	tested	test	VERB
cuesj-1229	8	11	positive	positive	ADJ
cuesj-1229	8	12	for	for	ADP
cuesj-1229	8	13	anti	anti	ADJ
cuesj-1229	8	14	-	-	ADJ
cuesj-1229	8	15	tox	tox	ADJ
cuesj-1229	8	16	immunoglobulin	immunoglobulin	NOUN
cuesj-1229	8	17	m	m	PROPN
cuesj-1229	8	18	(	(	PUNCT
cuesj-1229	8	19	igm	igm	PROPN
cuesj-1229	8	20	)	)	PUNCT
cuesj-1229	8	21	antibodies	antibodie	VERB
cuesj-1229	8	22	,	,	PUNCT
cuesj-1229	8	23	who	who	PRON
cuesj-1229	8	24	was	be	AUX
cuesj-1229	8	25	a	a	DET
cuesj-1229	8	26	32	32	NUM
cuesj-1229	8	27	-	-	PUNCT
cuesj-1229	8	28	year	year	NOUN
cuesj-1229	8	29	-	-	PUNCT
cuesj-1229	8	30	old	old	ADJ
cuesj-1229	8	31	female	female	NOUN
cuesj-1229	8	32	.	.	PUNCT
cuesj-1229	9	1	128	128	NUM
cuesj-1229	9	2	individuals	individual	NOUN
cuesj-1229	9	3	(	(	PUNCT
cuesj-1229	9	4	25.2	25.2	NUM
cuesj-1229	9	5	%	%	NOUN
cuesj-1229	9	6	)	)	PUNCT
cuesj-1229	9	7	(	(	PUNCT
cuesj-1229	9	8	all	all	DET
cuesj-1229	9	9	females	female	NOUN
cuesj-1229	9	10	)	)	PUNCT
cuesj-1229	9	11	tested	test	VERB
cuesj-1229	9	12	positive	positive	ADJ
cuesj-1229	9	13	for	for	SCONJ
cuesj-1229	9	14	anti	anti	ADJ
cuesj-1229	9	15	-	-	ADJ
cuesj-1229	9	16	rubella	rubella	ADJ
cuesj-1229	9	17	igg	igg	NOUN
cuesj-1229	9	18	antibodies	antibodie	VERB
cuesj-1229	9	19	.	.	PUNCT
cuesj-1229	10	1	40	40	NUM
cuesj-1229	10	2	individuals	individual	NOUN
cuesj-1229	10	3	(	(	PUNCT
cuesj-1229	10	4	7.87	7.87	NUM
cuesj-1229	10	5	%	%	NOUN
cuesj-1229	10	6	)	)	PUNCT
cuesj-1229	10	7	were	be	AUX
cuesj-1229	10	8	positive	positive	ADJ
cuesj-1229	10	9	for	for	SCONJ
cuesj-1229	10	10	anti	anti	ADJ
cuesj-1229	10	11	-	-	NOUN
cuesj-1229	10	12	cytomegalovirus	cytomegalovirus	ADJ
cuesj-1229	10	13	(	(	PUNCT
cuesj-1229	10	14	cmv	cmv	NOUN
cuesj-1229	10	15	)	)	PUNCT
cuesj-1229	10	16	igg	igg	PROPN
cuesj-1229	10	17	antibodies	antibodie	VERB
cuesj-1229	10	18	.	.	PUNCT
cuesj-1229	11	1	one	one	NUM
cuesj-1229	11	2	of	of	ADP
cuesj-1229	11	3	the	the	DET
cuesj-1229	11	4	40	40	NUM
cuesj-1229	11	5	 	 	SPACE
cuesj-1229	11	6	(	(	PUNCT
cuesj-1229	11	7	2.5	2.5	NUM
cuesj-1229	11	8	%	%	NOUN
cuesj-1229	11	9	)	)	PUNCT
cuesj-1229	11	10	also	also	ADV
cuesj-1229	11	11	tested	test	VERB
cuesj-1229	11	12	positive	positive	ADJ
cuesj-1229	11	13	for	for	ADP
cuesj-1229	11	14	anti	anti	ADJ
cuesj-1229	11	15	-	-	ADJ
cuesj-1229	11	16	cmv	cmv	ADJ
cuesj-1229	11	17	igm	igm	NOUN
cuesj-1229	11	18	antibodies	antibodie	VERB
cuesj-1229	11	19	,	,	PUNCT
cuesj-1229	11	20	who	who	PRON
cuesj-1229	11	21	was	be	AUX
cuesj-1229	11	22	a	a	DET
cuesj-1229	11	23	26	26	NUM
cuesj-1229	11	24	-	-	PUNCT
cuesj-1229	11	25	year	year	NOUN
cuesj-1229	11	26	-	-	PUNCT
cuesj-1229	11	27	old	old	ADJ
cuesj-1229	11	28	male	male	NOUN
cuesj-1229	11	29	.	.	PUNCT
cuesj-1229	12	1	18	18	NUM
cuesj-1229	12	2	individuals	individual	NOUN
cuesj-1229	12	3	(	(	PUNCT
cuesj-1229	12	4	3.54	3.54	NUM
cuesj-1229	12	5	%	%	NOUN
cuesj-1229	12	6	)	)	PUNCT
cuesj-1229	12	7	tested	test	VERB
cuesj-1229	12	8	positive	positive	ADJ
cuesj-1229	12	9	for	for	ADP
cuesj-1229	12	10	anti	anti	ADJ
cuesj-1229	12	11	-	-	ADJ
cuesj-1229	12	12	herpes	herpes	ADJ
cuesj-1229	12	13	simplex	simplex	NOUN
cuesj-1229	12	14	virus	virus	NOUN
cuesj-1229	12	15	(	(	PUNCT
cuesj-1229	12	16	hsv)-1	hsv)-1	PROPN
cuesj-1229	12	17	igg	igg	PROPN
cuesj-1229	12	18	antibodies	antibodie	VERB
cuesj-1229	12	19	.	.	PUNCT
cuesj-1229	13	1	one	one	NUM
cuesj-1229	13	2	of	of	ADP
cuesj-1229	13	3	the	the	DET
cuesj-1229	13	4	18	18	NUM
cuesj-1229	13	5	  	  	SPACE
cuesj-1229	13	6	(	(	PUNCT
cuesj-1229	13	7	5.56	5.56	NUM
cuesj-1229	13	8	%	%	NOUN
cuesj-1229	13	9	)	)	PUNCT
cuesj-1229	13	10	also	also	ADV
cuesj-1229	13	11	tested	test	VERB
cuesj-1229	13	12	positive	positive	ADJ
cuesj-1229	13	13	for	for	ADP
cuesj-1229	13	14	anti	anti	ADJ
cuesj-1229	13	15	-	-	ADJ
cuesj-1229	13	16	hsv-1	hsv-1	DET
cuesj-1229	13	17	igm	igm	NOUN
cuesj-1229	13	18	antibodies	antibodie	VERB
cuesj-1229	13	19	.	.	PUNCT
cuesj-1229	14	1	one	one	NUM
cuesj-1229	14	2	18	18	NUM
cuesj-1229	14	3	-	-	PUNCT
cuesj-1229	14	4	year	year	NOUN
cuesj-1229	14	5	-	-	PUNCT
cuesj-1229	14	6	old	old	ADJ
cuesj-1229	14	7	male	male	NOUN
cuesj-1229	14	8	(	(	PUNCT
cuesj-1229	14	9	0.2	0.2	NUM
cuesj-1229	14	10	%	%	NOUN
cuesj-1229	14	11	)	)	PUNCT
cuesj-1229	14	12	tested	test	VERB
cuesj-1229	14	13	positive	positive	ADJ
cuesj-1229	14	14	for	for	ADP
cuesj-1229	14	15	anti	anti	ADJ
cuesj-1229	14	16	-	-	ADJ
cuesj-1229	14	17	hsv-2	hsv-2	VERB
cuesj-1229	14	18	igg	igg	NOUN
cuesj-1229	14	19	antibodies	antibodie	VERB
cuesj-1229	14	20	,	,	PUNCT
cuesj-1229	14	21	and	and	CCONJ
cuesj-1229	14	22	none	none	NOUN
cuesj-1229	14	23	were	be	AUX
cuesj-1229	14	24	positive	positive	ADJ
cuesj-1229	14	25	for	for	ADP
cuesj-1229	14	26	anti	anti	ADJ
cuesj-1229	14	27	-	-	ADJ
cuesj-1229	14	28	hsv-2	hsv-2	ADJ
cuesj-1229	14	29	igm	igm	NOUN
cuesj-1229	14	30	antibodies	antibodie	VERB
cuesj-1229	14	31	.	.	PUNCT
cuesj-1229	15	1	the	the	DET
cuesj-1229	15	2	results	result	NOUN
cuesj-1229	15	3	suggest	suggest	VERB
cuesj-1229	15	4	the	the	DET
cuesj-1229	15	5	presence	presence	NOUN
cuesj-1229	15	6	of	of	ADP
cuesj-1229	15	7	toxoplasma	toxoplasma	NOUN
cuesj-1229	15	8	,	,	PUNCT
cuesj-1229	15	9	cmv	cmv	NOUN
cuesj-1229	15	10	,	,	PUNCT
cuesj-1229	15	11	hsv-1	hsv-1	PRON
cuesj-1229	15	12	,	,	PUNCT
cuesj-1229	15	13	and	and	CCONJ
cuesj-1229	15	14	hsv-2	hsv-2	NUM
cuesj-1229	15	15	infections	infection	NOUN
cuesj-1229	15	16	among	among	ADP
cuesj-1229	15	17	the	the	DET
cuesj-1229	15	18	community	community	NOUN
cuesj-1229	15	19	,	,	PUNCT
cuesj-1229	15	20	the	the	DET
cuesj-1229	15	21	majority	majority	NOUN
cuesj-1229	15	22	(	(	PUNCT
cuesj-1229	15	23	p	p	X
cuesj-1229	15	24	<	<	X
cuesj-1229	15	25	0.05	0.05	NUM
cuesj-1229	15	26	)	)	PUNCT
cuesj-1229	15	27	being	be	AUX
cuesj-1229	15	28	cmv	cmv	NOUN
cuesj-1229	15	29	followed	follow	VERB
cuesj-1229	15	30	by	by	ADP
cuesj-1229	15	31	tox	tox	NOUN
cuesj-1229	15	32	and	and	CCONJ
cuesj-1229	15	33	hsv-1	hsv-1	PUNCT
cuesj-1229	15	34	and	and	CCONJ
cuesj-1229	15	35	finally	finally	ADV
cuesj-1229	15	36	hsv-2	hsv-2	NOUN
cuesj-1229	15	37	.	.	PUNCT
cuesj-1229	16	1	the	the	DET
cuesj-1229	16	2	positive	positive	ADJ
cuesj-1229	16	3	igg	igg	NOUN
cuesj-1229	16	4	results	result	NOUN
cuesj-1229	16	5	of	of	ADP
cuesj-1229	16	6	rubella	rubella	NOUN
cuesj-1229	16	7	are	be	AUX
cuesj-1229	16	8	most	most	ADV
cuesj-1229	16	9	probably	probably	ADV
cuesj-1229	16	10	due	due	ADP
cuesj-1229	16	11	to	to	ADP
cuesj-1229	16	12	the	the	DET
cuesj-1229	16	13	obligatory	obligatory	ADJ
cuesj-1229	16	14	vaccination	vaccination	NOUN
cuesj-1229	16	15	program	program	NOUN
cuesj-1229	16	16	for	for	ADP
cuesj-1229	16	17	females	female	NOUN
cuesj-1229	16	18	.	.	PUNCT
cuesj-1229	17	1	despite	despite	SCONJ
cuesj-1229	17	2	the	the	DET
cuesj-1229	17	3	fact	fact	NOUN
cuesj-1229	17	4	that	that	SCONJ
cuesj-1229	17	5	the	the	DET
cuesj-1229	17	6	majority	majority	NOUN
cuesj-1229	17	7	of	of	ADP
cuesj-1229	17	8	positive	positive	ADJ
cuesj-1229	17	9	cases	case	NOUN
cuesj-1229	17	10	were	be	AUX
cuesj-1229	17	11	for	for	ADP
cuesj-1229	17	12	igg	igg	PROPN
cuesj-1229	17	13	,	,	PUNCT
cuesj-1229	17	14	enhancing	enhance	VERB
cuesj-1229	17	15	vaccination	vaccination	NOUN
cuesj-1229	17	16	efforts	effort	NOUN
cuesj-1229	17	17	and	and	CCONJ
cuesj-1229	17	18	providing	provide	VERB
cuesj-1229	17	19	comprehensive	comprehensive	ADJ
cuesj-1229	17	20	health	health	NOUN
cuesj-1229	17	21	education	education	NOUN
cuesj-1229	17	22	is	be	AUX
cuesj-1229	17	23	crucial	crucial	ADJ
cuesj-1229	17	24	for	for	ADP
cuesj-1229	17	25	enhancing	enhance	VERB
cuesj-1229	17	26	the	the	DET
cuesj-1229	17	27	well	well	ADV
cuesj-1229	17	28	-	-	PUNCT
cuesj-1229	17	29	being	being	NOUN
cuesj-1229	17	30	of	of	ADP
cuesj-1229	17	31	the	the	DET
cuesj-1229	17	32	erbil	erbil	PROPN
cuesj-1229	17	33	population	population	NOUN
cuesj-1229	17	34	.	.	PUNCT
cuesj-1229	18	1	keywords	keyword	NOUN
cuesj-1229	18	2	:	:	PUNCT
cuesj-1229	18	3	torch	torch	NOUN
cuesj-1229	18	4	,	,	PUNCT
cuesj-1229	18	5	epidemiology	epidemiology	NOUN
cuesj-1229	18	6	,	,	PUNCT
cuesj-1229	18	7	transmission	transmission	NOUN
cuesj-1229	18	8	,	,	PUNCT
cuesj-1229	18	9	prevalence	prevalence	NOUN
cuesj-1229	18	10	,	,	PUNCT
cuesj-1229	18	11	infectious	infectious	ADJ
cuesj-1229	18	12	diseases	disease	NOUN
cuesj-1229	18	13	introduction	introduction	NOUN
cuesj-1229	18	14	torch	torch	NOUN
cuesj-1229	18	15	stands	stand	VERB
cuesj-1229	18	16	for	for	ADP
cuesj-1229	18	17	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	18	18	,	,	PUNCT
cuesj-1229	18	19	rubella	rubella	NOUN
cuesj-1229	18	20	,	,	PUNCT
cuesj-1229	18	21	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	18	22	(	(	PUNCT
cuesj-1229	18	23	cmv	cmv	NOUN
cuesj-1229	18	24	)	)	PUNCT
cuesj-1229	18	25	,	,	PUNCT
cuesj-1229	18	26	and	and	CCONJ
cuesj-1229	18	27	herpes	herpe	NOUN
cuesj-1229	18	28	simplex	simplex	NOUN
cuesj-1229	18	29	virus	virus	NOUN
cuesj-1229	18	30	(	(	PUNCT
cuesj-1229	18	31	hsv	hsv	PROPN
cuesj-1229	18	32	)	)	PUNCT
cuesj-1229	18	33	,	,	PUNCT
cuesj-1229	18	34	which	which	PRON
cuesj-1229	18	35	are	be	AUX
cuesj-1229	18	36	four	four	NUM
cuesj-1229	18	37	well	well	ADV
cuesj-1229	18	38	-	-	PUNCT
cuesj-1229	18	39	known	know	VERB
cuesj-1229	18	40	causes	cause	NOUN
cuesj-1229	18	41	of	of	ADP
cuesj-1229	18	42	prenatal	prenatal	ADJ
cuesj-1229	18	43	illnesses	illness	NOUN
cuesj-1229	18	44	.	.	PUNCT
cuesj-1229	19	1	after	after	SCONJ
cuesj-1229	19	2	pregnancy	pregnancy	NOUN
cuesj-1229	19	3	ultrasound	ultrasound	NOUN
cuesj-1229	19	4	abnormalities	abnormality	NOUN
cuesj-1229	19	5	are	be	AUX
cuesj-1229	19	6	found	find	VERB
cuesj-1229	19	7	,	,	PUNCT
cuesj-1229	19	8	a	a	DET
cuesj-1229	19	9	torch	torch	NOUN
cuesj-1229	19	10	serology	serology	NOUN
cuesj-1229	19	11	panel	panel	NOUN
cuesj-1229	19	12	is	be	AUX
cuesj-1229	19	13	often	often	ADV
cuesj-1229	19	14	utilized	utilize	VERB
cuesj-1229	19	15	for	for	ADP
cuesj-1229	19	16	testing	test	VERB
cuesj-1229	19	17	maternal	maternal	ADJ
cuesj-1229	19	18	primary	primary	ADJ
cuesj-1229	19	19	infections.[1	infections.[1	NOUN
cuesj-1229	19	20	]	]	X
cuesj-1229	19	21	early	early	ADJ
cuesj-1229	19	22	recognition	recognition	NOUN
cuesj-1229	19	23	and	and	CCONJ
cuesj-1229	19	24	management	management	NOUN
cuesj-1229	19	25	of	of	ADP
cuesj-1229	19	26	congenital	congenital	ADJ
cuesj-1229	19	27	infections	infection	NOUN
cuesj-1229	19	28	is	be	AUX
cuesj-1229	19	29	important.[2	important.[2	ADV
cuesj-1229	19	30	]	]	PUNCT
cuesj-1229	19	31	however	however	ADV
cuesj-1229	19	32	,	,	PUNCT
cuesj-1229	19	33	most	most	ADJ
cuesj-1229	19	34	torch	torch	NOUN
cuesj-1229	19	35	infections	infection	NOUN
cuesj-1229	19	36	,	,	PUNCT
cuesj-1229	19	37	including	include	VERB
cuesj-1229	19	38	toxoplasma	toxoplasma	NOUN
cuesj-1229	19	39	gondii	gondii	NOUN
cuesj-1229	19	40	(	(	PUNCT
cuesj-1229	19	41	tox	tox	NOUN
cuesj-1229	19	42	)	)	PUNCT
cuesj-1229	19	43	,	,	PUNCT
cuesj-1229	19	44	rubella	rubella	NOUN
cuesj-1229	19	45	virus	virus	NOUN
cuesj-1229	19	46	(	(	PUNCT
cuesj-1229	19	47	rv	rv	NOUN
cuesj-1229	19	48	)	)	PUNCT
cuesj-1229	19	49	,	,	PUNCT
cuesj-1229	19	50	cmv	cmv	NOUN
cuesj-1229	19	51	,	,	PUNCT
cuesj-1229	19	52	and	and	CCONJ
cuesj-1229	19	53	hsv	hsv	PROPN
cuesj-1229	19	54	,	,	PUNCT
cuesj-1229	19	55	are	be	AUX
cuesj-1229	19	56	often	often	ADV
cuesj-1229	19	57	unnoticed	unnoticed	ADJ
cuesj-1229	19	58	and	and	CCONJ
cuesj-1229	19	59	pose	pose	VERB
cuesj-1229	19	60	diagnostic	diagnostic	ADJ
cuesj-1229	19	61	challenges	challenge	NOUN
cuesj-1229	19	62	due	due	ADP
cuesj-1229	19	63	to	to	ADP
cuesj-1229	19	64	their	their	PRON
cuesj-1229	19	65	frequently	frequently	ADV
cuesj-1229	19	66	asymptomatic	asymptomatic	ADJ
cuesj-1229	19	67	nature	nature	NOUN
cuesj-1229	19	68	and	and	CCONJ
cuesj-1229	19	69	moderate	moderate	ADJ
cuesj-1229	19	70	to	to	PART
cuesj-1229	19	71	mild	mild	ADJ
cuesj-1229	19	72	pathogenicity.[3	pathogenicity.[3	NOUN
cuesj-1229	19	73	]	]	PUNCT
cuesj-1229	19	74	assessing	assess	VERB
cuesj-1229	19	75	antibodies	antibody	NOUN
cuesj-1229	19	76	against	against	ADP
cuesj-1229	19	77	torch	torch	NOUN
cuesj-1229	19	78	antigens	antigen	NOUN
cuesj-1229	19	79	early	early	ADV
cuesj-1229	19	80	in	in	ADP
cuesj-1229	19	81	pregnancy	pregnancy	NOUN
cuesj-1229	19	82	improves	improve	VERB
cuesj-1229	19	83	the	the	DET
cuesj-1229	19	84	evaluation	evaluation	NOUN
cuesj-1229	19	85	of	of	ADP
cuesj-1229	19	86	both	both	PRON
cuesj-1229	19	87	maternal	maternal	ADJ
cuesj-1229	19	88	immunological	immunological	ADJ
cuesj-1229	19	89	state	state	NOUN
cuesj-1229	19	90	and	and	CCONJ
cuesj-1229	19	91	the	the	DET
cuesj-1229	19	92	related	related	ADJ
cuesj-1229	19	93	risks	risk	NOUN
cuesj-1229	19	94	of	of	ADP
cuesj-1229	19	95	negative	negative	ADJ
cuesj-1229	19	96	pregnancy	pregnancy	NOUN
cuesj-1229	19	97	outcomes.[4	outcomes.[4	X
cuesj-1229	19	98	]	]	X
cuesj-1229	19	99	maternal	maternal	ADJ
cuesj-1229	19	100	risk	risk	NOUN
cuesj-1229	19	101	factors	factor	NOUN
cuesj-1229	19	102	include	include	VERB
cuesj-1229	19	103	missed	miss	VERB
cuesj-1229	19	104	immunizations	immunization	NOUN
cuesj-1229	19	105	,	,	PUNCT
cuesj-1229	19	106	sexually	sexually	ADV
cuesj-1229	19	107	transmitted	transmit	VERB
cuesj-1229	19	108	diseases	disease	NOUN
cuesj-1229	19	109	,	,	PUNCT
cuesj-1229	19	110	and	and	CCONJ
cuesj-1229	19	111	exposures	exposure	NOUN
cuesj-1229	19	112	to	to	ADP
cuesj-1229	19	113	animals	animal	NOUN
cuesj-1229	19	114	during	during	ADP
cuesj-1229	19	115	pregnancy.[5	pregnancy.[5	NOUN
cuesj-1229	19	116	]	]	PUNCT
cuesj-1229	19	117	full	full	ADJ
cuesj-1229	19	118	screening	screening	NOUN
cuesj-1229	19	119	with	with	ADP
cuesj-1229	19	120	the	the	DET
cuesj-1229	19	121	torch	torch	NOUN
cuesj-1229	19	122	panel	panel	NOUN
cuesj-1229	19	123	is	be	AUX
cuesj-1229	19	124	not	not	PART
cuesj-1229	19	125	advised	advise	VERB
cuesj-1229	19	126	for	for	ADP
cuesj-1229	19	127	low	low	ADJ
cuesj-1229	19	128	-	-	PUNCT
cuesj-1229	19	129	risk	risk	NOUN
cuesj-1229	19	130	,	,	PUNCT
cuesj-1229	19	131	asymptomatic	asymptomatic	ADJ
cuesj-1229	19	132	expectant	expectant	ADJ
cuesj-1229	19	133	mothers.[6	mothers.[6	X
cuesj-1229	19	134	]	]	X
cuesj-1229	19	135	pregnant	pregnant	ADJ
cuesj-1229	19	136	women	woman	NOUN
cuesj-1229	19	137	without	without	ADP
cuesj-1229	19	138	rubella	rubella	NOUN
cuesj-1229	19	139	immunity	immunity	NOUN
cuesj-1229	19	140	are	be	AUX
cuesj-1229	19	141	at	at	ADP
cuesj-1229	19	142	an	an	DET
cuesj-1229	19	143	increased	increase	VERB
cuesj-1229	19	144	risk	risk	NOUN
cuesj-1229	19	145	of	of	ADP
cuesj-1229	19	146	congenital	congenital	ADJ
cuesj-1229	19	147	rubella	rubella	NOUN
cuesj-1229	19	148	infection.[7	infection.[7	X
cuesj-1229	19	149	]	]	PUNCT
cuesj-1229	19	150	in	in	ADP
cuesj-1229	19	151	addition	addition	NOUN
cuesj-1229	19	152	to	to	ADP
cuesj-1229	19	153	providing	provide	VERB
cuesj-1229	19	154	comprehensive	comprehensive	ADJ
cuesj-1229	19	155	medical	medical	ADJ
cuesj-1229	19	156	information	information	NOUN
cuesj-1229	19	157	regarding	regard	VERB
cuesj-1229	19	158	hospitalized	hospitalize	VERB
cuesj-1229	19	159	children	child	NOUN
cuesj-1229	19	160	,	,	PUNCT
cuesj-1229	19	161	this	this	DET
cuesj-1229	19	162	study	study	NOUN
cuesj-1229	19	163	concentrates	concentrate	VERB
cuesj-1229	19	164	on	on	ADP
cuesj-1229	19	165	the	the	DET
cuesj-1229	19	166	general	general	ADJ
cuesj-1229	19	167	screening	screening	NOUN
cuesj-1229	19	168	of	of	ADP
cuesj-1229	19	169	torch	torch	NOUN
cuesj-1229	19	170	in	in	ADP
cuesj-1229	19	171	women	woman	NOUN
cuesj-1229	19	172	of	of	ADP
cuesj-1229	19	173	reproductive	reproductive	ADJ
cuesj-1229	19	174	age	age	NOUN
cuesj-1229	19	175	,	,	PUNCT
cuesj-1229	19	176	while	while	SCONJ
cuesj-1229	19	177	congenital	congenital	ADJ
cuesj-1229	19	178	and	and	CCONJ
cuesj-1229	19	179	perinatal	perinatal	ADJ
cuesj-1229	19	180	torch	torch	NOUN
cuesj-1229	19	181	infections	infection	NOUN
cuesj-1229	19	182	are	be	AUX
cuesj-1229	19	183	not	not	PART
cuesj-1229	19	184	covered	cover	VERB
cuesj-1229	19	185	.	.	PUNCT
cuesj-1229	20	1	[	[	X
cuesj-1229	20	2	8	8	NUM
cuesj-1229	20	3	]	]	X
cuesj-1229	20	4	precise	precise	ADJ
cuesj-1229	20	5	information	information	NOUN
cuesj-1229	20	6	on	on	ADP
cuesj-1229	20	7	the	the	DET
cuesj-1229	20	8	global	global	ADJ
cuesj-1229	20	9	,	,	PUNCT
cuesj-1229	20	10	regional	regional	ADJ
cuesj-1229	20	11	,	,	PUNCT
cuesj-1229	20	12	and	and	CCONJ
cuesj-1229	20	13	national	national	ADJ
cuesj-1229	20	14	prevalence	prevalence	NOUN
cuesj-1229	20	15	of	of	ADP
cuesj-1229	20	16	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	20	17	during	during	ADP
cuesj-1229	20	18	pregnancy	pregnancy	NOUN
cuesj-1229	20	19	is	be	AUX
cuesj-1229	20	20	needed	need	VERB
cuesj-1229	20	21	to	to	ADP
cuesj-1229	20	22	corresponding	corresponding	ADJ
cuesj-1229	20	23	author	author	NOUN
cuesj-1229	20	24	:	:	PUNCT
cuesj-1229	20	25	ameena	ameena	PROPN
cuesj-1229	20	26	s.	s.	PROPN
cuesj-1229	20	27	m.	m.	PROPN
cuesj-1229	20	28	juma	juma	PROPN
cuesj-1229	20	29	,	,	PUNCT
cuesj-1229	20	30	department	department	PROPN
cuesj-1229	20	31	of	of	ADP
cuesj-1229	20	32	medical	medical	ADJ
cuesj-1229	20	33	microbiology	microbiology	NOUN
cuesj-1229	20	34	,	,	PUNCT
cuesj-1229	20	35	college	college	NOUN
cuesj-1229	20	36	of	of	ADP
cuesj-1229	20	37	science	science	NOUN
cuesj-1229	20	38	,	,	PUNCT
cuesj-1229	20	39	cihan	cihan	VERB
cuesj-1229	20	40	university	university	NOUN
cuesj-1229	20	41	-	-	PUNCT
cuesj-1229	20	42	erbil	erbil	PROPN
cuesj-1229	20	43	,	,	PUNCT
cuesj-1229	20	44	kurdistan	kurdistan	PROPN
cuesj-1229	20	45	region	region	NOUN
cuesj-1229	20	46	,	,	PUNCT
cuesj-1229	20	47	iraq	iraq	PROPN
cuesj-1229	20	48	.	.	PUNCT
cuesj-1229	21	1	e	e	X
cuesj-1229	21	2	-	-	NOUN
cuesj-1229	21	3	mail	mail	NOUN
cuesj-1229	21	4	:	:	PUNCT
cuesj-1229	21	5	ameena.sabah@cihanuniversity.edu.iq	ameena.sabah@cihanuniversity.edu.iq	NOUN
cuesj-1229	21	6	received	receive	VERB
cuesj-1229	21	7	:	:	PUNCT
cuesj-1229	21	8	may	may	AUX
cuesj-1229	21	9	25	25	NUM
cuesj-1229	21	10	,	,	PUNCT
cuesj-1229	21	11	2024	2024	NUM
cuesj-1229	21	12	accepted	accept	VERB
cuesj-1229	21	13	:	:	PUNCT
cuesj-1229	21	14	june	june	PROPN
cuesj-1229	21	15	30	30	NUM
cuesj-1229	21	16	,	,	PUNCT
cuesj-1229	21	17	2024	2024	NUM
cuesj-1229	21	18	published	publish	VERB
cuesj-1229	21	19	:	:	PUNCT
cuesj-1229	21	20	july	july	PROPN
cuesj-1229	21	21	30	30	NUM
cuesj-1229	21	22	,	,	PUNCT
cuesj-1229	21	23	2024	2024	NUM
cuesj-1229	21	24	doi	doi	NOUN
cuesj-1229	21	25	:	:	PUNCT
cuesj-1229	21	26	10.24086	10.24086	NUM
cuesj-1229	21	27	/	/	SYM
cuesj-1229	21	28	cuesj.v8n2y2024.pp26	cuesj.v8n2y2024.pp26	ADP
cuesj-1229	21	29	-	-	SYM
cuesj-1229	21	30	30	30	NUM
cuesj-1229	21	31	copyright	copyright	NOUN
cuesj-1229	21	32	©	©	PROPN
cuesj-1229	21	33	2024	2024	NUM
cuesj-1229	21	34	ameena	ameena	PROPN
cuesj-1229	21	35	s.	s.	PROPN
cuesj-1229	21	36	m.	m.	PROPN
cuesj-1229	21	37	juma	juma	PROPN
cuesj-1229	21	38	,	,	PUNCT
cuesj-1229	21	39	kamgar	kamgar	PROPN
cuesj-1229	21	40	a.	a.	PROPN
cuesj-1229	21	41	rasul	rasul	PROPN
cuesj-1229	21	42	,	,	PUNCT
cuesj-1229	21	43	muhsin	muhsin	PROPN
cuesj-1229	21	44	h.	h.	PROPN
cuesj-1229	21	45	ubeid	ubeid	PROPN
cuesj-1229	21	46	,	,	PUNCT
cuesj-1229	21	47	shakir	shakir	PROPN
cuesj-1229	21	48	m.	m.	PROPN
cuesj-1229	21	49	al	al	PROPN
cuesj-1229	21	50	-	-	PUNCT
cuesj-1229	21	51	awqati	awqati	PROPN
cuesj-1229	21	52	,	,	PUNCT
cuesj-1229	21	53	tanya	tanya	PROPN
cuesj-1229	21	54	s.	s.	PROPN
cuesj-1229	21	55	salih	salih	PROPN
cuesj-1229	21	56	,	,	PUNCT
cuesj-1229	21	57	muhamed	muhamed	PROPN
cuesj-1229	21	58	aydin	aydin	NOUN
cuesj-1229	21	59	abbas	abbas	PROPN
cuesj-1229	21	60	.	.	PUNCT
cuesj-1229	22	1	this	this	PRON
cuesj-1229	22	2	is	be	AUX
cuesj-1229	22	3	an	an	DET
cuesj-1229	22	4	openaccess	openaccess	ADJ
cuesj-1229	22	5	article	article	NOUN
cuesj-1229	22	6	distributed	distribute	VERB
cuesj-1229	22	7	under	under	ADP
cuesj-1229	22	8	the	the	DET
cuesj-1229	22	9	creative	creative	ADJ
cuesj-1229	22	10	commons	common	NOUN
cuesj-1229	22	11	attribution	attribution	NOUN
cuesj-1229	22	12	license	license	NOUN
cuesj-1229	22	13	.	.	PUNCT
cuesj-1229	23	1	cihan	cihan	VERB
cuesj-1229	23	2	university	university	NOUN
cuesj-1229	23	3	-	-	PUNCT
cuesj-1229	23	4	erbil	erbil	PROPN
cuesj-1229	23	5	scientific	scientific	ADJ
cuesj-1229	23	6	journal	journal	NOUN
cuesj-1229	23	7	(	(	PUNCT
cuesj-1229	23	8	cuesj	cuesj	PROPN
cuesj-1229	23	9	)	)	PUNCT
cuesj-1229	23	10	juma	juma	PROPN
cuesj-1229	23	11	,	,	PUNCT
cuesj-1229	23	12	et	et	PROPN
cuesj-1229	23	13	al	al	PROPN
cuesj-1229	23	14	.	.	PROPN
cuesj-1229	23	15	:	:	PUNCT
cuesj-1229	24	1	epidemiological	epidemiological	ADJ
cuesj-1229	24	2	insights	insight	NOUN
cuesj-1229	24	3	into	into	ADP
cuesj-1229	24	4	torch	torch	NOUN
cuesj-1229	24	5	27	27	NUM
cuesj-1229	24	6	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1229	24	7	cuesj	cuesj	ADJ
cuesj-1229	24	8	2024	2024	NUM
cuesj-1229	24	9	,	,	PUNCT
cuesj-1229	24	10	8	8	NUM
cuesj-1229	24	11	(	(	PUNCT
cuesj-1229	24	12	2	2	NUM
cuesj-1229	24	13	):	):	PUNCT
cuesj-1229	24	14	26	26	NUM
cuesj-1229	24	15	-	-	SYM
cuesj-1229	24	16	30	30	NUM
cuesj-1229	24	17	treat	treat	NOUN
cuesj-1229	24	18	expectant	expectant	ADJ
cuesj-1229	24	19	mothers	mother	NOUN
cuesj-1229	24	20	with	with	ADP
cuesj-1229	24	21	the	the	DET
cuesj-1229	24	22	proper	proper	ADJ
cuesj-1229	24	23	care.[9	care.[9	NOUN
cuesj-1229	24	24	]	]	X
cuesj-1229	24	25	1863	1863	NUM
cuesj-1229	24	26	pregnant	pregnant	ADJ
cuesj-1229	24	27	individuals	individual	NOUN
cuesj-1229	24	28	were	be	AUX
cuesj-1229	24	29	studied	study	VERB
cuesj-1229	24	30	to	to	PART
cuesj-1229	24	31	determine	determine	VERB
cuesj-1229	24	32	the	the	DET
cuesj-1229	24	33	relationship	relationship	NOUN
cuesj-1229	24	34	between	between	ADP
cuesj-1229	24	35	torch	torch	NOUN
cuesj-1229	24	36	infections	infection	NOUN
cuesj-1229	24	37	and	and	CCONJ
cuesj-1229	24	38	aberrant	aberrant	ADJ
cuesj-1229	24	39	pregnancy	pregnancy	NOUN
cuesj-1229	24	40	outcomes	outcome	NOUN
cuesj-1229	24	41	.	.	PUNCT
cuesj-1229	25	1	the	the	DET
cuesj-1229	25	2	results	result	NOUN
cuesj-1229	25	3	showed	show	VERB
cuesj-1229	25	4	that	that	SCONJ
cuesj-1229	25	5	torch	torch	NOUN
cuesj-1229	25	6	infection	infection	NOUN
cuesj-1229	25	7	was	be	AUX
cuesj-1229	25	8	a	a	DET
cuesj-1229	25	9	substantial	substantial	ADJ
cuesj-1229	25	10	risk	risk	NOUN
cuesj-1229	25	11	factor	factor	NOUN
cuesj-1229	25	12	for	for	ADP
cuesj-1229	25	13	severe	severe	ADJ
cuesj-1229	25	14	fetal	fetal	ADJ
cuesj-1229	25	15	harm	harm	NOUN
cuesj-1229	25	16	in	in	ADP
cuesj-1229	25	17	china	china	PROPN
cuesj-1229	25	18	,	,	PUNCT
cuesj-1229	25	19	particularly	particularly	ADV
cuesj-1229	25	20	congenital	congenital	ADJ
cuesj-1229	25	21	deformities.[10	deformities.[10	PROPN
cuesj-1229	25	22	]	]	PUNCT
cuesj-1229	25	23	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	25	24	is	be	AUX
cuesj-1229	25	25	a	a	DET
cuesj-1229	25	26	prevalent	prevalent	ADJ
cuesj-1229	25	27	opportunistic	opportunistic	ADJ
cuesj-1229	25	28	infection	infection	NOUN
cuesj-1229	25	29	that	that	PRON
cuesj-1229	25	30	kills	kill	VERB
cuesj-1229	25	31	people	people	NOUN
cuesj-1229	25	32	who	who	PRON
cuesj-1229	25	33	are	be	AUX
cuesj-1229	25	34	immunocompromised.[11	immunocompromised.[11	PROPN
cuesj-1229	25	35	]	]	PUNCT
cuesj-1229	25	36	transplacental	transplacental	ADJ
cuesj-1229	25	37	transmission	transmission	NOUN
cuesj-1229	25	38	is	be	AUX
cuesj-1229	25	39	one	one	NUM
cuesj-1229	25	40	way	way	NOUN
cuesj-1229	25	41	that	that	PRON
cuesj-1229	25	42	a	a	DET
cuesj-1229	25	43	primary	primary	ADJ
cuesj-1229	25	44	illness	illness	NOUN
cuesj-1229	25	45	in	in	ADP
cuesj-1229	25	46	a	a	DET
cuesj-1229	25	47	pregnant	pregnant	ADJ
cuesj-1229	25	48	woman	woman	NOUN
cuesj-1229	25	49	might	might	AUX
cuesj-1229	25	50	infect	infect	VERB
cuesj-1229	25	51	the	the	DET
cuesj-1229	25	52	fetus.[12	fetus.[12	PROPN
cuesj-1229	25	53	]	]	PUNCT
cuesj-1229	25	54	congenital	congenital	ADJ
cuesj-1229	25	55	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	25	56	in	in	ADP
cuesj-1229	25	57	humans	human	NOUN
cuesj-1229	25	58	has	have	VERB
cuesj-1229	25	59	a	a	DET
cuesj-1229	25	60	relatively	relatively	ADV
cuesj-1229	25	61	high	high	ADJ
cuesj-1229	25	62	morbidity	morbidity	NOUN
cuesj-1229	25	63	rate.[13	rate.[13	PROPN
cuesj-1229	25	64	]	]	PUNCT
cuesj-1229	25	65	the	the	DET
cuesj-1229	25	66	fetus	fetus	NOUN
cuesj-1229	25	67	may	may	AUX
cuesj-1229	25	68	suffer	suffer	VERB
cuesj-1229	25	69	serious	serious	ADJ
cuesj-1229	25	70	neurological	neurological	ADJ
cuesj-1229	25	71	and	and	CCONJ
cuesj-1229	25	72	ocular	ocular	ADJ
cuesj-1229	25	73	effects	effect	NOUN
cuesj-1229	25	74	if	if	SCONJ
cuesj-1229	25	75	the	the	DET
cuesj-1229	25	76	infection	infection	NOUN
cuesj-1229	25	77	is	be	AUX
cuesj-1229	25	78	passed	pass	VERB
cuesj-1229	25	79	from	from	ADP
cuesj-1229	25	80	the	the	DET
cuesj-1229	25	81	mother	mother	NOUN
cuesj-1229	25	82	to	to	ADP
cuesj-1229	25	83	the	the	DET
cuesj-1229	25	84	unborn	unborn	ADJ
cuesj-1229	25	85	kid.[14	kid.[14	NOUN
cuesj-1229	25	86	]	]	PUNCT
cuesj-1229	25	87	a	a	DET
cuesj-1229	25	88	growing	grow	VERB
cuesj-1229	25	89	amount	amount	NOUN
cuesj-1229	25	90	of	of	ADP
cuesj-1229	25	91	data	datum	NOUN
cuesj-1229	25	92	indicates	indicate	VERB
cuesj-1229	25	93	that	that	SCONJ
cuesj-1229	25	94	tox	tox	NOUN
cuesj-1229	25	95	exposure	exposure	NOUN
cuesj-1229	25	96	is	be	AUX
cuesj-1229	25	97	decreasing	decrease	VERB
cuesj-1229	25	98	in	in	ADP
cuesj-1229	25	99	many	many	ADJ
cuesj-1229	25	100	highincome	highincome	ADJ
cuesj-1229	25	101	nations	nation	NOUN
cuesj-1229	25	102	,	,	PUNCT
cuesj-1229	25	103	but	but	CCONJ
cuesj-1229	25	104	the	the	DET
cuesj-1229	25	105	precise	precise	ADJ
cuesj-1229	25	106	causes	cause	NOUN
cuesj-1229	25	107	of	of	ADP
cuesj-1229	25	108	this	this	DET
cuesj-1229	25	109	trend	trend	NOUN
cuesj-1229	25	110	are	be	AUX
cuesj-1229	25	111	still	still	ADV
cuesj-1229	25	112	unknown.[15	unknown.[15	NOUN
cuesj-1229	25	113	]	]	PUNCT
cuesj-1229	25	114	german	german	ADJ
cuesj-1229	25	115	measles	measle	NOUN
cuesj-1229	25	116	,	,	PUNCT
cuesj-1229	25	117	sometimes	sometimes	ADV
cuesj-1229	25	118	known	know	VERB
cuesj-1229	25	119	as	as	ADP
cuesj-1229	25	120	rubella	rubella	NOUN
cuesj-1229	25	121	,	,	PUNCT
cuesj-1229	25	122	are	be	AUX
cuesj-1229	25	123	a	a	DET
cuesj-1229	25	124	virus	virus	NOUN
cuesj-1229	25	125	that	that	PRON
cuesj-1229	25	126	can	can	AUX
cuesj-1229	25	127	cause	cause	VERB
cuesj-1229	25	128	congenital	congenital	ADJ
cuesj-1229	25	129	infections	infection	NOUN
cuesj-1229	25	130	and	and	CCONJ
cuesj-1229	25	131	devastating	devastating	ADJ
cuesj-1229	25	132	outcomes	outcome	NOUN
cuesj-1229	25	133	.	.	PUNCT
cuesj-1229	26	1	for	for	ADP
cuesj-1229	26	2	this	this	DET
cuesj-1229	26	3	reason	reason	NOUN
cuesj-1229	26	4	,	,	PUNCT
cuesj-1229	26	5	pregnant	pregnant	ADJ
cuesj-1229	26	6	women	woman	NOUN
cuesj-1229	26	7	should	should	AUX
cuesj-1229	26	8	be	be	AUX
cuesj-1229	26	9	especially	especially	ADV
cuesj-1229	26	10	concerned	concerned	ADJ
cuesj-1229	26	11	about	about	ADP
cuesj-1229	26	12	this	this	DET
cuesj-1229	26	13	illness.[16	illness.[16	PROPN
cuesj-1229	26	14	]	]	PUNCT
cuesj-1229	26	15	major	major	ADJ
cuesj-1229	26	16	abnormalities	abnormality	NOUN
cuesj-1229	26	17	primarily	primarily	ADV
cuesj-1229	26	18	stem	stem	VERB
cuesj-1229	26	19	from	from	ADP
cuesj-1229	26	20	rubella	rubella	NOUN
cuesj-1229	26	21	infection	infection	NOUN
cuesj-1229	26	22	during	during	ADP
cuesj-1229	26	23	the	the	DET
cuesj-1229	26	24	initial	initial	ADJ
cuesj-1229	26	25	16	16	NUM
cuesj-1229	26	26	weeks	week	NOUN
cuesj-1229	26	27	of	of	ADP
cuesj-1229	26	28	pregnancy	pregnancy	NOUN
cuesj-1229	26	29	.	.	PUNCT
cuesj-1229	27	1	these	these	DET
cuesj-1229	27	2	abnormalities	abnormality	NOUN
cuesj-1229	27	3	encompass	encompass	VERB
cuesj-1229	27	4	deafness	deafness	NOUN
cuesj-1229	27	5	,	,	PUNCT
cuesj-1229	27	6	eye	eye	NOUN
cuesj-1229	27	7	and	and	CCONJ
cuesj-1229	27	8	cardiovascular	cardiovascular	ADJ
cuesj-1229	27	9	defects	defect	NOUN
cuesj-1229	27	10	,	,	PUNCT
cuesj-1229	27	11	central	central	ADJ
cuesj-1229	27	12	nervous	nervous	ADJ
cuesj-1229	27	13	system	system	NOUN
cuesj-1229	27	14	damage	damage	NOUN
cuesj-1229	27	15	leading	lead	VERB
cuesj-1229	27	16	to	to	ADP
cuesj-1229	27	17	intellectual	intellectual	ADJ
cuesj-1229	27	18	disability	disability	NOUN
cuesj-1229	27	19	,	,	PUNCT
cuesj-1229	27	20	and	and	CCONJ
cuesj-1229	27	21	a	a	DET
cuesj-1229	27	22	50	50	NUM
cuesj-1229	27	23	-	-	ADJ
cuesj-1229	27	24	fold	fold	ADJ
cuesj-1229	27	25	elevated	elevated	ADJ
cuesj-1229	27	26	risk	risk	NOUN
cuesj-1229	27	27	of	of	ADP
cuesj-1229	27	28	lateronset	lateronset	NOUN
cuesj-1229	27	29	type	type	NOUN
cuesj-1229	27	30	1	1	NUM
cuesj-1229	27	31	diabetes.[17	diabetes.[17	PROPN
cuesj-1229	27	32	]	]	PUNCT
cuesj-1229	27	33	cmv	cmv	NOUN
cuesj-1229	27	34	is	be	AUX
cuesj-1229	27	35	the	the	DET
cuesj-1229	27	36	most	most	ADV
cuesj-1229	27	37	common	common	ADJ
cuesj-1229	27	38	congenital	congenital	ADJ
cuesj-1229	27	39	infection.[18	infection.[18	PROPN
cuesj-1229	27	40	]	]	PUNCT
cuesj-1229	27	41	congenital	congenital	ADJ
cuesj-1229	27	42	cmv	cmv	NOUN
cuesj-1229	27	43	is	be	AUX
cuesj-1229	27	44	the	the	DET
cuesj-1229	27	45	largest	large	ADJ
cuesj-1229	27	46	cause	cause	NOUN
cuesj-1229	27	47	of	of	ADP
cuesj-1229	27	48	non	non	ADJ
cuesj-1229	27	49	-	-	ADJ
cuesj-1229	27	50	genetic	genetic	ADJ
cuesj-1229	27	51	congenital	congenital	ADJ
cuesj-1229	27	52	hearing	hearing	NOUN
cuesj-1229	27	53	loss	loss	NOUN
cuesj-1229	27	54	in	in	ADP
cuesj-1229	27	55	much	much	ADJ
cuesj-1229	27	56	of	of	ADP
cuesj-1229	27	57	the	the	DET
cuesj-1229	27	58	world	world	NOUN
cuesj-1229	27	59	,	,	PUNCT
cuesj-1229	27	60	as	as	ADV
cuesj-1229	27	61	well	well	ADV
cuesj-1229	27	62	as	as	ADP
cuesj-1229	27	63	a	a	DET
cuesj-1229	27	64	major	major	ADJ
cuesj-1229	27	65	cause	cause	NOUN
cuesj-1229	27	66	of	of	ADP
cuesj-1229	27	67	neurodevelopmental	neurodevelopmental	ADJ
cuesj-1229	27	68	disorders.[19	disorders.[19	PROPN
cuesj-1229	27	69	]	]	PUNCT
cuesj-1229	27	70	hsv	hsv	PROPN
cuesj-1229	27	71	causes	cause	VERB
cuesj-1229	27	72	both	both	CCONJ
cuesj-1229	27	73	oral	oral	ADJ
cuesj-1229	27	74	and	and	CCONJ
cuesj-1229	27	75	genital	genital	ADJ
cuesj-1229	27	76	herpes	herpe	NOUN
cuesj-1229	27	77	.	.	PUNCT
cuesj-1229	28	1	hsv	hsv	PROPN
cuesj-1229	28	2	could	could	AUX
cuesj-1229	28	3	be	be	AUX
cuesj-1229	28	4	passed	pass	VERB
cuesj-1229	28	5	to	to	ADP
cuesj-1229	28	6	the	the	DET
cuesj-1229	28	7	fetus	fetus	NOUN
cuesj-1229	28	8	,	,	PUNCT
cuesj-1229	28	9	and	and	CCONJ
cuesj-1229	28	10	hsv	hsv	PROPN
cuesj-1229	28	11	on	on	ADP
cuesj-1229	28	12	an	an	DET
cuesj-1229	28	13	embryo	embryo	NOUN
cuesj-1229	28	14	may	may	AUX
cuesj-1229	28	15	cause	cause	VERB
cuesj-1229	28	16	a	a	DET
cuesj-1229	28	17	variety	variety	NOUN
cuesj-1229	28	18	of	of	ADP
cuesj-1229	28	19	clinical	clinical	ADJ
cuesj-1229	28	20	consequences	consequence	NOUN
cuesj-1229	28	21	,	,	PUNCT
cuesj-1229	28	22	including	include	VERB
cuesj-1229	28	23	ventriculomegaly	ventriculomegaly	ADJ
cuesj-1229	28	24	,	,	PUNCT
cuesj-1229	28	25	microcephaly	microcephaly	NOUN
cuesj-1229	28	26	,	,	PUNCT
cuesj-1229	28	27	intracerebral	intracerebral	ADJ
cuesj-1229	28	28	calcifications	calcification	NOUN
cuesj-1229	28	29	,	,	PUNCT
cuesj-1229	28	30	limb	limb	NOUN
cuesj-1229	28	31	dysplasia	dysplasia	NOUN
cuesj-1229	28	32	,	,	PUNCT
cuesj-1229	28	33	eye	eye	NOUN
cuesj-1229	28	34	problems	problem	NOUN
cuesj-1229	28	35	,	,	PUNCT
cuesj-1229	28	36	and	and	CCONJ
cuesj-1229	28	37	fetal	fetal	ADJ
cuesj-1229	28	38	loss.[20	loss.[20	PROPN
cuesj-1229	28	39	]	]	PUNCT
cuesj-1229	28	40	all	all	DET
cuesj-1229	28	41	the	the	DET
cuesj-1229	28	42	previously	previously	ADV
cuesj-1229	28	43	mentioned	mention	VERB
cuesj-1229	28	44	results	result	NOUN
cuesj-1229	28	45	have	have	AUX
cuesj-1229	28	46	been	be	AUX
cuesj-1229	28	47	among	among	ADP
cuesj-1229	28	48	childbearing	childbeare	VERB
cuesj-1229	28	49	women	woman	NOUN
cuesj-1229	28	50	.	.	PUNCT
cuesj-1229	29	1	however	however	ADV
cuesj-1229	29	2	,	,	PUNCT
cuesj-1229	29	3	scarce	scarce	ADJ
cuesj-1229	29	4	data	datum	NOUN
cuesj-1229	29	5	are	be	AUX
cuesj-1229	29	6	available	available	ADJ
cuesj-1229	29	7	regarding	regard	VERB
cuesj-1229	29	8	torch	torch	NOUN
cuesj-1229	29	9	among	among	ADP
cuesj-1229	29	10	the	the	DET
cuesj-1229	29	11	normal	normal	ADJ
cuesj-1229	29	12	population	population	NOUN
cuesj-1229	29	13	,	,	PUNCT
cuesj-1229	29	14	including	include	VERB
cuesj-1229	29	15	males	male	NOUN
cuesj-1229	29	16	who	who	PRON
cuesj-1229	29	17	may	may	AUX
cuesj-1229	29	18	be	be	AUX
cuesj-1229	29	19	a	a	DET
cuesj-1229	29	20	source	source	NOUN
cuesj-1229	29	21	of	of	ADP
cuesj-1229	29	22	infection	infection	NOUN
cuesj-1229	29	23	to	to	ADP
cuesj-1229	29	24	females	female	NOUN
cuesj-1229	29	25	,	,	PUNCT
cuesj-1229	29	26	especially	especially	ADV
cuesj-1229	29	27	in	in	ADP
cuesj-1229	29	28	erbil	erbil	PROPN
cuesj-1229	29	29	city	city	PROPN
cuesj-1229	29	30	.	.	PUNCT
cuesj-1229	30	1	thus	thus	ADV
cuesj-1229	30	2	,	,	PUNCT
cuesj-1229	30	3	the	the	DET
cuesj-1229	30	4	purpose	purpose	NOUN
cuesj-1229	30	5	of	of	ADP
cuesj-1229	30	6	this	this	DET
cuesj-1229	30	7	study	study	NOUN
cuesj-1229	30	8	was	be	AUX
cuesj-1229	30	9	to	to	PART
cuesj-1229	30	10	determine	determine	VERB
cuesj-1229	30	11	the	the	DET
cuesj-1229	30	12	prevalence	prevalence	NOUN
cuesj-1229	30	13	of	of	ADP
cuesj-1229	30	14	torch	torch	NOUN
cuesj-1229	30	15	among	among	ADP
cuesj-1229	30	16	inhabitants	inhabitant	NOUN
cuesj-1229	30	17	of	of	ADP
cuesj-1229	30	18	erbil	erbil	PROPN
cuesj-1229	30	19	city	city	PROPN
cuesj-1229	30	20	and	and	CCONJ
cuesj-1229	30	21	the	the	DET
cuesj-1229	30	22	possible	possible	ADJ
cuesj-1229	30	23	risk	risk	NOUN
cuesj-1229	30	24	factors	factor	NOUN
cuesj-1229	30	25	that	that	PRON
cuesj-1229	30	26	lead	lead	VERB
cuesj-1229	30	27	to	to	ADP
cuesj-1229	30	28	these	these	DET
cuesj-1229	30	29	infections	infection	NOUN
cuesj-1229	30	30	.	.	PUNCT
cuesj-1229	31	1	methodology	methodology	NOUN
cuesj-1229	31	2	508	508	NUM
cuesj-1229	31	3	blood	blood	NOUN
cuesj-1229	31	4	samples	sample	NOUN
cuesj-1229	31	5	were	be	AUX
cuesj-1229	31	6	collected	collect	VERB
cuesj-1229	31	7	from	from	ADP
cuesj-1229	31	8	randomly	randomly	ADV
cuesj-1229	31	9	selected	select	VERB
cuesj-1229	31	10	individuals	individual	NOUN
cuesj-1229	31	11	living	live	VERB
cuesj-1229	31	12	in	in	ADP
cuesj-1229	31	13	erbil	erbil	PROPN
cuesj-1229	31	14	city	city	PROPN
cuesj-1229	31	15	.	.	PUNCT
cuesj-1229	32	1	all	all	PRON
cuesj-1229	32	2	of	of	ADP
cuesj-1229	32	3	them	they	PRON
cuesj-1229	32	4	were	be	AUX
cuesj-1229	32	5	apparently	apparently	ADV
cuesj-1229	32	6	healthy	healthy	ADJ
cuesj-1229	32	7	and	and	CCONJ
cuesj-1229	32	8	had	have	VERB
cuesj-1229	32	9	no	no	DET
cuesj-1229	32	10	chronic	chronic	ADJ
cuesj-1229	32	11	illnesses	illness	NOUN
cuesj-1229	32	12	.	.	PUNCT
cuesj-1229	33	1	the	the	DET
cuesj-1229	33	2	samples	sample	NOUN
cuesj-1229	33	3	were	be	AUX
cuesj-1229	33	4	collected	collect	VERB
cuesj-1229	33	5	during	during	ADP
cuesj-1229	33	6	the	the	DET
cuesj-1229	33	7	period	period	NOUN
cuesj-1229	33	8	of	of	ADP
cuesj-1229	33	9	june	june	PROPN
cuesj-1229	33	10	2021	2021	NUM
cuesj-1229	33	11	and	and	CCONJ
cuesj-1229	33	12	june	june	PROPN
cuesj-1229	33	13	2023	2023	NUM
cuesj-1229	33	14	.	.	PUNCT
cuesj-1229	34	1	each	each	DET
cuesj-1229	34	2	individual	individual	NOUN
cuesj-1229	34	3	provided	provide	VERB
cuesj-1229	34	4	verbal	verbal	ADJ
cuesj-1229	34	5	consent	consent	NOUN
cuesj-1229	34	6	.	.	PUNCT
cuesj-1229	35	1	each	each	DET
cuesj-1229	35	2	person	person	NOUN
cuesj-1229	35	3	had	have	VERB
cuesj-1229	35	4	5	5	NUM
cuesj-1229	35	5	ml	ml	NOUN
cuesj-1229	35	6	of	of	ADP
cuesj-1229	35	7	blood	blood	NOUN
cuesj-1229	35	8	withdrawn	withdraw	VERB
cuesj-1229	35	9	from	from	ADP
cuesj-1229	35	10	them	they	PRON
cuesj-1229	35	11	and	and	CCONJ
cuesj-1229	35	12	transferred	transfer	VERB
cuesj-1229	35	13	into	into	ADP
cuesj-1229	35	14	a	a	DET
cuesj-1229	35	15	gel	gel	NOUN
cuesj-1229	35	16	tube	tube	NOUN
cuesj-1229	35	17	to	to	PART
cuesj-1229	35	18	separate	separate	VERB
cuesj-1229	35	19	the	the	DET
cuesj-1229	35	20	serum	serum	NOUN
cuesj-1229	35	21	.	.	PUNCT
cuesj-1229	36	1	centrifugation	centrifugation	NOUN
cuesj-1229	36	2	was	be	AUX
cuesj-1229	36	3	used	use	VERB
cuesj-1229	36	4	to	to	PART
cuesj-1229	36	5	separate	separate	VERB
cuesj-1229	36	6	the	the	DET
cuesj-1229	36	7	serum	serum	NOUN
cuesj-1229	36	8	for	for	ADP
cuesj-1229	36	9	10	10	NUM
cuesj-1229	36	10	min	min	NOUN
cuesj-1229	36	11	at	at	ADP
cuesj-1229	36	12	2200–2500	2200–2500	NUM
cuesj-1229	36	13	revolutions	revolution	NOUN
cuesj-1229	36	14	per	per	ADP
cuesj-1229	36	15	minute	minute	NOUN
cuesj-1229	36	16	.	.	PUNCT
cuesj-1229	37	1	torch	torch	NOUN
cuesj-1229	37	2	testing	testing	NOUN
cuesj-1229	37	3	was	be	AUX
cuesj-1229	37	4	conducted	conduct	VERB
cuesj-1229	37	5	on	on	ADP
cuesj-1229	37	6	the	the	DET
cuesj-1229	37	7	serum	serum	NOUN
cuesj-1229	37	8	samples	sample	NOUN
cuesj-1229	37	9	to	to	PART
cuesj-1229	37	10	identify	identify	VERB
cuesj-1229	37	11	specific	specific	ADJ
cuesj-1229	37	12	immunoglobulin	immunoglobulin	NOUN
cuesj-1229	37	13	g	g	PROPN
cuesj-1229	37	14	(	(	PUNCT
cuesj-1229	37	15	igg	igg	PROPN
cuesj-1229	37	16	)	)	PUNCT
cuesj-1229	37	17	and	and	CCONJ
cuesj-1229	37	18	immunoglobulin	immunoglobulin	NOUN
cuesj-1229	37	19	m	m	PROPN
cuesj-1229	37	20	(	(	PUNCT
cuesj-1229	37	21	igm	igm	PROPN
cuesj-1229	37	22	)	)	PUNCT
cuesj-1229	37	23	antibodies	antibodie	VERB
cuesj-1229	37	24	,	,	PUNCT
cuesj-1229	37	25	employing	employ	VERB
cuesj-1229	37	26	an	an	DET
cuesj-1229	37	27	accessible	accessible	ADJ
cuesj-1229	37	28	commercial	commercial	ADJ
cuesj-1229	37	29	rapid	rapid	ADJ
cuesj-1229	37	30	strip	strip	NOUN
cuesj-1229	37	31	test	test	NOUN
cuesj-1229	37	32	(	(	PUNCT
cuesj-1229	37	33	qingdao	qingdao	PROPN
cuesj-1229	37	34	hightop	hightop	PROPN
cuesj-1229	37	35	biotech	biotech	PROPN
cuesj-1229	37	36	co.	co.	PROPN
cuesj-1229	37	37	ltd	ltd	PROPN
cuesj-1229	37	38	.	.	PROPN
cuesj-1229	37	39	,	,	PUNCT
cuesj-1229	37	40	china	china	PROPN
cuesj-1229	37	41	)	)	PUNCT
cuesj-1229	37	42	,	,	PUNCT
cuesj-1229	37	43	following	follow	VERB
cuesj-1229	37	44	the	the	DET
cuesj-1229	37	45	instructions	instruction	NOUN
cuesj-1229	37	46	of	of	ADP
cuesj-1229	37	47	the	the	DET
cuesj-1229	37	48	manufacturer	manufacturer	NOUN
cuesj-1229	37	49	.	.	PUNCT
cuesj-1229	38	1	to	to	PART
cuesj-1229	38	2	analyze	analyze	VERB
cuesj-1229	38	3	the	the	DET
cuesj-1229	38	4	torch	torch	NOUN
cuesj-1229	38	5	igg	igg	PROPN
cuesj-1229	38	6	and	and	CCONJ
cuesj-1229	38	7	igm	igm	PROPN
cuesj-1229	38	8	results	result	NOUN
cuesj-1229	38	9	,	,	PUNCT
cuesj-1229	38	10	the	the	DET
cuesj-1229	38	11	data	datum	NOUN
cuesj-1229	38	12	were	be	AUX
cuesj-1229	38	13	entered	enter	VERB
cuesj-1229	38	14	into	into	ADP
cuesj-1229	38	15	the	the	DET
cuesj-1229	38	16	statistical	statistical	ADJ
cuesj-1229	38	17	package	package	NOUN
cuesj-1229	38	18	for	for	ADP
cuesj-1229	38	19	the	the	DET
cuesj-1229	38	20	social	social	ADJ
cuesj-1229	38	21	sciences	sciences	PROPN
cuesj-1229	38	22	version	version	PROPN
cuesj-1229	38	23	22	22	NUM
cuesj-1229	38	24	(	(	PUNCT
cuesj-1229	38	25	ibm	ibm	PROPN
cuesj-1229	38	26	corp	corp	PROPN
cuesj-1229	38	27	.	.	PROPN
cuesj-1229	38	28	,	,	PUNCT
cuesj-1229	38	29	armonk	armonk	PROPN
cuesj-1229	38	30	,	,	PUNCT
cuesj-1229	38	31	ny	ny	PROPN
cuesj-1229	38	32	,	,	PUNCT
cuesj-1229	38	33	usa	usa	PROPN
cuesj-1229	38	34	)	)	PUNCT
cuesj-1229	38	35	.	.	PUNCT
cuesj-1229	39	1	a	a	DET
cuesj-1229	39	2	5	5	NUM
cuesj-1229	39	3	%	%	NOUN
cuesj-1229	39	4	threshold	threshold	NOUN
cuesj-1229	39	5	for	for	ADP
cuesj-1229	39	6	significance	significance	NOUN
cuesj-1229	39	7	was	be	AUX
cuesj-1229	39	8	established	establish	VERB
cuesj-1229	39	9	,	,	PUNCT
cuesj-1229	39	10	meaning	mean	VERB
cuesj-1229	39	11	that	that	SCONJ
cuesj-1229	39	12	a	a	DET
cuesj-1229	39	13	p	p	X
cuesj-1229	39	14	<	<	X
cuesj-1229	39	15	0.05	0.05	NUM
cuesj-1229	39	16	was	be	AUX
cuesj-1229	39	17	considered	consider	VERB
cuesj-1229	39	18	statistically	statistically	ADV
cuesj-1229	39	19	significant	significant	ADJ
cuesj-1229	39	20	.	.	PUNCT
cuesj-1229	40	1	results	result	NOUN
cuesj-1229	40	2	there	there	PRON
cuesj-1229	40	3	were	be	VERB
cuesj-1229	40	4	508	508	NUM
cuesj-1229	40	5	participants	participant	NOUN
cuesj-1229	40	6	in	in	ADP
cuesj-1229	40	7	this	this	DET
cuesj-1229	40	8	study	study	NOUN
cuesj-1229	40	9	.	.	PUNCT
cuesj-1229	41	1	of	of	ADP
cuesj-1229	41	2	the	the	DET
cuesj-1229	41	3	508	508	NUM
cuesj-1229	41	4	,	,	PUNCT
cuesj-1229	41	5	218	218	NUM
cuesj-1229	41	6	(	(	PUNCT
cuesj-1229	41	7	42.91	42.91	NUM
cuesj-1229	41	8	%	%	NOUN
cuesj-1229	41	9	)	)	PUNCT
cuesj-1229	41	10	were	be	AUX
cuesj-1229	41	11	females	female	NOUN
cuesj-1229	41	12	and	and	CCONJ
cuesj-1229	41	13	290	290	NUM
cuesj-1229	41	14	(	(	PUNCT
cuesj-1229	41	15	57.09	57.09	NUM
cuesj-1229	41	16	%	%	NOUN
cuesj-1229	41	17	)	)	PUNCT
cuesj-1229	41	18	were	be	AUX
cuesj-1229	41	19	males	male	NOUN
cuesj-1229	42	1	[	[	X
cuesj-1229	42	2	table	table	NOUN
cuesj-1229	42	3	1	1	NUM
cuesj-1229	42	4	]	]	PUNCT
cuesj-1229	42	5	.	.	PUNCT
cuesj-1229	43	1	the	the	DET
cuesj-1229	43	2	ages	age	NOUN
cuesj-1229	43	3	ranged	range	VERB
cuesj-1229	43	4	from	from	ADP
cuesj-1229	43	5	13	13	NUM
cuesj-1229	43	6	to	to	PART
cuesj-1229	43	7	63	63	NUM
cuesj-1229	43	8	year	year	NOUN
cuesj-1229	43	9	,	,	PUNCT
cuesj-1229	43	10	the	the	DET
cuesj-1229	43	11	majority	majority	NOUN
cuesj-1229	43	12	being	be	AUX
cuesj-1229	43	13	within	within	ADP
cuesj-1229	43	14	(	(	PUNCT
cuesj-1229	43	15	21–30	21–30	NUM
cuesj-1229	43	16	years	year	NOUN
cuesj-1229	43	17	)	)	PUNCT
cuesj-1229	43	18	,	,	PUNCT
cuesj-1229	43	19	162	162	NUM
cuesj-1229	43	20	(	(	PUNCT
cuesj-1229	43	21	31.89	31.89	NUM
cuesj-1229	43	22	%	%	NOUN
cuesj-1229	43	23	)	)	PUNCT
cuesj-1229	44	1	(	(	PUNCT
cuesj-1229	44	2	p	p	X
cuesj-1229	44	3	<	<	X
cuesj-1229	44	4	0.05	0.05	NUM
cuesj-1229	44	5	)	)	PUNCT
cuesj-1229	45	1	[	[	X
cuesj-1229	45	2	table	table	NOUN
cuesj-1229	45	3	2	2	NUM
cuesj-1229	45	4	]	]	PUNCT
cuesj-1229	45	5	.	.	PUNCT
cuesj-1229	46	1	20	20	NUM
cuesj-1229	46	2	individuals	individual	NOUN
cuesj-1229	46	3	(	(	PUNCT
cuesj-1229	46	4	3.94	3.94	NUM
cuesj-1229	46	5	%	%	NOUN
cuesj-1229	46	6	)	)	PUNCT
cuesj-1229	46	7	(	(	PUNCT
cuesj-1229	46	8	8	8	NUM
cuesj-1229	46	9	[	[	SYM
cuesj-1229	46	10	40	40	NUM
cuesj-1229	46	11	%	%	NOUN
cuesj-1229	46	12	]	]	PUNCT
cuesj-1229	46	13	females	female	NOUN
cuesj-1229	46	14	and	and	CCONJ
cuesj-1229	46	15	12	12	NUM
cuesj-1229	46	16	[	[	SYM
cuesj-1229	46	17	60	60	NUM
cuesj-1229	46	18	%	%	NOUN
cuesj-1229	46	19	]	]	PUNCT
cuesj-1229	46	20	males	male	NOUN
cuesj-1229	46	21	)	)	PUNCT
cuesj-1229	46	22	tested	test	VERB
cuesj-1229	46	23	positive	positive	ADJ
cuesj-1229	46	24	for	for	ADP
cuesj-1229	46	25	anti	anti	ADJ
cuesj-1229	46	26	-	-	ADJ
cuesj-1229	46	27	tox	tox	ADJ
cuesj-1229	46	28	igg	igg	PROPN
cuesj-1229	46	29	antibodies	antibodie	VERB
cuesj-1229	46	30	(	(	PUNCT
cuesj-1229	46	31	one	one	NUM
cuesj-1229	46	32	of	of	ADP
cuesj-1229	46	33	20	20	NUM
cuesj-1229	46	34	[	[	SYM
cuesj-1229	46	35	5	5	NUM
cuesj-1229	46	36	%	%	NOUN
cuesj-1229	46	37	]	]	PUNCT
cuesj-1229	46	38	18	18	NUM
cuesj-1229	46	39	years	year	NOUN
cuesj-1229	46	40	old	old	ADJ
cuesj-1229	46	41	,	,	PUNCT
cuesj-1229	46	42	3	3	NUM
cuesj-1229	46	43	of	of	ADP
cuesj-1229	46	44	20	20	NUM
cuesj-1229	46	45	[	[	SYM
cuesj-1229	46	46	15	15	NUM
cuesj-1229	46	47	%	%	NOUN
cuesj-1229	46	48	]	]	PUNCT
cuesj-1229	46	49	were	be	AUX
cuesj-1229	46	50	[	[	X
cuesj-1229	46	51	21–30	21–30	NUM
cuesj-1229	46	52	years	year	NOUN
cuesj-1229	46	53	]	]	PUNCT
cuesj-1229	46	54	,	,	PUNCT
cuesj-1229	46	55	14	14	NUM
cuesj-1229	46	56	of	of	ADP
cuesj-1229	46	57	20	20	NUM
cuesj-1229	46	58	[	[	SYM
cuesj-1229	46	59	70	70	NUM
cuesj-1229	46	60	%	%	NOUN
cuesj-1229	46	61	]	]	PUNCT
cuesj-1229	46	62	were	be	AUX
cuesj-1229	46	63	[	[	X
cuesj-1229	46	64	31–40	31–40	NUM
cuesj-1229	46	65	years	year	NOUN
cuesj-1229	46	66	]	]	PUNCT
cuesj-1229	46	67	,	,	PUNCT
cuesj-1229	46	68	and	and	CCONJ
cuesj-1229	46	69	2	2	NUM
cuesj-1229	46	70	of	of	ADP
cuesj-1229	46	71	20	20	NUM
cuesj-1229	46	72	[	[	SYM
cuesj-1229	46	73	10	10	NUM
cuesj-1229	46	74	%	%	NOUN
cuesj-1229	46	75	]	]	PUNCT
cuesj-1229	46	76	were	be	AUX
cuesj-1229	46	77	[	[	X
cuesj-1229	46	78	41	41	NUM
cuesj-1229	46	79	–	–	SYM
cuesj-1229	46	80	50	50	NUM
cuesj-1229	46	81	years	year	NOUN
cuesj-1229	46	82	]	]	PUNCT
cuesj-1229	46	83	)	)	PUNCT
cuesj-1229	46	84	.	.	PUNCT
cuesj-1229	47	1	one	one	NUM
cuesj-1229	47	2	of	of	ADP
cuesj-1229	47	3	the	the	DET
cuesj-1229	47	4	20	20	NUM
cuesj-1229	47	5	(	(	PUNCT
cuesj-1229	47	6	5	5	NUM
cuesj-1229	47	7	%	%	NOUN
cuesj-1229	47	8	)	)	PUNCT
cuesj-1229	47	9	tested	test	VERB
cuesj-1229	47	10	positive	positive	ADJ
cuesj-1229	47	11	for	for	ADP
cuesj-1229	47	12	anti	anti	ADJ
cuesj-1229	47	13	-	-	ADJ
cuesj-1229	47	14	tox	tox	ADJ
cuesj-1229	47	15	igm	igm	PROPN
cuesj-1229	47	16	antibodies	antibodie	VERB
cuesj-1229	47	17	,	,	PUNCT
cuesj-1229	47	18	who	who	PRON
cuesj-1229	47	19	was	be	AUX
cuesj-1229	47	20	a	a	DET
cuesj-1229	47	21	32	32	NUM
cuesj-1229	47	22	-	-	PUNCT
cuesj-1229	47	23	year	year	NOUN
cuesj-1229	47	24	-	-	PUNCT
cuesj-1229	47	25	old	old	ADJ
cuesj-1229	47	26	female	female	NOUN
cuesj-1229	47	27	.	.	PUNCT
cuesj-1229	48	1	128	128	NUM
cuesj-1229	48	2	individuals	individual	NOUN
cuesj-1229	48	3	(	(	PUNCT
cuesj-1229	48	4	25.2	25.2	NUM
cuesj-1229	48	5	%	%	NOUN
cuesj-1229	48	6	)	)	PUNCT
cuesj-1229	48	7	(	(	PUNCT
cuesj-1229	48	8	all	all	DET
cuesj-1229	48	9	females	female	NOUN
cuesj-1229	48	10	and	and	CCONJ
cuesj-1229	48	11	all	all	PRON
cuesj-1229	48	12	received	receive	VERB
cuesj-1229	48	13	the	the	DET
cuesj-1229	48	14	rubella	rubella	NOUN
cuesj-1229	48	15	vaccine	vaccine	NOUN
cuesj-1229	48	16	)	)	PUNCT
cuesj-1229	48	17	tested	test	VERB
cuesj-1229	48	18	positive	positive	ADJ
cuesj-1229	48	19	for	for	ADP
cuesj-1229	48	20	anti	anti	ADJ
cuesj-1229	48	21	-	-	ADJ
cuesj-1229	48	22	rubella	rubella	ADJ
cuesj-1229	48	23	igg	igg	NOUN
cuesj-1229	48	24	antibodies	antibodie	VERB
cuesj-1229	48	25	(	(	PUNCT
cuesj-1229	48	26	51	51	NUM
cuesj-1229	48	27	of	of	ADP
cuesj-1229	48	28	128	128	NUM
cuesj-1229	48	29	[	[	X
cuesj-1229	48	30	39.84	39.84	NUM
cuesj-1229	48	31	%	%	NOUN
cuesj-1229	48	32	]	]	PUNCT
cuesj-1229	48	33	were	be	AUX
cuesj-1229	48	34	[	[	X
cuesj-1229	48	35	21–30	21–30	NUM
cuesj-1229	48	36	years	year	NOUN
cuesj-1229	48	37	]	]	PUNCT
cuesj-1229	48	38	,	,	PUNCT
cuesj-1229	48	39	49	49	NUM
cuesj-1229	48	40	of	of	ADP
cuesj-1229	48	41	128	128	NUM
cuesj-1229	49	1	[	[	X
cuesj-1229	49	2	38.28	38.28	NUM
cuesj-1229	49	3	%	%	NOUN
cuesj-1229	49	4	]	]	PUNCT
cuesj-1229	49	5	were	be	AUX
cuesj-1229	49	6	[	[	X
cuesj-1229	49	7	31–40	31–40	NUM
cuesj-1229	49	8	years	year	NOUN
cuesj-1229	49	9	]	]	PUNCT
cuesj-1229	49	10	,	,	PUNCT
cuesj-1229	49	11	27	27	NUM
cuesj-1229	49	12	of	of	ADP
cuesj-1229	49	13	128	128	NUM
cuesj-1229	49	14	[	[	X
cuesj-1229	49	15	21.09	21.09	NUM
cuesj-1229	49	16	%	%	NOUN
cuesj-1229	49	17	]	]	PUNCT
cuesj-1229	49	18	were	be	AUX
cuesj-1229	49	19	[	[	X
cuesj-1229	49	20	41–50	41–50	NUM
cuesj-1229	49	21	years	year	NOUN
cuesj-1229	49	22	]	]	PUNCT
cuesj-1229	49	23	,	,	PUNCT
cuesj-1229	49	24	and	and	CCONJ
cuesj-1229	49	25	only	only	ADV
cuesj-1229	49	26	one	one	NUM
cuesj-1229	49	27	of	of	ADP
cuesj-1229	49	28	128	128	NUM
cuesj-1229	49	29	was	be	AUX
cuesj-1229	49	30	52	52	NUM
cuesj-1229	49	31	years	year	NOUN
cuesj-1229	49	32	old	old	ADJ
cuesj-1229	49	33	)	)	PUNCT
cuesj-1229	49	34	.	.	PUNCT
cuesj-1229	50	1	40	40	NUM
cuesj-1229	50	2	individuals	individual	NOUN
cuesj-1229	50	3	(	(	PUNCT
cuesj-1229	50	4	7.87	7.87	NUM
cuesj-1229	50	5	%	%	NOUN
cuesj-1229	50	6	)	)	PUNCT
cuesj-1229	50	7	(	(	PUNCT
cuesj-1229	50	8	19	19	NUM
cuesj-1229	50	9	[	[	SYM
cuesj-1229	50	10	47.5	47.5	NUM
cuesj-1229	50	11	%	%	NOUN
cuesj-1229	50	12	]	]	PUNCT
cuesj-1229	50	13	females	female	NOUN
cuesj-1229	50	14	and	and	CCONJ
cuesj-1229	50	15	21	21	NUM
cuesj-1229	50	16	[	[	SYM
cuesj-1229	50	17	52.5	52.5	NUM
cuesj-1229	50	18	%	%	NOUN
cuesj-1229	50	19	]	]	PUNCT
cuesj-1229	50	20	males	male	NOUN
cuesj-1229	50	21	)	)	PUNCT
cuesj-1229	50	22	tested	test	VERB
cuesj-1229	50	23	positive	positive	ADJ
cuesj-1229	50	24	for	for	ADP
cuesj-1229	50	25	anti	anti	ADJ
cuesj-1229	50	26	-	-	ADJ
cuesj-1229	50	27	cmv	cmv	ADJ
cuesj-1229	50	28	igg	igg	PROPN
cuesj-1229	50	29	antibodies	antibodie	VERB
cuesj-1229	50	30	(	(	PUNCT
cuesj-1229	50	31	28	28	NUM
cuesj-1229	50	32	of	of	ADP
cuesj-1229	50	33	40	40	NUM
cuesj-1229	51	1	[	[	SYM
cuesj-1229	51	2	70	70	NUM
cuesj-1229	51	3	%	%	NOUN
cuesj-1229	51	4	]	]	PUNCT
cuesj-1229	51	5	were	be	AUX
cuesj-1229	51	6	[	[	X
cuesj-1229	51	7	21–30	21–30	NUM
cuesj-1229	51	8	years	year	NOUN
cuesj-1229	51	9	]	]	PUNCT
cuesj-1229	51	10	,	,	PUNCT
cuesj-1229	51	11	11	11	NUM
cuesj-1229	51	12	of	of	ADP
cuesj-1229	51	13	40	40	NUM
cuesj-1229	51	14	[	[	SYM
cuesj-1229	51	15	27.5	27.5	NUM
cuesj-1229	51	16	%	%	NOUN
cuesj-1229	51	17	]	]	PUNCT
cuesj-1229	51	18	were	be	AUX
cuesj-1229	51	19	[	[	X
cuesj-1229	51	20	31–40	31–40	NUM
cuesj-1229	51	21	years	year	NOUN
cuesj-1229	51	22	]	]	PUNCT
cuesj-1229	51	23	,	,	PUNCT
cuesj-1229	51	24	and	and	CCONJ
cuesj-1229	51	25	only	only	ADV
cuesj-1229	51	26	one	one	NUM
cuesj-1229	51	27	of	of	ADP
cuesj-1229	51	28	40	40	NUM
cuesj-1229	51	29	[	[	SYM
cuesj-1229	51	30	2.5	2.5	NUM
cuesj-1229	51	31	%	%	NOUN
cuesj-1229	51	32	]	]	PUNCT
cuesj-1229	51	33	was	be	AUX
cuesj-1229	51	34	in	in	ADP
cuesj-1229	51	35	[	[	X
cuesj-1229	51	36	41	41	NUM
cuesj-1229	51	37	–	–	SYM
cuesj-1229	51	38	50	50	NUM
cuesj-1229	51	39	years	year	NOUN
cuesj-1229	51	40	]	]	PUNCT
cuesj-1229	51	41	)	)	PUNCT
cuesj-1229	51	42	.	.	PUNCT
cuesj-1229	52	1	one	one	NUM
cuesj-1229	52	2	of	of	ADP
cuesj-1229	52	3	the	the	DET
cuesj-1229	52	4	40	40	NUM
cuesj-1229	52	5	(	(	PUNCT
cuesj-1229	52	6	2.5	2.5	NUM
cuesj-1229	52	7	%	%	NOUN
cuesj-1229	52	8	)	)	PUNCT
cuesj-1229	52	9	also	also	ADV
cuesj-1229	52	10	tested	test	VERB
cuesj-1229	52	11	positive	positive	ADJ
cuesj-1229	52	12	for	for	ADP
cuesj-1229	52	13	anticmv	anticmv	PROPN
cuesj-1229	52	14	igm	igm	PROPN
cuesj-1229	52	15	antibodies	antibody	NOUN
cuesj-1229	52	16	,	,	PUNCT
cuesj-1229	52	17	who	who	PRON
cuesj-1229	52	18	was	be	AUX
cuesj-1229	52	19	a	a	DET
cuesj-1229	52	20	26	26	NUM
cuesj-1229	52	21	-	-	PUNCT
cuesj-1229	52	22	year	year	NOUN
cuesj-1229	52	23	-	-	PUNCT
cuesj-1229	52	24	old	old	ADJ
cuesj-1229	52	25	male	male	NOUN
cuesj-1229	52	26	.	.	PUNCT
cuesj-1229	53	1	18	18	NUM
cuesj-1229	53	2	individuals	individual	NOUN
cuesj-1229	53	3	(	(	PUNCT
cuesj-1229	53	4	3.54	3.54	NUM
cuesj-1229	53	5	%	%	NOUN
cuesj-1229	53	6	)	)	PUNCT
cuesj-1229	53	7	(	(	PUNCT
cuesj-1229	53	8	8	8	NUM
cuesj-1229	53	9	[	[	SYM
cuesj-1229	53	10	44.44	44.44	NUM
cuesj-1229	53	11	%	%	NOUN
cuesj-1229	53	12	]	]	PUNCT
cuesj-1229	53	13	females	female	NOUN
cuesj-1229	53	14	and	and	CCONJ
cuesj-1229	53	15	10	10	NUM
cuesj-1229	53	16	[	[	X
cuesj-1229	53	17	55.56	55.56	NUM
cuesj-1229	53	18	%	%	NOUN
cuesj-1229	53	19	]	]	PUNCT
cuesj-1229	53	20	males	male	NOUN
cuesj-1229	53	21	)	)	PUNCT
cuesj-1229	53	22	tested	test	VERB
cuesj-1229	53	23	positive	positive	ADJ
cuesj-1229	53	24	for	for	ADP
cuesj-1229	53	25	anti	anti	ADJ
cuesj-1229	53	26	-	-	ADJ
cuesj-1229	53	27	hsv-1	hsv-1	PRON
cuesj-1229	53	28	igg	igg	PROPN
cuesj-1229	53	29	antibodies	antibodie	VERB
cuesj-1229	53	30	(	(	PUNCT
cuesj-1229	53	31	one	one	NUM
cuesj-1229	53	32	of	of	ADP
cuesj-1229	53	33	18	18	NUM
cuesj-1229	53	34	[	[	SYM
cuesj-1229	53	35	5.56	5.56	NUM
cuesj-1229	53	36	%	%	NOUN
cuesj-1229	53	37	]	]	PUNCT
cuesj-1229	53	38	was	be	AUX
cuesj-1229	53	39	19	19	NUM
cuesj-1229	53	40	years	year	NOUN
cuesj-1229	53	41	old	old	ADJ
cuesj-1229	53	42	,	,	PUNCT
cuesj-1229	53	43	12	12	NUM
cuesj-1229	53	44	of	of	ADP
cuesj-1229	53	45	18	18	NUM
cuesj-1229	53	46	[	[	SYM
cuesj-1229	53	47	66.7	66.7	NUM
cuesj-1229	53	48	%	%	NOUN
cuesj-1229	53	49	]	]	PUNCT
cuesj-1229	53	50	were	be	AUX
cuesj-1229	53	51	[	[	X
cuesj-1229	53	52	21–30	21–30	NUM
cuesj-1229	53	53	years	year	NOUN
cuesj-1229	53	54	]	]	PUNCT
cuesj-1229	53	55	,	,	PUNCT
cuesj-1229	53	56	4	4	NUM
cuesj-1229	53	57	of	of	ADP
cuesj-1229	53	58	18	18	NUM
cuesj-1229	53	59	[	[	SYM
cuesj-1229	53	60	22.2	22.2	NUM
cuesj-1229	53	61	%	%	NOUN
cuesj-1229	53	62	]	]	PUNCT
cuesj-1229	53	63	were	be	AUX
cuesj-1229	53	64	[	[	X
cuesj-1229	53	65	31–40	31–40	NUM
cuesj-1229	53	66	years	year	NOUN
cuesj-1229	53	67	]	]	PUNCT
cuesj-1229	53	68	,	,	PUNCT
cuesj-1229	53	69	and	and	CCONJ
cuesj-1229	53	70	1	1	NUM
cuesj-1229	53	71	of	of	ADP
cuesj-1229	53	72	18	18	NUM
cuesj-1229	53	73	[	[	SYM
cuesj-1229	53	74	5.56	5.56	NUM
cuesj-1229	53	75	%	%	NOUN
cuesj-1229	53	76	]	]	PUNCT
cuesj-1229	53	77	was	be	AUX
cuesj-1229	53	78	[	[	X
cuesj-1229	53	79	41–50	41–50	NUM
cuesj-1229	53	80	years	year	NOUN
cuesj-1229	53	81	]	]	PUNCT
cuesj-1229	53	82	)	)	PUNCT
cuesj-1229	53	83	.	.	PUNCT
cuesj-1229	54	1	one	one	NUM
cuesj-1229	54	2	of	of	ADP
cuesj-1229	54	3	the	the	DET
cuesj-1229	54	4	18	18	NUM
cuesj-1229	54	5	(	(	PUNCT
cuesj-1229	54	6	5.56	5.56	NUM
cuesj-1229	54	7	%	%	NOUN
cuesj-1229	54	8	)	)	PUNCT
cuesj-1229	54	9	also	also	ADV
cuesj-1229	54	10	tested	test	VERB
cuesj-1229	54	11	positive	positive	ADJ
cuesj-1229	54	12	for	for	ADP
cuesj-1229	54	13	anti	anti	ADJ
cuesj-1229	54	14	-	-	ADJ
cuesj-1229	54	15	hsv-1	hsv-1	DET
cuesj-1229	54	16	igm	igm	NOUN
cuesj-1229	54	17	antibodies	antibodie	VERB
cuesj-1229	54	18	.	.	PUNCT
cuesj-1229	55	1	one	one	NUM
cuesj-1229	55	2	18	18	NUM
cuesj-1229	55	3	-	-	PUNCT
cuesj-1229	55	4	year	year	NOUN
cuesj-1229	55	5	-	-	PUNCT
cuesj-1229	55	6	old	old	ADJ
cuesj-1229	55	7	male	male	NOUN
cuesj-1229	55	8	(	(	PUNCT
cuesj-1229	55	9	0.2	0.2	NUM
cuesj-1229	55	10	%	%	NOUN
cuesj-1229	55	11	)	)	PUNCT
cuesj-1229	55	12	tested	test	VERB
cuesj-1229	55	13	positive	positive	ADJ
cuesj-1229	55	14	for	for	ADP
cuesj-1229	55	15	anti	anti	ADJ
cuesj-1229	55	16	-	-	ADJ
cuesj-1229	55	17	hsv-2	hsv-2	VERB
cuesj-1229	55	18	igg	igg	NOUN
cuesj-1229	55	19	antibodies	antibodie	VERB
cuesj-1229	55	20	,	,	PUNCT
cuesj-1229	55	21	and	and	CCONJ
cuesj-1229	55	22	none	none	NOUN
cuesj-1229	55	23	were	be	AUX
cuesj-1229	55	24	positive	positive	ADJ
cuesj-1229	55	25	for	for	ADP
cuesj-1229	55	26	anti	anti	ADJ
cuesj-1229	55	27	-	-	ADJ
cuesj-1229	55	28	hsv-2	hsv-2	ADJ
cuesj-1229	55	29	igm	igm	NOUN
cuesj-1229	55	30	antibodies	antibodie	VERB
cuesj-1229	56	1	[	[	X
cuesj-1229	56	2	table	table	NOUN
cuesj-1229	56	3	3	3	NUM
cuesj-1229	56	4	]	]	PUNCT
cuesj-1229	56	5	.	.	PUNCT
cuesj-1229	57	1	discussion	discussion	NOUN
cuesj-1229	57	2	torch	torch	NOUN
cuesj-1229	57	3	represents	represent	VERB
cuesj-1229	57	4	a	a	DET
cuesj-1229	57	5	group	group	NOUN
cuesj-1229	57	6	of	of	ADP
cuesj-1229	57	7	pathogens	pathogen	NOUN
cuesj-1229	57	8	linked	link	VERB
cuesj-1229	57	9	to	to	ADP
cuesj-1229	57	10	complications	complication	NOUN
cuesj-1229	57	11	and	and	CCONJ
cuesj-1229	57	12	consequences	consequence	NOUN
cuesj-1229	57	13	for	for	ADP
cuesj-1229	57	14	both	both	CCONJ
cuesj-1229	57	15	unborn	unborn	ADJ
cuesj-1229	57	16	and	and	CCONJ
cuesj-1229	57	17	newborn	newborn	ADJ
cuesj-1229	57	18	children	child	NOUN
cuesj-1229	57	19	table	table	VERB
cuesj-1229	57	20	2	2	NUM
cuesj-1229	57	21	:	:	PUNCT
cuesj-1229	57	22	age	age	NOUN
cuesj-1229	57	23	groups	group	NOUN
cuesj-1229	57	24	of	of	ADP
cuesj-1229	57	25	individuals	individual	NOUN
cuesj-1229	57	26	included	include	VERB
cuesj-1229	57	27	in	in	ADP
cuesj-1229	57	28	studying	study	VERB
cuesj-1229	57	29	the	the	DET
cuesj-1229	57	30	prevalence	prevalence	NOUN
cuesj-1229	57	31	of	of	ADP
cuesj-1229	57	32	torch	torch	NOUN
cuesj-1229	57	33	among	among	ADP
cuesj-1229	57	34	erbil	erbil	PROPN
cuesj-1229	57	35	city	city	PROPN
cuesj-1229	57	36	inhabitants	inhabitant	NOUN
cuesj-1229	57	37	total	total	ADJ
cuesj-1229	57	38	samples	sample	NOUN
cuesj-1229	57	39	508	508	NUM
cuesj-1229	57	40	no	no	NOUN
cuesj-1229	57	41	.	.	PUNCT
cuesj-1229	58	1	%	%	NOUN
cuesj-1229	59	1	13–20	13–20	NUM
cuesj-1229	59	2	77	77	NUM
cuesj-1229	59	3	15.16	15.16	NUM
cuesj-1229	59	4	21–30	21–30	NUM
cuesj-1229	59	5	162	162	NUM
cuesj-1229	59	6	31.89	31.89	NUM
cuesj-1229	59	7	31–40	31–40	NUM
cuesj-1229	59	8	147	147	NUM
cuesj-1229	59	9	28.94	28.94	NUM
cuesj-1229	59	10	41–50	41–50	NUM
cuesj-1229	59	11	79	79	NUM
cuesj-1229	59	12	15.56	15.56	NUM
cuesj-1229	59	13	51–60	51–60	NUM
cuesj-1229	59	14	41	41	NUM
cuesj-1229	59	15	8.07	8.07	NUM
cuesj-1229	59	16	61–63	61–63	NUM
cuesj-1229	59	17	2	2	NUM
cuesj-1229	59	18	0.39	0.39	NUM
cuesj-1229	59	19	table	table	NOUN
cuesj-1229	59	20	1	1	NUM
cuesj-1229	59	21	:	:	PUNCT
cuesj-1229	59	22	gender	gender	NOUN
cuesj-1229	59	23	of	of	ADP
cuesj-1229	59	24	individuals	individual	NOUN
cuesj-1229	59	25	included	include	VERB
cuesj-1229	59	26	in	in	ADP
cuesj-1229	59	27	studying	study	VERB
cuesj-1229	59	28	the	the	DET
cuesj-1229	59	29	prevalence	prevalence	NOUN
cuesj-1229	59	30	of	of	ADP
cuesj-1229	59	31	torch	torch	NOUN
cuesj-1229	59	32	among	among	ADP
cuesj-1229	59	33	erbil	erbil	PROPN
cuesj-1229	59	34	city	city	PROPN
cuesj-1229	59	35	inhabitants	inhabitant	NOUN
cuesj-1229	59	36	total	total	ADJ
cuesj-1229	59	37	samples	sample	NOUN
cuesj-1229	59	38	508	508	NUM
cuesj-1229	59	39	no	no	NOUN
cuesj-1229	59	40	.	.	PUNCT
cuesj-1229	60	1	%	%	NOUN
cuesj-1229	60	2	females	female	NOUN
cuesj-1229	60	3	218	218	NUM
cuesj-1229	60	4	42.91	42.91	NUM
cuesj-1229	60	5	males	male	NOUN
cuesj-1229	60	6	290	290	NUM
cuesj-1229	60	7	57.09	57.09	NUM
cuesj-1229	60	8	juma	juma	PROPN
cuesj-1229	60	9	,	,	PUNCT
cuesj-1229	60	10	et	et	PROPN
cuesj-1229	60	11	al	al	PROPN
cuesj-1229	60	12	.	.	PROPN
cuesj-1229	60	13	:	:	PUNCT
cuesj-1229	61	1	epidemiological	epidemiological	ADJ
cuesj-1229	61	2	insights	insight	NOUN
cuesj-1229	61	3	into	into	ADP
cuesj-1229	61	4	torch	torch	NOUN
cuesj-1229	61	5	28	28	NUM
cuesj-1229	61	6	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1229	61	7	cuesj	cuesj	ADJ
cuesj-1229	61	8	2024	2024	NUM
cuesj-1229	61	9	,	,	PUNCT
cuesj-1229	61	10	8	8	NUM
cuesj-1229	61	11	(	(	PUNCT
cuesj-1229	61	12	2	2	NUM
cuesj-1229	61	13	):	):	PUNCT
cuesj-1229	61	14	26	26	NUM
cuesj-1229	61	15	-	-	SYM
cuesj-1229	61	16	30	30	NUM
cuesj-1229	61	17	table	table	NOUN
cuesj-1229	61	18	3	3	NUM
cuesj-1229	61	19	:	:	PUNCT
cuesj-1229	61	20	results	result	NOUN
cuesj-1229	61	21	of	of	ADP
cuesj-1229	61	22	torch	torch	NOUN
cuesj-1229	61	23	in	in	ADP
cuesj-1229	61	24	individuals	individual	NOUN
cuesj-1229	61	25	included	include	VERB
cuesj-1229	61	26	in	in	ADP
cuesj-1229	61	27	studying	study	VERB
cuesj-1229	61	28	the	the	DET
cuesj-1229	61	29	prevalence	prevalence	NOUN
cuesj-1229	61	30	of	of	ADP
cuesj-1229	61	31	torch	torch	NOUN
cuesj-1229	61	32	among	among	ADP
cuesj-1229	61	33	erbil	erbil	PROPN
cuesj-1229	61	34	city	city	PROPN
cuesj-1229	61	35	inhabitants	inhabitant	NOUN
cuesj-1229	61	36	test	test	VERB
cuesj-1229	61	37	overall	overall	ADV
cuesj-1229	61	38	positive	positive	ADJ
cuesj-1229	61	39	no	no	NOUN
cuesj-1229	61	40	.	.	PUNCT
cuesj-1229	62	1	%	%	INTJ
cuesj-1229	63	1	no	no	INTJ
cuesj-1229	63	2	.	.	PUNCT
cuesj-1229	64	1	of	of	ADP
cuesj-1229	64	2	igg	igg	PROPN
cuesj-1229	64	3	positive	positive	ADJ
cuesj-1229	64	4	%	%	INTJ
cuesj-1229	64	5	no	no	INTJ
cuesj-1229	64	6	.	.	PUNCT
cuesj-1229	65	1	of	of	ADP
cuesj-1229	65	2	igm	igm	PROPN
cuesj-1229	65	3	positive	positive	ADJ
cuesj-1229	65	4	%	%	NOUN
cuesj-1229	65	5	toxoplasma+ve	toxoplasma+ve	ADJ
cuesj-1229	65	6	20	20	NUM
cuesj-1229	65	7	3.94	3.94	NUM
cuesj-1229	65	8	20	20	NUM
cuesj-1229	65	9	3.94	3.94	NUM
cuesj-1229	65	10	1	1	NUM
cuesj-1229	65	11	0.20	0.20	NUM
cuesj-1229	65	12	rubella	rubella	NOUN
cuesj-1229	65	13	virus+ve	virus+ve	CCONJ
cuesj-1229	65	14	128	128	NUM
cuesj-1229	65	15	25.20	25.20	NUM
cuesj-1229	65	16	128	128	NUM
cuesj-1229	65	17	25.20	25.20	NUM
cuesj-1229	65	18	0	0	NUM
cuesj-1229	65	19	0	0	SYM
cuesj-1229	66	1	cmv+ve	cmv+ve	NUM
cuesj-1229	66	2	40	40	NUM
cuesj-1229	66	3	7.87	7.87	NUM
cuesj-1229	66	4	40	40	NUM
cuesj-1229	66	5	7.87	7.87	NUM
cuesj-1229	66	6	1	1	NUM
cuesj-1229	66	7	0.20	0.20	NUM
cuesj-1229	66	8	hsv-1+ve	hsv-1+ve	ADP
cuesj-1229	66	9	18	18	NUM
cuesj-1229	66	10	3.54	3.54	NUM
cuesj-1229	66	11	18	18	NUM
cuesj-1229	66	12	3.54	3.54	NUM
cuesj-1229	66	13	1	1	NUM
cuesj-1229	66	14	0.20	0.20	NUM
cuesj-1229	66	15	hsv-2+ve	hsv-2+ve	NOUN
cuesj-1229	66	16	1	1	NUM
cuesj-1229	66	17	0.20	0.20	NUM
cuesj-1229	66	18	1	1	NUM
cuesj-1229	66	19	0.20	0.20	NUM
cuesj-1229	66	20	0	0	NUM
cuesj-1229	66	21	0	0	NUM
cuesj-1229	66	22	igg	igg	PROPN
cuesj-1229	66	23	:	:	PUNCT
cuesj-1229	66	24	immunoglobulin	immunoglobulin	NOUN
cuesj-1229	66	25	g	g	PROPN
cuesj-1229	66	26	,	,	PUNCT
cuesj-1229	66	27	igm	igm	PROPN
cuesj-1229	66	28	:	:	PUNCT
cuesj-1229	66	29	immunoglobulin	immunoglobulin	PROPN
cuesj-1229	66	30	m	m	PROPN
cuesj-1229	66	31	,	,	PUNCT
cuesj-1229	66	32	cmv	cmv	NOUN
cuesj-1229	66	33	:	:	PUNCT
cuesj-1229	66	34	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	66	35	during	during	ADP
cuesj-1229	66	36	pregnancy	pregnancy	NOUN
cuesj-1229	66	37	.	.	PUNCT
cuesj-1229	67	1	elevated	elevated	ADJ
cuesj-1229	67	2	risk	risk	NOUN
cuesj-1229	67	3	is	be	AUX
cuesj-1229	67	4	particularly	particularly	ADV
cuesj-1229	67	5	associated	associate	VERB
cuesj-1229	67	6	with	with	ADP
cuesj-1229	67	7	primary	primary	ADJ
cuesj-1229	67	8	infections	infection	NOUN
cuesj-1229	67	9	during	during	ADP
cuesj-1229	67	10	pregnancy	pregnancy	NOUN
cuesj-1229	67	11	.	.	PUNCT
cuesj-1229	68	1	countries	country	NOUN
cuesj-1229	68	2	lacking	lack	VERB
cuesj-1229	68	3	robust	robust	ADJ
cuesj-1229	68	4	disease	disease	NOUN
cuesj-1229	68	5	surveillance	surveillance	NOUN
cuesj-1229	68	6	systems	system	NOUN
cuesj-1229	68	7	,	,	PUNCT
cuesj-1229	68	8	the	the	DET
cuesj-1229	68	9	seroprevalence	seroprevalence	NOUN
cuesj-1229	68	10	data	datum	NOUN
cuesj-1229	68	11	concerning	concern	VERB
cuesj-1229	68	12	torch	torch	NOUN
cuesj-1229	68	13	infections	infection	NOUN
cuesj-1229	68	14	are	be	AUX
cuesj-1229	68	15	essential	essential	ADJ
cuesj-1229	68	16	for	for	ADP
cuesj-1229	68	17	estimating	estimate	VERB
cuesj-1229	68	18	levels	level	NOUN
cuesj-1229	68	19	of	of	ADP
cuesj-1229	68	20	immunity	immunity	NOUN
cuesj-1229	68	21	and	and	CCONJ
cuesj-1229	68	22	vaccination	vaccination	NOUN
cuesj-1229	68	23	.	.	PUNCT
cuesj-1229	69	1	in	in	ADP
cuesj-1229	69	2	addition	addition	NOUN
cuesj-1229	69	3	,	,	PUNCT
cuesj-1229	69	4	they	they	PRON
cuesj-1229	69	5	help	help	VERB
cuesj-1229	69	6	gauge	gauge	VERB
cuesj-1229	69	7	exposure	exposure	NOUN
cuesj-1229	69	8	rates	rate	NOUN
cuesj-1229	69	9	and	and	CCONJ
cuesj-1229	69	10	,	,	PUNCT
cuesj-1229	69	11	consequently	consequently	ADV
cuesj-1229	69	12	,	,	PUNCT
cuesj-1229	69	13	the	the	DET
cuesj-1229	69	14	risk	risk	NOUN
cuesj-1229	69	15	of	of	ADP
cuesj-1229	69	16	infection	infection	NOUN
cuesj-1229	69	17	during	during	ADP
cuesj-1229	69	18	pregnancy	pregnancy	NOUN
cuesj-1229	69	19	.	.	PUNCT
cuesj-1229	70	1	a	a	DET
cuesj-1229	70	2	comprehensive	comprehensive	ADJ
cuesj-1229	70	3	review	review	NOUN
cuesj-1229	70	4	of	of	ADP
cuesj-1229	70	5	the	the	DET
cuesj-1229	70	6	literature	literature	NOUN
cuesj-1229	70	7	covering	cover	VERB
cuesj-1229	70	8	30	30	NUM
cuesj-1229	70	9	years	year	NOUN
cuesj-1229	70	10	was	be	AUX
cuesj-1229	70	11	undertaken	undertake	VERB
cuesj-1229	70	12	to	to	PART
cuesj-1229	70	13	identify	identify	VERB
cuesj-1229	70	14	serosurveys	serosurvey	NOUN
cuesj-1229	70	15	on	on	ADP
cuesj-1229	70	16	torch	torch	NOUN
cuesj-1229	70	17	pathogens	pathogen	NOUN
cuesj-1229	70	18	in	in	ADP
cuesj-1229	70	19	southeast	southeast	PROPN
cuesj-1229	70	20	asia	asia	PROPN
cuesj-1229	70	21	.	.	PUNCT
cuesj-1229	71	1	the	the	DET
cuesj-1229	71	2	analysis	analysis	NOUN
cuesj-1229	71	3	of	of	ADP
cuesj-1229	71	4	96	96	NUM
cuesj-1229	71	5	identified	identify	VERB
cuesj-1229	71	6	studies	study	NOUN
cuesj-1229	71	7	revealed	reveal	VERB
cuesj-1229	71	8	variations	variation	NOUN
cuesj-1229	71	9	in	in	ADP
cuesj-1229	71	10	the	the	DET
cuesj-1229	71	11	extent	extent	NOUN
cuesj-1229	71	12	of	of	ADP
cuesj-1229	71	13	research	research	NOUN
cuesj-1229	71	14	for	for	ADP
cuesj-1229	71	15	different	different	ADJ
cuesj-1229	71	16	pathogens	pathogen	NOUN
cuesj-1229	71	17	,	,	PUNCT
cuesj-1229	71	18	with	with	ADP
cuesj-1229	71	19	some	some	DET
cuesj-1229	71	20	well	well	ADV
cuesj-1229	71	21	studied	study	VERB
cuesj-1229	71	22	and	and	CCONJ
cuesj-1229	71	23	others	other	NOUN
cuesj-1229	71	24	having	having	AUX
cuesj-1229	71	25	limited	limit	VERB
cuesj-1229	71	26	available	available	ADJ
cuesj-1229	71	27	data	datum	NOUN
cuesj-1229	71	28	.	.	PUNCT
cuesj-1229	72	1	studies	study	NOUN
cuesj-1229	72	2	from	from	ADP
cuesj-1229	72	3	the	the	DET
cuesj-1229	72	4	more	more	ADV
cuesj-1229	72	5	developed	develop	VERB
cuesj-1229	72	6	countries	country	NOUN
cuesj-1229	72	7	in	in	ADP
cuesj-1229	72	8	the	the	DET
cuesj-1229	72	9	region	region	NOUN
cuesj-1229	72	10	were	be	AUX
cuesj-1229	72	11	more	more	ADV
cuesj-1229	72	12	prevalent	prevalent	ADJ
cuesj-1229	72	13	.	.	PUNCT
cuesj-1229	73	1	in	in	ADP
cuesj-1229	73	2	addition	addition	NOUN
cuesj-1229	73	3	,	,	PUNCT
cuesj-1229	73	4	seroprevalence	seroprevalence	NOUN
cuesj-1229	73	5	data	datum	NOUN
cuesj-1229	73	6	were	be	AUX
cuesj-1229	73	7	often	often	ADV
cuesj-1229	73	8	restricted	restrict	VERB
cuesj-1229	73	9	to	to	ADP
cuesj-1229	73	10	specific	specific	ADJ
cuesj-1229	73	11	geographic	geographic	ADJ
cuesj-1229	73	12	regions	region	NOUN
cuesj-1229	73	13	or	or	CCONJ
cuesj-1229	73	14	cohorts	cohort	NOUN
cuesj-1229	73	15	within	within	ADP
cuesj-1229	73	16	a	a	DET
cuesj-1229	73	17	country	country	NOUN
cuesj-1229	73	18	.	.	PUNCT
cuesj-1229	74	1	there	there	PRON
cuesj-1229	74	2	was	be	VERB
cuesj-1229	74	3	a	a	DET
cuesj-1229	74	4	noticeable	noticeable	ADJ
cuesj-1229	74	5	scarcity	scarcity	NOUN
cuesj-1229	74	6	of	of	ADP
cuesj-1229	74	7	recent	recent	ADJ
cuesj-1229	74	8	serosurveys	serosurvey	NOUN
cuesj-1229	74	9	,	,	PUNCT
cuesj-1229	74	10	and	and	CCONJ
cuesj-1229	74	11	the	the	DET
cuesj-1229	74	12	overall	overall	ADJ
cuesj-1229	74	13	study	study	NOUN
cuesj-1229	74	14	quality	quality	NOUN
cuesj-1229	74	15	was	be	AUX
cuesj-1229	74	16	frequently	frequently	ADV
cuesj-1229	74	17	deemed	deem	VERB
cuesj-1229	74	18	inadequate	inadequate	ADJ
cuesj-1229	74	19	.	.	PUNCT
cuesj-1229	75	1	there	there	PRON
cuesj-1229	75	2	is	be	VERB
cuesj-1229	75	3	a	a	DET
cuesj-1229	75	4	clear	clear	ADJ
cuesj-1229	75	5	need	need	NOUN
cuesj-1229	75	6	for	for	ADP
cuesj-1229	75	7	well	well	ADV
cuesj-1229	75	8	-	-	PUNCT
cuesj-1229	75	9	designed	design	VERB
cuesj-1229	75	10	,	,	PUNCT
cuesj-1229	75	11	extensive	extensive	ADJ
cuesj-1229	75	12	serosurveys	serosurvey	NOUN
cuesj-1229	75	13	focusing	focus	VERB
cuesj-1229	75	14	on	on	ADP
cuesj-1229	75	15	torch	torch	NOUN
cuesj-1229	75	16	pathogens	pathogen	NOUN
cuesj-1229	75	17	.	.	PUNCT
cuesj-1229	76	1	if	if	SCONJ
cuesj-1229	76	2	coupled	couple	VERB
cuesj-1229	76	3	with	with	ADP
cuesj-1229	76	4	risk	risk	NOUN
cuesj-1229	76	5	factor	factor	NOUN
cuesj-1229	76	6	analysis	analysis	NOUN
cuesj-1229	76	7	,	,	PUNCT
cuesj-1229	76	8	these	these	DET
cuesj-1229	76	9	studies	study	NOUN
cuesj-1229	76	10	have	have	VERB
cuesj-1229	76	11	the	the	DET
cuesj-1229	76	12	potential	potential	NOUN
cuesj-1229	76	13	to	to	PART
cuesj-1229	76	14	direct	direct	VERB
cuesj-1229	76	15	the	the	DET
cuesj-1229	76	16	creation	creation	NOUN
cuesj-1229	76	17	and	and	CCONJ
cuesj-1229	76	18	application	application	NOUN
cuesj-1229	76	19	of	of	ADP
cuesj-1229	76	20	efficient	efficient	ADJ
cuesj-1229	76	21	infection	infection	NOUN
cuesj-1229	76	22	control	control	NOUN
cuesj-1229	76	23	strategies	strategy	NOUN
cuesj-1229	76	24	,	,	PUNCT
cuesj-1229	76	25	especially	especially	ADV
cuesj-1229	76	26	during	during	ADP
cuesj-1229	76	27	pregnancy	pregnancy	NOUN
cuesj-1229	76	28	.	.	PUNCT
cuesj-1229	77	1	furthermore	furthermore	ADV
cuesj-1229	77	2	,	,	PUNCT
cuesj-1229	77	3	urgent	urgent	ADJ
cuesj-1229	77	4	attention	attention	NOUN
cuesj-1229	77	5	is	be	AUX
cuesj-1229	77	6	required	require	VERB
cuesj-1229	77	7	for	for	ADP
cuesj-1229	77	8	educational	educational	ADJ
cuesj-1229	77	9	programs	program	NOUN
cuesj-1229	77	10	targeting	target	VERB
cuesj-1229	77	11	health	health	NOUN
cuesj-1229	77	12	-	-	PUNCT
cuesj-1229	77	13	care	care	NOUN
cuesj-1229	77	14	workers	worker	NOUN
cuesj-1229	77	15	and	and	CCONJ
cuesj-1229	77	16	pregnant	pregnant	ADJ
cuesj-1229	77	17	women	woman	NOUN
cuesj-1229	77	18	during	during	ADP
cuesj-1229	77	19	antenatal	antenatal	ADJ
cuesj-1229	77	20	care.[21	care.[21	NOUN
cuesj-1229	77	21	]	]	PUNCT
cuesj-1229	77	22	the	the	DET
cuesj-1229	77	23	study	study	NOUN
cuesj-1229	77	24	of	of	ADP
cuesj-1229	77	25	infectious	infectious	ADJ
cuesj-1229	77	26	diseases	disease	NOUN
cuesj-1229	77	27	affecting	affect	VERB
cuesj-1229	77	28	both	both	DET
cuesj-1229	77	29	mothers	mother	NOUN
cuesj-1229	77	30	and	and	CCONJ
cuesj-1229	77	31	fetuses	fetus	NOUN
cuesj-1229	77	32	is	be	AUX
cuesj-1229	77	33	vital	vital	ADJ
cuesj-1229	77	34	in	in	ADP
cuesj-1229	77	35	the	the	DET
cuesj-1229	77	36	realms	realm	NOUN
cuesj-1229	77	37	of	of	ADP
cuesj-1229	77	38	neonatology	neonatology	NOUN
cuesj-1229	77	39	and	and	CCONJ
cuesj-1229	77	40	obstetrics	obstetric	NOUN
cuesj-1229	77	41	-	-	PUNCT
cuesj-1229	77	42	gynecology	gynecology	NOUN
cuesj-1229	77	43	,	,	PUNCT
cuesj-1229	77	44	as	as	SCONJ
cuesj-1229	77	45	it	it	PRON
cuesj-1229	77	46	directly	directly	ADV
cuesj-1229	77	47	affects	affect	VERB
cuesj-1229	77	48	both	both	DET
cuesj-1229	77	49	fields	field	NOUN
cuesj-1229	77	50	’	'	PUNCT
cuesj-1229	77	51	health	health	NOUN
cuesj-1229	77	52	individuals.[22	individuals.[22	PROPN
cuesj-1229	77	53	]	]	PUNCT
cuesj-1229	77	54	such	such	ADJ
cuesj-1229	77	55	infections	infection	NOUN
cuesj-1229	77	56	are	be	AUX
cuesj-1229	77	57	more	more	ADV
cuesj-1229	77	58	prevalent	prevalent	ADJ
cuesj-1229	77	59	among	among	ADP
cuesj-1229	77	60	immunodeficient	immunodeficient	NOUN
cuesj-1229	77	61	populations	population	NOUN
cuesj-1229	77	62	,	,	PUNCT
cuesj-1229	77	63	including	include	VERB
cuesj-1229	77	64	those	those	DET
cuesj-1229	77	65	hiv	hiv	PROPN
cuesj-1229	77	66	infections	infection	NOUN
cuesj-1229	77	67	,	,	PUNCT
cuesj-1229	77	68	organ	organ	NOUN
cuesj-1229	77	69	transplants	transplant	NOUN
cuesj-1229	77	70	,	,	PUNCT
cuesj-1229	77	71	and	and	CCONJ
cuesj-1229	77	72	other	other	ADJ
cuesj-1229	77	73	conditions	condition	NOUN
cuesj-1229	77	74	compromising	compromise	VERB
cuesj-1229	77	75	the	the	DET
cuesj-1229	77	76	immune	immune	ADJ
cuesj-1229	77	77	system.[23,24	system.[23,24	NOUN
cuesj-1229	77	78	]	]	PUNCT
cuesj-1229	77	79	this	this	DET
cuesj-1229	77	80	research	research	NOUN
cuesj-1229	77	81	underscores	underscore	VERB
cuesj-1229	77	82	the	the	DET
cuesj-1229	77	83	importance	importance	NOUN
cuesj-1229	77	84	of	of	ADP
cuesj-1229	77	85	conducting	conduct	VERB
cuesj-1229	77	86	serological	serological	ADJ
cuesj-1229	77	87	tests	test	NOUN
cuesj-1229	77	88	for	for	ADP
cuesj-1229	77	89	infectious	infectious	ADJ
cuesj-1229	77	90	agents	agent	NOUN
cuesj-1229	77	91	included	include	VERB
cuesj-1229	77	92	in	in	ADP
cuesj-1229	77	93	the	the	DET
cuesj-1229	77	94	torch	torch	NOUN
cuesj-1229	77	95	panel	panel	NOUN
cuesj-1229	77	96	within	within	ADP
cuesj-1229	77	97	the	the	DET
cuesj-1229	77	98	population	population	NOUN
cuesj-1229	77	99	.	.	PUNCT
cuesj-1229	78	1	this	this	PRON
cuesj-1229	78	2	is	be	AUX
cuesj-1229	78	3	crucial	crucial	ADJ
cuesj-1229	78	4	for	for	ADP
cuesj-1229	78	5	assessing	assess	VERB
cuesj-1229	78	6	the	the	DET
cuesj-1229	78	7	overall	overall	ADJ
cuesj-1229	78	8	health	health	NOUN
cuesj-1229	78	9	status	status	NOUN
cuesj-1229	78	10	,	,	PUNCT
cuesj-1229	78	11	particularly	particularly	ADV
cuesj-1229	78	12	among	among	ADP
cuesj-1229	78	13	females	female	NOUN
cuesj-1229	78	14	,	,	PUNCT
cuesj-1229	78	15	and	and	CCONJ
cuesj-1229	78	16	for	for	ADP
cuesj-1229	78	17	preventing	prevent	VERB
cuesj-1229	78	18	infections	infection	NOUN
cuesj-1229	78	19	during	during	ADP
cuesj-1229	78	20	pregnancy	pregnancy	NOUN
cuesj-1229	78	21	.	.	PUNCT
cuesj-1229	79	1	in	in	ADP
cuesj-1229	79	2	our	our	PRON
cuesj-1229	79	3	current	current	ADJ
cuesj-1229	79	4	study	study	NOUN
cuesj-1229	79	5	,	,	PUNCT
cuesj-1229	79	6	the	the	DET
cuesj-1229	79	7	prevalence	prevalence	NOUN
cuesj-1229	79	8	of	of	ADP
cuesj-1229	79	9	all	all	DET
cuesj-1229	79	10	five	five	NUM
cuesj-1229	79	11	agents	agent	NOUN
cuesj-1229	79	12	was	be	AUX
cuesj-1229	79	13	relatively	relatively	ADV
cuesj-1229	79	14	low	low	ADJ
cuesj-1229	79	15	.	.	PUNCT
cuesj-1229	80	1	this	this	PRON
cuesj-1229	80	2	may	may	AUX
cuesj-1229	80	3	be	be	AUX
cuesj-1229	80	4	attributed	attribute	VERB
cuesj-1229	80	5	to	to	ADP
cuesj-1229	80	6	the	the	DET
cuesj-1229	80	7	improvement	improvement	NOUN
cuesj-1229	80	8	of	of	ADP
cuesj-1229	80	9	life	life	NOUN
cuesj-1229	80	10	quality	quality	NOUN
cuesj-1229	80	11	in	in	ADP
cuesj-1229	80	12	erbil	erbil	PROPN
cuesj-1229	80	13	city	city	PROPN
cuesj-1229	80	14	and	and	CCONJ
cuesj-1229	80	15	the	the	DET
cuesj-1229	80	16	increase	increase	NOUN
cuesj-1229	80	17	in	in	ADP
cuesj-1229	80	18	education	education	NOUN
cuesj-1229	80	19	regarding	regard	VERB
cuesj-1229	80	20	infectious	infectious	ADJ
cuesj-1229	80	21	diseases	disease	NOUN
cuesj-1229	80	22	,	,	PUNCT
cuesj-1229	80	23	in	in	ADP
cuesj-1229	80	24	addition	addition	NOUN
cuesj-1229	80	25	to	to	ADP
cuesj-1229	80	26	the	the	DET
cuesj-1229	80	27	mandatory	mandatory	ADJ
cuesj-1229	80	28	vaccination	vaccination	NOUN
cuesj-1229	80	29	programs	program	NOUN
cuesj-1229	80	30	implemented	implement	VERB
cuesj-1229	80	31	on	on	ADP
cuesj-1229	80	32	all	all	DET
cuesj-1229	80	33	children	child	NOUN
cuesj-1229	80	34	and	and	CCONJ
cuesj-1229	80	35	adults	adult	NOUN
cuesj-1229	80	36	,	,	PUNCT
cuesj-1229	80	37	especially	especially	ADV
cuesj-1229	80	38	pregnant	pregnant	ADJ
cuesj-1229	80	39	women	woman	NOUN
cuesj-1229	80	40	.	.	PUNCT
cuesj-1229	81	1	in	in	ADP
cuesj-1229	81	2	a	a	DET
cuesj-1229	81	3	previous	previous	ADJ
cuesj-1229	81	4	study	study	NOUN
cuesj-1229	81	5	examining	examine	VERB
cuesj-1229	81	6	the	the	DET
cuesj-1229	81	7	prevalence	prevalence	NOUN
cuesj-1229	81	8	of	of	ADP
cuesj-1229	81	9	torch	torch	NOUN
cuesj-1229	81	10	panel	panel	NOUN
cuesj-1229	81	11	,	,	PUNCT
cuesj-1229	81	12	serum	serum	NOUN
cuesj-1229	81	13	igg	igg	PROPN
cuesj-1229	81	14	testing	testing	NOUN
cuesj-1229	81	15	for	for	ADP
cuesj-1229	81	16	infections	infection	NOUN
cuesj-1229	81	17	revealed	reveal	VERB
cuesj-1229	81	18	positive	positive	ADJ
cuesj-1229	81	19	results	result	NOUN
cuesj-1229	81	20	for	for	ADP
cuesj-1229	81	21	t.	t.	NOUN
cuesj-1229	81	22	gondii	gondii	NOUN
cuesj-1229	81	23	at	at	ADP
cuesj-1229	81	24	27.4	27.4	NUM
cuesj-1229	81	25	%	%	NOUN
cuesj-1229	81	26	,	,	PUNCT
cuesj-1229	81	27	hsv-1	hsv-1	X
cuesj-1229	81	28	at	at	ADP
cuesj-1229	81	29	94.7	94.7	NUM
cuesj-1229	81	30	%	%	NOUN
cuesj-1229	81	31	,	,	PUNCT
cuesj-1229	81	32	and	and	CCONJ
cuesj-1229	81	33	hsv-2	hsv-2	PUNCT
cuesj-1229	81	34	among	among	ADP
cuesj-1229	81	35	women	woman	NOUN
cuesj-1229	81	36	visiting	visit	VERB
cuesj-1229	81	37	the	the	DET
cuesj-1229	81	38	prenatal	prenatal	ADJ
cuesj-1229	81	39	care	care	NOUN
cuesj-1229	81	40	clinic	clinic	NOUN
cuesj-1229	81	41	at	at	ADP
cuesj-1229	81	42	a	a	DET
cuesj-1229	81	43	maternity	maternity	NOUN
cuesj-1229	81	44	hospital	hospital	NOUN
cuesj-1229	81	45	in	in	ADP
cuesj-1229	81	46	abha	abha	NOUN
cuesj-1229	81	47	,	,	PUNCT
cuesj-1229	81	48	southwest	southwest	ADJ
cuesj-1229	81	49	saudi	saudi	PROPN
cuesj-1229	81	50	arabia	arabia	PROPN
cuesj-1229	81	51	0.5	0.5	NUM
cuesj-1229	81	52	%	%	NOUN
cuesj-1229	81	53	,	,	PUNCT
cuesj-1229	81	54	cmv	cmv	NOUN
cuesj-1229	81	55	at	at	ADP
cuesj-1229	81	56	100	100	NUM
cuesj-1229	81	57	%	%	NOUN
cuesj-1229	81	58	,	,	PUNCT
cuesj-1229	81	59	and	and	CCONJ
cuesj-1229	81	60	rubella	rubella	NOUN
cuesj-1229	81	61	at	at	ADP
cuesj-1229	81	62	88.9	88.9	NUM
cuesj-1229	81	63	%	%	NOUN
cuesj-1229	81	64	.	.	PUNCT
cuesj-1229	82	1	only	only	ADV
cuesj-1229	82	2	9.5	9.5	NUM
cuesj-1229	82	3	%	%	NOUN
cuesj-1229	82	4	of	of	ADP
cuesj-1229	82	5	serum	serum	NOUN
cuesj-1229	82	6	igm	igm	PROPN
cuesj-1229	82	7	tested	test	VERB
cuesj-1229	82	8	positive	positive	ADJ
cuesj-1229	82	9	for	for	ADP
cuesj-1229	82	10	cmv.[25	cmv.[25	ADJ
cuesj-1229	82	11	]	]	X
cuesj-1229	82	12	these	these	DET
cuesj-1229	82	13	findings	finding	NOUN
cuesj-1229	82	14	significantly	significantly	ADV
cuesj-1229	82	15	exceed	exceed	VERB
cuesj-1229	82	16	the	the	DET
cuesj-1229	82	17	results	result	NOUN
cuesj-1229	82	18	obtained	obtain	VERB
cuesj-1229	82	19	in	in	ADP
cuesj-1229	82	20	our	our	PRON
cuesj-1229	82	21	present	present	ADJ
cuesj-1229	82	22	study	study	NOUN
cuesj-1229	82	23	.	.	PUNCT
cuesj-1229	83	1	a	a	DET
cuesj-1229	83	2	nationwide	nationwide	ADJ
cuesj-1229	83	3	seroepidemiological	seroepidemiological	ADJ
cuesj-1229	83	4	investigation	investigation	NOUN
cuesj-1229	83	5	of	of	ADP
cuesj-1229	83	6	torch	torch	NOUN
cuesj-1229	83	7	was	be	AUX
cuesj-1229	83	8	carried	carry	VERB
cuesj-1229	83	9	out	out	ADP
cuesj-1229	83	10	among	among	ADP
cuesj-1229	83	11	rural	rural	ADJ
cuesj-1229	83	12	women	woman	NOUN
cuesj-1229	83	13	in	in	ADP
cuesj-1229	83	14	china	china	PROPN
cuesj-1229	83	15	to	to	PART
cuesj-1229	83	16	establish	establish	VERB
cuesj-1229	83	17	foundational	foundational	ADJ
cuesj-1229	83	18	data	datum	NOUN
cuesj-1229	83	19	regarding	regard	VERB
cuesj-1229	83	20	torch	torch	NOUN
cuesj-1229	83	21	prevalence	prevalence	NOUN
cuesj-1229	83	22	.	.	PUNCT
cuesj-1229	84	1	from	from	ADP
cuesj-1229	84	2	2010	2010	NUM
cuesj-1229	84	3	to	to	ADP
cuesj-1229	84	4	2012	2012	NUM
cuesj-1229	84	5	,	,	PUNCT
cuesj-1229	84	6	1,541,329	1,541,329	NUM
cuesj-1229	84	7	women	woman	NOUN
cuesj-1229	84	8	of	of	ADP
cuesj-1229	84	9	reproductive	reproductive	ADJ
cuesj-1229	84	10	age	age	NOUN
cuesj-1229	84	11	took	take	VERB
cuesj-1229	84	12	part	part	NOUN
cuesj-1229	84	13	in	in	ADP
cuesj-1229	84	14	the	the	DET
cuesj-1229	84	15	survey	survey	NOUN
cuesj-1229	84	16	.	.	PUNCT
cuesj-1229	85	1	anti	anti	ADJ
cuesj-1229	85	2	-	-	ADJ
cuesj-1229	85	3	cmv	cmv	ADJ
cuesj-1229	85	4	antibodies	antibody	NOUN
cuesj-1229	85	5	were	be	AUX
cuesj-1229	85	6	detected	detect	VERB
cuesj-1229	85	7	in	in	ADP
cuesj-1229	85	8	602,251	602,251	NUM
cuesj-1229	85	9	of	of	ADP
cuesj-1229	85	10	the	the	DET
cuesj-1229	85	11	samples	sample	NOUN
cuesj-1229	85	12	,	,	PUNCT
cuesj-1229	85	13	40,055	40,055	NUM
cuesj-1229	85	14	for	for	ADP
cuesj-1229	85	15	anti	anti	ADJ
cuesj-1229	85	16	-	-	ADJ
cuesj-1229	85	17	tox	tox	ADJ
cuesj-1229	85	18	antibodies	antibody	NOUN
cuesj-1229	85	19	,	,	PUNCT
cuesj-1229	85	20	and	and	CCONJ
cuesj-1229	85	21	858,072	858,072	NUM
cuesj-1229	85	22	for	for	ADP
cuesj-1229	85	23	anti	anti	ADJ
cuesj-1229	85	24	-	-	ADJ
cuesj-1229	85	25	rv	rv	ADJ
cuesj-1229	85	26	igg	igg	PROPN
cuesj-1229	85	27	antibodies	antibodie	VERB
cuesj-1229	85	28	.	.	PUNCT
cuesj-1229	86	1	young	young	ADJ
cuesj-1229	86	2	individuals	individual	NOUN
cuesj-1229	86	3	(	(	PUNCT
cuesj-1229	86	4	25–34	25–34	NUM
cuesj-1229	86	5	years	year	NOUN
cuesj-1229	86	6	)	)	PUNCT
cuesj-1229	86	7	had	have	VERB
cuesj-1229	86	8	significantly	significantly	ADV
cuesj-1229	86	9	greater	great	ADJ
cuesj-1229	86	10	torch	torch	NOUN
cuesj-1229	86	11	prevalence	prevalence	NOUN
cuesj-1229	86	12	(	(	PUNCT
cuesj-1229	86	13	p	p	X
cuesj-1229	86	14	<	<	X
cuesj-1229	86	15	0.0001	0.0001	NUM
cuesj-1229	86	16	)	)	PUNCT
cuesj-1229	86	17	.	.	PUNCT
cuesj-1229	87	1	49,988	49,988	NUM
cuesj-1229	87	2	(	(	PUNCT
cuesj-1229	87	3	72.2	72.2	NUM
cuesj-1229	87	4	%	%	NOUN
cuesj-1229	87	5	)	)	PUNCT
cuesj-1229	87	6	of	of	ADP
cuesj-1229	87	7	the	the	DET
cuesj-1229	87	8	69,220	69,220	NUM
cuesj-1229	87	9	women	woman	NOUN
cuesj-1229	87	10	(	(	PUNCT
cuesj-1229	87	11	4.49	4.49	NUM
cuesj-1229	87	12	%	%	NOUN
cuesj-1229	87	13	)	)	PUNCT
cuesj-1229	87	14	who	who	PRON
cuesj-1229	87	15	had	have	AUX
cuesj-1229	87	16	gotten	get	VERB
cuesj-1229	87	17	the	the	DET
cuesj-1229	87	18	rv	rv	PROPN
cuesj-1229	87	19	vaccine	vaccine	NOUN
cuesj-1229	87	20	had	have	AUX
cuesj-1229	87	21	gained	gain	VERB
cuesj-1229	87	22	immunity	immunity	NOUN
cuesj-1229	87	23	as	as	ADP
cuesj-1229	87	24	a	a	DET
cuesj-1229	87	25	result	result	NOUN
cuesj-1229	87	26	of	of	ADP
cuesj-1229	87	27	it	it	PRON
cuesj-1229	87	28	.	.	PUNCT
cuesj-1229	88	1	6,107	6,107	NUM
cuesj-1229	88	2	(	(	PUNCT
cuesj-1229	88	3	0.40	0.40	NUM
cuesj-1229	88	4	%	%	NOUN
cuesj-1229	88	5	)	)	PUNCT
cuesj-1229	88	6	of	of	ADP
cuesj-1229	88	7	the	the	DET
cuesj-1229	88	8	1,541,329	1,541,329	NUM
cuesj-1229	88	9	women	woman	NOUN
cuesj-1229	88	10	had	have	VERB
cuesj-1229	88	11	positive	positive	ADJ
cuesj-1229	88	12	anti	anti	ADJ
cuesj-1229	88	13	-	-	ADJ
cuesj-1229	88	14	tox	tox	ADJ
cuesj-1229	88	15	igm	igm	NOUN
cuesj-1229	88	16	antibody	antibody	NOUN
cuesj-1229	88	17	tests	test	NOUN
cuesj-1229	88	18	,	,	PUNCT
cuesj-1229	88	19	while	while	SCONJ
cuesj-1229	88	20	6,646	6,646	NUM
cuesj-1229	88	21	(	(	PUNCT
cuesj-1229	88	22	0.43	0.43	NUM
cuesj-1229	88	23	%	%	NOUN
cuesj-1229	88	24	)	)	PUNCT
cuesj-1229	88	25	had	have	VERB
cuesj-1229	88	26	positive	positive	ADJ
cuesj-1229	88	27	anticmv	anticmv	ADJ
cuesj-1229	88	28	igm	igm	NOUN
cuesj-1229	88	29	antibody	antibody	NOUN
cuesj-1229	88	30	tests	test	NOUN
cuesj-1229	88	31	,	,	PUNCT
cuesj-1229	88	32	indicating	indicate	VERB
cuesj-1229	88	33	tox	tox	NOUN
cuesj-1229	88	34	and	and	CCONJ
cuesj-1229	88	35	cmv	cmv	NOUN
cuesj-1229	88	36	infections	infection	NOUN
cuesj-1229	88	37	.	.	PUNCT
cuesj-1229	89	1	these	these	DET
cuesj-1229	89	2	findings	finding	NOUN
cuesj-1229	89	3	were	be	AUX
cuesj-1229	89	4	discovered	discover	VERB
cuesj-1229	89	5	to	to	PART
cuesj-1229	89	6	be	be	AUX
cuesj-1229	89	7	lower	low	ADJ
cuesj-1229	89	8	than	than	ADP
cuesj-1229	89	9	in	in	ADP
cuesj-1229	89	10	prior	prior	ADJ
cuesj-1229	89	11	research	research	NOUN
cuesj-1229	89	12	,	,	PUNCT
cuesj-1229	89	13	presumably	presumably	ADV
cuesj-1229	89	14	due	due	ADP
cuesj-1229	89	15	to	to	ADP
cuesj-1229	89	16	advances	advance	NOUN
cuesj-1229	89	17	in	in	ADP
cuesj-1229	89	18	living	living	NOUN
cuesj-1229	89	19	standards	standard	NOUN
cuesj-1229	89	20	and	and	CCONJ
cuesj-1229	89	21	health	health	NOUN
cuesj-1229	89	22	practices	practice	NOUN
cuesj-1229	89	23	in	in	ADP
cuesj-1229	89	24	china.[26	china.[26	NOUN
cuesj-1229	89	25	]	]	PUNCT
cuesj-1229	89	26	there	there	PRON
cuesj-1229	89	27	are	be	VERB
cuesj-1229	89	28	large	large	ADJ
cuesj-1229	89	29	regional	regional	ADJ
cuesj-1229	89	30	variations	variation	NOUN
cuesj-1229	89	31	in	in	ADP
cuesj-1229	89	32	the	the	DET
cuesj-1229	89	33	incidence	incidence	NOUN
cuesj-1229	89	34	of	of	ADP
cuesj-1229	89	35	torch	torch	NOUN
cuesj-1229	89	36	infections	infection	NOUN
cuesj-1229	89	37	in	in	ADP
cuesj-1229	89	38	women	woman	NOUN
cuesj-1229	89	39	who	who	PRON
cuesj-1229	89	40	are	be	AUX
cuesj-1229	89	41	fertile	fertile	ADJ
cuesj-1229	89	42	.	.	PUNCT
cuesj-1229	90	1	for	for	ADP
cuesj-1229	90	2	example	example	NOUN
cuesj-1229	90	3	,	,	PUNCT
cuesj-1229	90	4	the	the	DET
cuesj-1229	90	5	percentage	percentage	NOUN
cuesj-1229	90	6	of	of	ADP
cuesj-1229	90	7	people	people	NOUN
cuesj-1229	90	8	who	who	PRON
cuesj-1229	90	9	contract	contract	VERB
cuesj-1229	90	10	tox	tox	NOUN
cuesj-1229	90	11	infections	infection	NOUN
cuesj-1229	90	12	varies	vary	VERB
cuesj-1229	90	13	from	from	ADP
cuesj-1229	90	14	roughly	roughly	ADV
cuesj-1229	90	15	10	10	NUM
cuesj-1229	90	16	%	%	NOUN
cuesj-1229	90	17	in	in	ADP
cuesj-1229	90	18	the	the	DET
cuesj-1229	90	19	us	us	PROPN
cuesj-1229	90	20	and	and	CCONJ
cuesj-1229	90	21	switzerland	switzerland	VERB
cuesj-1229	90	22	to	to	ADP
cuesj-1229	90	23	over	over	ADP
cuesj-1229	90	24	60	60	NUM
cuesj-1229	90	25	%	%	NOUN
cuesj-1229	90	26	in	in	ADP
cuesj-1229	90	27	iran	iran	PROPN
cuesj-1229	90	28	and	and	CCONJ
cuesj-1229	90	29	indonesia.[27	indonesia.[27	PROPN
cuesj-1229	90	30	]	]	PUNCT
cuesj-1229	90	31	comparably	comparably	ADV
cuesj-1229	90	32	,	,	PUNCT
cuesj-1229	90	33	cmv	cmv	NOUN
cuesj-1229	90	34	infections	infection	NOUN
cuesj-1229	90	35	show	show	VERB
cuesj-1229	90	36	variation	variation	NOUN
cuesj-1229	90	37	,	,	PUNCT
cuesj-1229	90	38	with	with	ADP
cuesj-1229	90	39	rates	rate	NOUN
cuesj-1229	90	40	as	as	ADV
cuesj-1229	90	41	high	high	ADJ
cuesj-1229	90	42	as	as	ADP
cuesj-1229	90	43	90	90	NUM
cuesj-1229	90	44	%	%	NOUN
cuesj-1229	90	45	in	in	ADP
cuesj-1229	90	46	turkey	turkey	PROPN
cuesj-1229	90	47	and	and	CCONJ
cuesj-1229	90	48	korea	korea	PROPN
cuesj-1229	90	49	and	and	CCONJ
cuesj-1229	90	50	fewer	few	ADJ
cuesj-1229	90	51	than	than	ADP
cuesj-1229	90	52	50	50	NUM
cuesj-1229	90	53	%	%	NOUN
cuesj-1229	90	54	in	in	ADP
cuesj-1229	90	55	ireland	ireland	PROPN
cuesj-1229	90	56	,	,	PUNCT
cuesj-1229	90	57	france	france	PROPN
cuesj-1229	90	58	,	,	PUNCT
cuesj-1229	90	59	and	and	CCONJ
cuesj-1229	90	60	the	the	DET
cuesj-1229	90	61	united	united	PROPN
cuesj-1229	90	62	kingdom.[28,29	kingdom.[28,29	PROPN
cuesj-1229	90	63	]	]	X
cuesj-1229	90	64	one	one	NUM
cuesj-1229	90	65	of	of	ADP
cuesj-1229	90	66	the	the	DET
cuesj-1229	90	67	most	most	ADV
cuesj-1229	90	68	populous	populous	ADJ
cuesj-1229	90	69	nations	nation	NOUN
cuesj-1229	90	70	,	,	PUNCT
cuesj-1229	90	71	china	china	PROPN
cuesj-1229	90	72	,	,	PUNCT
cuesj-1229	90	73	had	have	AUX
cuesj-1229	90	74	estimated	estimate	VERB
cuesj-1229	90	75	countrywide	countrywide	NOUN
cuesj-1229	90	76	seroprevalence	seroprevalence	NOUN
cuesj-1229	90	77	rates	rate	NOUN
cuesj-1229	90	78	of	of	ADP
cuesj-1229	90	79	2.3%,[30	2.3%,[30	NUM
cuesj-1229	90	80	]	]	PUNCT
cuesj-1229	90	81	38.6%,[31	38.6%,[31	NUM
cuesj-1229	90	82	]	]	PUNCT
cuesj-1229	90	83	and	and	CCONJ
cuesj-1229	90	84	58.4%[32	58.4%[32	NUM
cuesj-1229	90	85	]	]	PUNCT
cuesj-1229	90	86	for	for	ADP
cuesj-1229	90	87	tox	tox	NOUN
cuesj-1229	90	88	,	,	PUNCT
cuesj-1229	90	89	cmv	cmv	NOUN
cuesj-1229	90	90	,	,	PUNCT
cuesj-1229	90	91	and	and	CCONJ
cuesj-1229	90	92	rv	rv	PROPN
cuesj-1229	90	93	igg	igg	PROPN
cuesj-1229	90	94	antibodies	antibodie	VERB
cuesj-1229	90	95	in	in	ADP
cuesj-1229	90	96	2010	2010	NUM
cuesj-1229	90	97	and	and	CCONJ
cuesj-1229	90	98	2012	2012	NUM
cuesj-1229	90	99	.	.	PUNCT
cuesj-1229	91	1	in	in	ADP
cuesj-1229	91	2	a	a	DET
cuesj-1229	91	3	different	different	ADJ
cuesj-1229	91	4	study	study	NOUN
cuesj-1229	91	5	carried	carry	VERB
cuesj-1229	91	6	out	out	ADP
cuesj-1229	91	7	in	in	ADP
cuesj-1229	91	8	china	china	PROPN
cuesj-1229	91	9	,	,	PUNCT
cuesj-1229	91	10	which	which	PRON
cuesj-1229	91	11	involved	involve	VERB
cuesj-1229	91	12	women	woman	NOUN
cuesj-1229	91	13	in	in	ADP
cuesj-1229	91	14	the	the	DET
cuesj-1229	91	15	preconception	preconception	NOUN
cuesj-1229	91	16	stage	stage	NOUN
cuesj-1229	91	17	.	.	PUNCT
cuesj-1229	92	1	it	it	PRON
cuesj-1229	92	2	included	include	VERB
cuesj-1229	92	3	igg	igg	PROPN
cuesj-1229	92	4	antibodies	antibody	NOUN
cuesj-1229	92	5	for	for	ADP
cuesj-1229	92	6	tox	tox	NOUN
cuesj-1229	92	7	,	,	PUNCT
cuesj-1229	92	8	cmv	cmv	NOUN
cuesj-1229	92	9	,	,	PUNCT
cuesj-1229	92	10	and	and	CCONJ
cuesj-1229	92	11	rv	rv	PROPN
cuesj-1229	92	12	,	,	PUNCT
cuesj-1229	92	13	which	which	PRON
cuesj-1229	92	14	were	be	AUX
cuesj-1229	92	15	found	find	VERB
cuesj-1229	92	16	in	in	ADP
cuesj-1229	92	17	2,409,137	2,409,137	NUM
cuesj-1229	92	18	persons	person	NOUN
cuesj-1229	92	19	with	with	ADP
cuesj-1229	92	20	a	a	DET
cuesj-1229	92	21	prevalence	prevalence	NOUN
cuesj-1229	92	22	of	of	ADP
cuesj-1229	92	23	3.20	3.20	NUM
cuesj-1229	92	24	%	%	NOUN
cuesj-1229	92	25	(	(	PUNCT
cuesj-1229	92	26	95	95	NUM
cuesj-1229	92	27	%	%	NOUN
cuesj-1229	92	28	confidence	confidence	NOUN
cuesj-1229	92	29	interval	interval	NOUN
cuesj-1229	93	1	[	[	X
cuesj-1229	93	2	ci	ci	X
cuesj-1229	93	3	]	]	X
cuesj-1229	93	4	:	:	PUNCT
cuesj-1229	93	5	3.18	3.18	NUM
cuesj-1229	93	6	–	–	PUNCT
cuesj-1229	93	7	3.22	3.22	NUM
cuesj-1229	93	8	%	%	NOUN
cuesj-1229	93	9	)	)	PUNCT
cuesj-1229	93	10	,	,	PUNCT
cuesj-1229	93	11	77.67	77.67	NUM
cuesj-1229	93	12	%	%	NOUN
cuesj-1229	93	13	(	(	PUNCT
cuesj-1229	93	14	95	95	NUM
cuesj-1229	93	15	%	%	NOUN
cuesj-1229	93	16	ci	ci	NOUN
cuesj-1229	93	17	:	:	PUNCT
cuesj-1229	93	18	77.62–77.71	77.62–77.71	NUM
cuesj-1229	93	19	%	%	NOUN
cuesj-1229	93	20	)	)	PUNCT
cuesj-1229	93	21	,	,	PUNCT
cuesj-1229	93	22	and	and	CCONJ
cuesj-1229	93	23	76.03	76.03	NUM
cuesj-1229	93	24	%	%	NOUN
cuesj-1229	93	25	(	(	PUNCT
cuesj-1229	93	26	95	95	NUM
cuesj-1229	93	27	%	%	NOUN
cuesj-1229	93	28	ci	ci	NOUN
cuesj-1229	93	29	:	:	PUNCT
cuesj-1229	93	30	75.98–76.07	75.98–76.07	NUM
cuesj-1229	93	31	%	%	NOUN
cuesj-1229	93	32	)	)	PUNCT
cuesj-1229	93	33	,	,	PUNCT
cuesj-1229	93	34	in	in	ADP
cuesj-1229	93	35	tox	tox	NOUN
cuesj-1229	93	36	,	,	PUNCT
cuesj-1229	93	37	cmv	cmv	NOUN
cuesj-1229	93	38	,	,	PUNCT
cuesj-1229	93	39	and	and	CCONJ
cuesj-1229	93	40	rv	rv	PROPN
cuesj-1229	93	41	,	,	PUNCT
cuesj-1229	93	42	respectively	respectively	ADV
cuesj-1229	93	43	.	.	PUNCT
cuesj-1229	94	1	for	for	ADP
cuesj-1229	94	2	tox	tox	PROPN
cuesj-1229	94	3	,	,	PUNCT
cuesj-1229	94	4	rv	rv	PROPN
cuesj-1229	94	5	,	,	PUNCT
cuesj-1229	94	6	cmv	cmv	NOUN
cuesj-1229	94	7	,	,	PUNCT
cuesj-1229	94	8	hsv-1	hsv-1	PRON
cuesj-1229	94	9	,	,	PUNCT
cuesj-1229	94	10	and	and	CCONJ
cuesj-1229	94	11	hsv-2	hsv-2	X
cuesj-1229	94	12	,	,	PUNCT
cuesj-1229	94	13	the	the	DET
cuesj-1229	94	14	overall	overall	ADJ
cuesj-1229	94	15	igg	igg	PROPN
cuesj-1229	94	16	/	/	SYM
cuesj-1229	94	17	igm	igm	PROPN
cuesj-1229	94	18	seropositivity	seropositivity	NOUN
cuesj-1229	94	19	rates	rate	NOUN
cuesj-1229	94	20	in	in	ADP
cuesj-1229	94	21	china	china	PROPN
cuesj-1229	94	22	were	be	AUX
cuesj-1229	94	23	4.35%/0.35	4.35%/0.35	NUM
cuesj-1229	94	24	,	,	PUNCT
cuesj-1229	94	25	90%/0.63	90%/0.63	NOUN
cuesj-1229	94	26	,	,	PUNCT
cuesj-1229	94	27	96.79%/0.97	96.79%/0.97	NOUN
cuesj-1229	94	28	,	,	PUNCT
cuesj-1229	94	29	81.11%/0.14	81.11%/0.14	NUM
cuesj-1229	94	30	,	,	PUNCT
cuesj-1229	94	31	and	and	CCONJ
cuesj-1229	95	1	6.1%/0.19%.[3	6.1%/0.19%.[3	NUM
cuesj-1229	95	2	]	]	PUNCT
cuesj-1229	95	3	these	these	DET
cuesj-1229	95	4	figures	figure	NOUN
cuesj-1229	95	5	were	be	AUX
cuesj-1229	95	6	considerably	considerably	ADV
cuesj-1229	95	7	higher	high	ADJ
cuesj-1229	95	8	than	than	SCONJ
cuesj-1229	95	9	those	those	PRON
cuesj-1229	95	10	previously	previously	ADV
cuesj-1229	95	11	reported	report	VERB
cuesj-1229	95	12	in	in	ADP
cuesj-1229	95	13	croatia.[33	croatia.[33	PROPN
cuesj-1229	95	14	]	]	PUNCT
cuesj-1229	95	15	data	datum	NOUN
cuesj-1229	95	16	on	on	ADP
cuesj-1229	95	17	the	the	DET
cuesj-1229	95	18	seroprevalence	seroprevalence	NOUN
cuesj-1229	95	19	of	of	ADP
cuesj-1229	95	20	igg	igg	PROPN
cuesj-1229	95	21	and	and	CCONJ
cuesj-1229	95	22	igm	igm	PROPN
cuesj-1229	95	23	antibodies	antibody	NOUN
cuesj-1229	95	24	against	against	ADP
cuesj-1229	95	25	torch	torch	NOUN
cuesj-1229	95	26	compounds	compound	NOUN
cuesj-1229	95	27	in	in	ADP
cuesj-1229	95	28	romanian	romanian	ADJ
cuesj-1229	95	29	women	woman	NOUN
cuesj-1229	95	30	were	be	AUX
cuesj-1229	95	31	gathered	gather	VERB
cuesj-1229	95	32	by	by	ADP
cuesj-1229	95	33	a	a	DET
cuesj-1229	95	34	comprehensive	comprehensive	ADJ
cuesj-1229	95	35	analysis	analysis	NOUN
cuesj-1229	95	36	.	.	PUNCT
cuesj-1229	96	1	finding	find	VERB
cuesj-1229	96	2	population	population	NOUN
cuesj-1229	96	3	and	and	CCONJ
cuesj-1229	96	4	regional	regional	ADJ
cuesj-1229	96	5	variations	variation	NOUN
cuesj-1229	96	6	as	as	ADV
cuesj-1229	96	7	well	well	ADV
cuesj-1229	96	8	as	as	ADP
cuesj-1229	96	9	related	relate	VERB
cuesj-1229	96	10	risk	risk	NOUN
cuesj-1229	96	11	factors	factor	NOUN
cuesj-1229	96	12	were	be	AUX
cuesj-1229	96	13	the	the	DET
cuesj-1229	96	14	goal	goal	NOUN
cuesj-1229	96	15	.	.	PUNCT
cuesj-1229	97	1	twenty	twenty	NUM
cuesj-1229	97	2	studies	study	NOUN
cuesj-1229	97	3	were	be	AUX
cuesj-1229	97	4	included	include	VERB
cuesj-1229	97	5	in	in	ADP
cuesj-1229	97	6	the	the	DET
cuesj-1229	97	7	evaluation	evaluation	NOUN
cuesj-1229	97	8	,	,	PUNCT
cuesj-1229	97	9	and	and	CCONJ
cuesj-1229	97	10	they	they	PRON
cuesj-1229	97	11	showed	show	VERB
cuesj-1229	97	12	that	that	SCONJ
cuesj-1229	97	13	seroprevalence	seroprevalence	NOUN
cuesj-1229	97	14	rates	rate	NOUN
cuesj-1229	97	15	differed	differ	VERB
cuesj-1229	97	16	across	across	ADP
cuesj-1229	97	17	the	the	DET
cuesj-1229	97	18	nation	nation	NOUN
cuesj-1229	97	19	.	.	PUNCT
cuesj-1229	98	1	significantly	significantly	ADV
cuesj-1229	98	2	,	,	PUNCT
cuesj-1229	98	3	compared	compare	VERB
cuesj-1229	98	4	to	to	ADP
cuesj-1229	98	5	bihor	bihor	NOUN
cuesj-1229	98	6	,	,	PUNCT
cuesj-1229	98	7	anti	anti	ADJ
cuesj-1229	98	8	-	-	ADJ
cuesj-1229	98	9	t.	t.	ADJ
cuesj-1229	98	10	gondii	gondii	NOUN
cuesj-1229	98	11	igg	igg	PROPN
cuesj-1229	98	12	seroprevalence	seroprevalence	NOUN
cuesj-1229	98	13	rates	rate	NOUN
cuesj-1229	98	14	were	be	AUX
cuesj-1229	98	15	greater	great	ADJ
cuesj-1229	98	16	in	in	ADP
cuesj-1229	98	17	moldavia	moldavia	PROPN
cuesj-1229	98	18	and	and	CCONJ
cuesj-1229	98	19	banat	banat	PROPN
cuesj-1229	98	20	,	,	PUNCT
cuesj-1229	98	21	juma	juma	PROPN
cuesj-1229	98	22	,	,	PUNCT
cuesj-1229	98	23	et	et	PROPN
cuesj-1229	98	24	al	al	PROPN
cuesj-1229	98	25	.	.	PROPN
cuesj-1229	98	26	:	:	PUNCT
cuesj-1229	99	1	epidemiological	epidemiological	ADJ
cuesj-1229	99	2	insights	insight	NOUN
cuesj-1229	99	3	into	into	ADP
cuesj-1229	99	4	torch	torch	NOUN
cuesj-1229	99	5	29	29	NUM
cuesj-1229	99	6	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1229	99	7	cuesj	cuesj	ADJ
cuesj-1229	99	8	2024	2024	NUM
cuesj-1229	99	9	,	,	PUNCT
cuesj-1229	99	10	8	8	NUM
cuesj-1229	99	11	(	(	PUNCT
cuesj-1229	99	12	2	2	NUM
cuesj-1229	99	13	):	):	PUNCT
cuesj-1229	99	14	26	26	NUM
cuesj-1229	99	15	-	-	SYM
cuesj-1229	99	16	30	30	NUM
cuesj-1229	99	17	with	with	ADP
cuesj-1229	99	18	notable	notable	ADJ
cuesj-1229	99	19	declines	decline	NOUN
cuesj-1229	99	20	in	in	ADP
cuesj-1229	99	21	banat	banat	PROPN
cuesj-1229	99	22	.	.	PUNCT
cuesj-1229	100	1	higher	high	ADJ
cuesj-1229	100	2	t.	t.	PROPN
cuesj-1229	100	3	gondii	gondii	PROPN
cuesj-1229	100	4	igg	igg	PROPN
cuesj-1229	100	5	levels	level	NOUN
cuesj-1229	100	6	were	be	AUX
cuesj-1229	100	7	seen	see	VERB
cuesj-1229	100	8	in	in	ADP
cuesj-1229	100	9	older	old	ADJ
cuesj-1229	100	10	,	,	PUNCT
cuesj-1229	100	11	multiparous	multiparous	ADJ
cuesj-1229	100	12	,	,	PUNCT
cuesj-1229	100	13	rural	rural	ADJ
cuesj-1229	100	14	women	woman	NOUN
cuesj-1229	100	15	.	.	PUNCT
cuesj-1229	101	1	anti	anti	ADJ
cuesj-1229	101	2	-	-	ADJ
cuesj-1229	101	3	rubella	rubella	ADJ
cuesj-1229	101	4	igg	igg	NOUN
cuesj-1229	101	5	antibody	antibody	NOUN
cuesj-1229	101	6	prevalence	prevalence	NOUN
cuesj-1229	101	7	was	be	AUX
cuesj-1229	101	8	considerably	considerably	ADV
cuesj-1229	101	9	reduced	reduce	VERB
cuesj-1229	101	10	once	once	ADV
cuesj-1229	101	11	the	the	DET
cuesj-1229	101	12	anti	anti	ADJ
cuesj-1229	101	13	-	-	ADJ
cuesj-1229	101	14	rubella	rubella	ADJ
cuesj-1229	101	15	vaccine	vaccine	NOUN
cuesj-1229	101	16	was	be	AUX
cuesj-1229	101	17	introduced	introduce	VERB
cuesj-1229	101	18	although	although	SCONJ
cuesj-1229	101	19	recent	recent	ADJ
cuesj-1229	101	20	drops	drop	NOUN
cuesj-1229	101	21	in	in	ADP
cuesj-1229	101	22	immunization	immunization	NOUN
cuesj-1229	101	23	rates	rate	NOUN
cuesj-1229	101	24	have	have	AUX
cuesj-1229	101	25	caused	cause	VERB
cuesj-1229	101	26	some	some	DET
cuesj-1229	101	27	worry	worry	NOUN
cuesj-1229	101	28	.	.	PUNCT
cuesj-1229	102	1	geographic	geographic	ADJ
cuesj-1229	102	2	differences	difference	NOUN
cuesj-1229	102	3	were	be	AUX
cuesj-1229	102	4	noted	note	VERB
cuesj-1229	102	5	in	in	ADP
cuesj-1229	102	6	the	the	DET
cuesj-1229	102	7	seroprevalence	seroprevalence	NOUN
cuesj-1229	102	8	of	of	ADP
cuesj-1229	102	9	cmv	cmv	NOUN
cuesj-1229	102	10	and	and	CCONJ
cuesj-1229	102	11	hsv	hsv	PROPN
cuesj-1229	102	12	,	,	PUNCT
cuesj-1229	102	13	with	with	ADP
cuesj-1229	102	14	rural	rural	ADJ
cuesj-1229	102	15	areas	area	NOUN
cuesj-1229	102	16	typically	typically	ADV
cuesj-1229	102	17	having	have	VERB
cuesj-1229	102	18	higher	high	ADJ
cuesj-1229	102	19	rates	rate	NOUN
cuesj-1229	102	20	of	of	ADP
cuesj-1229	102	21	cmv	cmv	NOUN
cuesj-1229	102	22	and	and	CCONJ
cuesj-1229	102	23	hsv	hsv	PROPN
cuesj-1229	102	24	being	be	AUX
cuesj-1229	102	25	influenced	influence	VERB
cuesj-1229	102	26	by	by	ADP
cuesj-1229	102	27	variables	variable	NOUN
cuesj-1229	102	28	including	include	VERB
cuesj-1229	102	29	number	number	NOUN
cuesj-1229	102	30	of	of	ADP
cuesj-1229	102	31	sexual	sexual	ADJ
cuesj-1229	102	32	partners	partner	NOUN
cuesj-1229	102	33	and	and	CCONJ
cuesj-1229	102	34	education	education	NOUN
cuesj-1229	102	35	level	level	NOUN
cuesj-1229	102	36	.	.	PUNCT
cuesj-1229	103	1	in	in	ADP
cuesj-1229	103	2	many	many	ADJ
cuesj-1229	103	3	cases	case	NOUN
cuesj-1229	103	4	,	,	PUNCT
cuesj-1229	103	5	the	the	DET
cuesj-1229	103	6	simultaneous	simultaneous	ADJ
cuesj-1229	103	7	seroprevalence	seroprevalence	NOUN
cuesj-1229	103	8	of	of	ADP
cuesj-1229	103	9	several	several	ADJ
cuesj-1229	103	10	torch	torch	NOUN
cuesj-1229	103	11	components	component	NOUN
cuesj-1229	103	12	indicates	indicate	VERB
cuesj-1229	103	13	possible	possible	ADJ
cuesj-1229	103	14	shared	shared	ADJ
cuesj-1229	103	15	risk	risk	NOUN
cuesj-1229	103	16	factors.[34	factors.[34	NOUN
cuesj-1229	103	17	]	]	PUNCT
cuesj-1229	103	18	a	a	DET
cuesj-1229	103	19	study	study	NOUN
cuesj-1229	103	20	similar	similar	ADJ
cuesj-1229	103	21	to	to	ADP
cuesj-1229	103	22	the	the	DET
cuesj-1229	103	23	present	present	ADJ
cuesj-1229	103	24	one	one	NOUN
cuesj-1229	103	25	was	be	AUX
cuesj-1229	103	26	carried	carry	VERB
cuesj-1229	103	27	out	out	ADP
cuesj-1229	103	28	in	in	ADP
cuesj-1229	103	29	uzbekistan	uzbekistan	PROPN
cuesj-1229	103	30	,	,	PUNCT
cuesj-1229	103	31	focusing	focus	VERB
cuesj-1229	103	32	on	on	ADP
cuesj-1229	103	33	the	the	DET
cuesj-1229	103	34	analysis	analysis	NOUN
cuesj-1229	103	35	of	of	ADP
cuesj-1229	103	36	torch	torch	NOUN
cuesj-1229	103	37	infections	infection	NOUN
cuesj-1229	103	38	in	in	ADP
cuesj-1229	103	39	the	the	DET
cuesj-1229	103	40	republican	republican	ADJ
cuesj-1229	103	41	blood	blood	NOUN
cuesj-1229	103	42	transfusion	transfusion	NOUN
cuesj-1229	103	43	center	center	NOUN
cuesj-1229	103	44	among	among	ADP
cuesj-1229	103	45	blood	blood	NOUN
cuesj-1229	103	46	donors	donor	NOUN
cuesj-1229	103	47	.	.	PUNCT
cuesj-1229	104	1	out	out	ADP
cuesj-1229	104	2	of	of	ADP
cuesj-1229	104	3	the	the	DET
cuesj-1229	104	4	90	90	NUM
cuesj-1229	104	5	donors	donor	NOUN
cuesj-1229	104	6	examined	examine	VERB
cuesj-1229	104	7	,	,	PUNCT
cuesj-1229	104	8	66	66	NUM
cuesj-1229	104	9	were	be	AUX
cuesj-1229	104	10	men	man	NOUN
cuesj-1229	104	11	and	and	CCONJ
cuesj-1229	104	12	24	24	NUM
cuesj-1229	104	13	were	be	AUX
cuesj-1229	104	14	women	woman	NOUN
cuesj-1229	104	15	,	,	PUNCT
cuesj-1229	104	16	within	within	ADP
cuesj-1229	104	17	the	the	DET
cuesj-1229	104	18	age	age	NOUN
cuesj-1229	104	19	range	range	NOUN
cuesj-1229	104	20	of	of	ADP
cuesj-1229	104	21	18–60	18–60	NUM
cuesj-1229	104	22	years	year	NOUN
cuesj-1229	104	23	.	.	PUNCT
cuesj-1229	105	1	the	the	DET
cuesj-1229	105	2	study	study	NOUN
cuesj-1229	105	3	revealed	reveal	VERB
cuesj-1229	105	4	overall	overall	ADJ
cuesj-1229	105	5	seropositivity	seropositivity	NOUN
cuesj-1229	105	6	of	of	ADP
cuesj-1229	105	7	20	20	NUM
cuesj-1229	105	8	(	(	PUNCT
cuesj-1229	105	9	22.2	22.2	NUM
cuesj-1229	105	10	%	%	NOUN
cuesj-1229	105	11	)	)	PUNCT
cuesj-1229	105	12	,	,	PUNCT
cuesj-1229	105	13	90	90	NUM
cuesj-1229	105	14	(	(	PUNCT
cuesj-1229	105	15	100	100	NUM
cuesj-1229	105	16	%	%	NOUN
cuesj-1229	105	17	)	)	PUNCT
cuesj-1229	105	18	,	,	PUNCT
cuesj-1229	105	19	88	88	NUM
cuesj-1229	105	20	(	(	PUNCT
cuesj-1229	105	21	97.8	97.8	NUM
cuesj-1229	105	22	%	%	NOUN
cuesj-1229	105	23	)	)	PUNCT
cuesj-1229	105	24	,	,	PUNCT
cuesj-1229	105	25	and	and	CCONJ
cuesj-1229	105	26	90	90	NUM
cuesj-1229	105	27	(	(	PUNCT
cuesj-1229	105	28	100	100	NUM
cuesj-1229	105	29	%	%	NOUN
cuesj-1229	105	30	)	)	PUNCT
cuesj-1229	105	31	for	for	ADP
cuesj-1229	105	32	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	105	33	,	,	PUNCT
cuesj-1229	105	34	cmv	cmv	NOUN
cuesj-1229	105	35	,	,	PUNCT
cuesj-1229	105	36	rubella	rubella	NOUN
cuesj-1229	105	37	,	,	PUNCT
cuesj-1229	105	38	and	and	CCONJ
cuesj-1229	105	39	herpes	herpe	NOUN
cuesj-1229	105	40	,	,	PUNCT
cuesj-1229	105	41	respectively	respectively	ADV
cuesj-1229	105	42	,	,	PUNCT
cuesj-1229	105	43	based	base	VERB
cuesj-1229	105	44	on	on	ADP
cuesj-1229	105	45	igg	igg	PROPN
cuesj-1229	105	46	antibodies.[35	antibodies.[35	PROPN
cuesj-1229	105	47	]	]	PUNCT
cuesj-1229	105	48	the	the	DET
cuesj-1229	105	49	occurrence	occurrence	NOUN
cuesj-1229	105	50	of	of	ADP
cuesj-1229	105	51	rv	rv	PROPN
cuesj-1229	105	52	infection	infection	NOUN
cuesj-1229	105	53	in	in	ADP
cuesj-1229	105	54	industrialized	industrialized	ADJ
cuesj-1229	105	55	countries	country	NOUN
cuesj-1229	105	56	was	be	AUX
cuesj-1229	105	57	shown	show	VERB
cuesj-1229	105	58	to	to	PART
cuesj-1229	105	59	be	be	AUX
cuesj-1229	105	60	minimal	minimal	ADJ
cuesj-1229	105	61	,	,	PUNCT
cuesj-1229	105	62	primarily	primarily	ADV
cuesj-1229	105	63	attributed	attribute	VERB
cuesj-1229	105	64	to	to	ADP
cuesj-1229	105	65	vaccination	vaccination	NOUN
cuesj-1229	105	66	initiatives	initiative	NOUN
cuesj-1229	105	67	.	.	PUNCT
cuesj-1229	106	1	however	however	ADV
cuesj-1229	106	2	,	,	PUNCT
cuesj-1229	106	3	in	in	ADP
cuesj-1229	106	4	various	various	ADJ
cuesj-1229	106	5	countries	country	NOUN
cuesj-1229	106	6	,	,	PUNCT
cuesj-1229	106	7	nigeria	nigeria	PROPN
cuesj-1229	106	8	(	(	PUNCT
cuesj-1229	106	9	97.9	97.9	NUM
cuesj-1229	106	10	%	%	NOUN
cuesj-1229	106	11	)	)	PUNCT
cuesj-1229	106	12	,	,	PUNCT
cuesj-1229	106	13	turkey	turkey	NOUN
cuesj-1229	106	14	(	(	PUNCT
cuesj-1229	106	15	96.3%),[36	96.3%),[36	PROPN
cuesj-1229	106	16	]	]	X
cuesj-1229	106	17	india	india	PROPN
cuesj-1229	106	18	(	(	PUNCT
cuesj-1229	106	19	83.4	83.4	NUM
cuesj-1229	106	20	%	%	NOUN
cuesj-1229	106	21	)	)	PUNCT
cuesj-1229	106	22	,	,	PUNCT
cuesj-1229	106	23	and	and	CCONJ
cuesj-1229	106	24	southern	southern	PROPN
cuesj-1229	106	25	italy	italy	PROPN
cuesj-1229	106	26	(	(	PUNCT
cuesj-1229	106	27	85.8%)[37	85.8%)[37	NOUN
cuesj-1229	106	28	]	]	PUNCT
cuesj-1229	106	29	are	be	AUX
cuesj-1229	106	30	among	among	ADP
cuesj-1229	106	31	the	the	DET
cuesj-1229	106	32	countries	country	NOUN
cuesj-1229	106	33	where	where	SCONJ
cuesj-1229	106	34	the	the	DET
cuesj-1229	106	35	frequency	frequency	NOUN
cuesj-1229	106	36	varies	vary	VERB
cuesj-1229	106	37	from	from	ADP
cuesj-1229	106	38	83.4	83.4	NUM
cuesj-1229	106	39	%	%	NOUN
cuesj-1229	106	40	to	to	ADP
cuesj-1229	106	41	97.9%.[38	97.9%.[38	NOUN
cuesj-1229	106	42	]	]	PUNCT
cuesj-1229	106	43	several	several	ADJ
cuesj-1229	106	44	studies	study	NOUN
cuesj-1229	106	45	have	have	AUX
cuesj-1229	106	46	been	be	AUX
cuesj-1229	106	47	conducted	conduct	VERB
cuesj-1229	106	48	in	in	ADP
cuesj-1229	106	49	erbil	erbil	PROPN
cuesj-1229	106	50	city	city	PROPN
cuesj-1229	106	51	for	for	ADP
cuesj-1229	106	52	the	the	DET
cuesj-1229	106	53	prevalence	prevalence	NOUN
cuesj-1229	106	54	of	of	ADP
cuesj-1229	106	55	certain	certain	ADJ
cuesj-1229	106	56	microbial	microbial	ADJ
cuesj-1229	106	57	diseases	disease	NOUN
cuesj-1229	106	58	,	,	PUNCT
cuesj-1229	106	59	including	include	VERB
cuesj-1229	106	60	torch,[39	torch,[39	NOUN
cuesj-1229	106	61	]	]	X
cuesj-1229	106	62	hiv	hiv	PROPN
cuesj-1229	106	63	,	,	PUNCT
cuesj-1229	106	64	hepatitis	hepatitis	PROPN
cuesj-1229	106	65	b	b	PROPN
cuesj-1229	106	66	virus	virus	NOUN
cuesj-1229	106	67	,	,	PUNCT
cuesj-1229	106	68	and	and	CCONJ
cuesj-1229	106	69	hepatitis	hepatitis	PROPN
cuesj-1229	106	70	c	c	PROPN
cuesj-1229	106	71	virus[40,41	virus[40,41	PROPN
cuesj-1229	106	72	]	]	PUNCT
cuesj-1229	106	73	in	in	ADP
cuesj-1229	106	74	dumpsite	dumpsite	ADJ
cuesj-1229	106	75	workers	worker	NOUN
cuesj-1229	106	76	,	,	PUNCT
cuesj-1229	106	77	all	all	PRON
cuesj-1229	106	78	of	of	ADP
cuesj-1229	106	79	which	which	PRON
cuesj-1229	106	80	call	call	VERB
cuesj-1229	106	81	for	for	ADP
cuesj-1229	106	82	an	an	DET
cuesj-1229	106	83	urge	urge	NOUN
cuesj-1229	106	84	for	for	ADP
cuesj-1229	106	85	microbiological	microbiological	ADJ
cuesj-1229	106	86	surveys	survey	NOUN
cuesj-1229	106	87	in	in	ADP
cuesj-1229	106	88	erbil	erbil	PROPN
cuesj-1229	106	89	city	city	PROPN
cuesj-1229	106	90	.	.	PUNCT
cuesj-1229	107	1	conclusion	conclusion	NOUN
cuesj-1229	107	2	our	our	PRON
cuesj-1229	107	3	current	current	ADJ
cuesj-1229	107	4	study	study	NOUN
cuesj-1229	107	5	could	could	AUX
cuesj-1229	107	6	be	be	AUX
cuesj-1229	107	7	considered	consider	VERB
cuesj-1229	107	8	a	a	DET
cuesj-1229	107	9	preliminary	preliminary	ADJ
cuesj-1229	107	10	study	study	NOUN
cuesj-1229	107	11	that	that	PRON
cuesj-1229	107	12	needs	need	VERB
cuesj-1229	107	13	further	further	ADJ
cuesj-1229	107	14	investigation	investigation	NOUN
cuesj-1229	107	15	.	.	PUNCT
cuesj-1229	108	1	it	it	PRON
cuesj-1229	108	2	emphasizes	emphasize	VERB
cuesj-1229	108	3	how	how	SCONJ
cuesj-1229	108	4	important	important	ADJ
cuesj-1229	108	5	it	it	PRON
cuesj-1229	108	6	is	be	AUX
cuesj-1229	108	7	to	to	PART
cuesj-1229	108	8	continue	continue	VERB
cuesj-1229	108	9	surveillance	surveillance	NOUN
cuesj-1229	108	10	and	and	CCONJ
cuesj-1229	108	11	take	take	VERB
cuesj-1229	108	12	preventative	preventative	ADJ
cuesj-1229	108	13	measures	measure	NOUN
cuesj-1229	108	14	,	,	PUNCT
cuesj-1229	108	15	such	such	ADJ
cuesj-1229	108	16	as	as	ADP
cuesj-1229	108	17	immunizations	immunization	NOUN
cuesj-1229	108	18	and	and	CCONJ
cuesj-1229	108	19	awareness	awareness	NOUN
cuesj-1229	108	20	campaigns	campaign	NOUN
cuesj-1229	108	21	to	to	PART
cuesj-1229	108	22	lessen	lessen	VERB
cuesj-1229	108	23	the	the	DET
cuesj-1229	108	24	negative	negative	ADJ
cuesj-1229	108	25	effects	effect	NOUN
cuesj-1229	108	26	on	on	ADP
cuesj-1229	108	27	pregnant	pregnant	ADJ
cuesj-1229	108	28	women	woman	NOUN
cuesj-1229	108	29	’s	’s	PART
cuesj-1229	108	30	health	health	NOUN
cuesj-1229	108	31	.	.	PUNCT
cuesj-1229	109	1	acknowledgments	acknowledgment	NOUN
cuesj-1229	109	2	we	we	PRON
cuesj-1229	109	3	would	would	AUX
cuesj-1229	109	4	like	like	VERB
cuesj-1229	109	5	to	to	PART
cuesj-1229	109	6	thank	thank	VERB
cuesj-1229	109	7	cihan	cihan	VERB
cuesj-1229	109	8	university	university	NOUN
cuesj-1229	109	9	-	-	PUNCT
cuesj-1229	109	10	erbil	erbil	PROPN
cuesj-1229	109	11	for	for	ADP
cuesj-1229	109	12	allowing	allow	VERB
cuesj-1229	109	13	us	we	PRON
cuesj-1229	109	14	to	to	PART
cuesj-1229	109	15	conduct	conduct	VERB
cuesj-1229	109	16	research	research	NOUN
cuesj-1229	109	17	at	at	ADP
cuesj-1229	109	18	their	their	PRON
cuesj-1229	109	19	laboratories	laboratory	NOUN
cuesj-1229	109	20	.	.	PUNCT
cuesj-1229	110	1	references	reference	NOUN
cuesj-1229	110	2	1	1	NUM
cuesj-1229	110	3	.	.	PUNCT
cuesj-1229	110	4	d.	d.	PROPN
cuesj-1229	110	5	fitzpatrick	fitzpatrick	PROPN
cuesj-1229	110	6	,	,	PUNCT
cuesj-1229	110	7	n.	n.	PROPN
cuesj-1229	110	8	e.	e.	PROPN
cuesj-1229	110	9	holmes	holmes	PROPN
cuesj-1229	110	10	and	and	CCONJ
cuesj-1229	110	11	l.	l.	PROPN
cuesj-1229	110	12	hui	hui	PROPN
cuesj-1229	110	13	.	.	PUNCT
cuesj-1229	111	1	a	a	DET
cuesj-1229	111	2	systematic	systematic	ADJ
cuesj-1229	111	3	review	review	NOUN
cuesj-1229	111	4	of	of	ADP
cuesj-1229	111	5	maternal	maternal	ADJ
cuesj-1229	111	6	torch	torch	NOUN
cuesj-1229	111	7	serology	serology	NOUN
cuesj-1229	111	8	as	as	ADP
cuesj-1229	111	9	a	a	DET
cuesj-1229	111	10	screen	screen	NOUN
cuesj-1229	111	11	for	for	ADP
cuesj-1229	111	12	suspected	suspect	VERB
cuesj-1229	111	13	fetal	fetal	ADJ
cuesj-1229	111	14	infection	infection	NOUN
cuesj-1229	111	15	.	.	PUNCT
cuesj-1229	112	1	prenatal	prenatal	ADJ
cuesj-1229	112	2	diagnosis	diagnosis	NOUN
cuesj-1229	112	3	,	,	PUNCT
cuesj-1229	112	4	vol	vol	NOUN
cuesj-1229	112	5	.	.	PROPN
cuesj-1229	112	6	42	42	NUM
cuesj-1229	112	7	,	,	PUNCT
cuesj-1229	112	8	no	no	INTJ
cuesj-1229	112	9	.	.	NOUN
cuesj-1229	112	10	1	1	NUM
cuesj-1229	112	11	,	,	PUNCT
cuesj-1229	112	12	pp	pp	ADJ
cuesj-1229	112	13	.	.	PUNCT
cuesj-1229	113	1	87	87	NUM
cuesj-1229	113	2	-	-	SYM
cuesj-1229	113	3	96	96	NUM
cuesj-1229	113	4	,	,	PUNCT
cuesj-1229	113	5	2022	2022	NUM
cuesj-1229	113	6	.	.	PUNCT
cuesj-1229	114	1	2	2	NUM
cuesj-1229	114	2	.	.	PUNCT
cuesj-1229	114	3	j.	j.	PROPN
cuesj-1229	114	4	penner	penner	PROPN
cuesj-1229	114	5	,	,	PUNCT
cuesj-1229	114	6	h.	h.	PROPN
cuesj-1229	114	7	hernstadt	hernstadt	PROPN
cuesj-1229	114	8	,	,	PUNCT
cuesj-1229	114	9	j.	j.	PROPN
cuesj-1229	114	10	e.	e.	PROPN
cuesj-1229	114	11	burns	burns	PROPN
cuesj-1229	114	12	,	,	PUNCT
cuesj-1229	114	13	p.	p.	PROPN
cuesj-1229	114	14	randell	randell	PROPN
cuesj-1229	114	15	and	and	CCONJ
cuesj-1229	114	16	h.	h.	PROPN
cuesj-1229	114	17	lyall	lyall	PROPN
cuesj-1229	114	18	.	.	PUNCT
cuesj-1229	115	1	stop	stop	PROPN
cuesj-1229	115	2	,	,	PUNCT
cuesj-1229	115	3	think	think	VERB
cuesj-1229	115	4	scortch	scortch	NOUN
cuesj-1229	115	5	:	:	PUNCT
cuesj-1229	115	6	rethinking	rethink	VERB
cuesj-1229	115	7	the	the	DET
cuesj-1229	115	8	traditional	traditional	ADJ
cuesj-1229	115	9	‘	'	PUNCT
cuesj-1229	115	10	torch	torch	NOUN
cuesj-1229	115	11	’	'	PUNCT
cuesj-1229	115	12	screen	screen	NOUN
cuesj-1229	115	13	in	in	ADP
cuesj-1229	115	14	an	an	DET
cuesj-1229	115	15	era	era	NOUN
cuesj-1229	115	16	of	of	ADP
cuesj-1229	115	17	re	re	ADJ
cuesj-1229	115	18	-	-	ADJ
cuesj-1229	115	19	emerging	emerge	VERB
cuesj-1229	115	20	syphilis	syphili	NOUN
cuesj-1229	115	21	.	.	PUNCT
cuesj-1229	116	1	archives	archive	NOUN
cuesj-1229	116	2	of	of	ADP
cuesj-1229	116	3	disease	disease	NOUN
cuesj-1229	116	4	in	in	ADP
cuesj-1229	116	5	childhood	childhood	NOUN
cuesj-1229	116	6	,	,	PUNCT
cuesj-1229	116	7	vol	vol	NOUN
cuesj-1229	116	8	.	.	PROPN
cuesj-1229	116	9	106	106	NUM
cuesj-1229	116	10	,	,	PUNCT
cuesj-1229	116	11	no	no	INTJ
cuesj-1229	116	12	.	.	NOUN
cuesj-1229	116	13	2	2	NUM
cuesj-1229	116	14	,	,	PUNCT
cuesj-1229	116	15	pp	pp	ADJ
cuesj-1229	116	16	.	.	PUNCT
cuesj-1229	117	1	117	117	NUM
cuesj-1229	117	2	-	-	SYM
cuesj-1229	117	3	124	124	NUM
cuesj-1229	117	4	,	,	PUNCT
cuesj-1229	117	5	2021	2021	NUM
cuesj-1229	117	6	.	.	PUNCT
cuesj-1229	118	1	3	3	X
cuesj-1229	118	2	.	.	X
cuesj-1229	118	3	l.	l.	PROPN
cuesj-1229	118	4	c.	c.	PROPN
cuesj-1229	118	5	wang	wang	PROPN
cuesj-1229	118	6	,	,	PUNCT
cuesj-1229	118	7	f.	f.	PROPN
cuesj-1229	118	8	yan	yan	PROPN
cuesj-1229	118	9	,	,	PUNCT
cuesj-1229	118	10	j.	j.	PROPN
cuesj-1229	118	11	x.	x.	PROPN
cuesj-1229	118	12	ruan	ruan	PROPN
cuesj-1229	118	13	,	,	PUNCT
cuesj-1229	118	14	y.	y.	PROPN
cuesj-1229	118	15	xiao	xiao	PROPN
cuesj-1229	118	16	and	and	CCONJ
cuesj-1229	118	17	y.	y.	PROPN
cuesj-1229	118	18	yu	yu	PROPN
cuesj-1229	118	19	.	.	PUNCT
cuesj-1229	119	1	torch	torch	NOUN
cuesj-1229	119	2	screening	screening	NOUN
cuesj-1229	119	3	used	use	VERB
cuesj-1229	119	4	appropriately	appropriately	ADV
cuesj-1229	119	5	in	in	ADP
cuesj-1229	119	6	china?-three	china?-three	NOUN
cuesj-1229	119	7	years	year	NOUN
cuesj-1229	119	8	results	result	NOUN
cuesj-1229	119	9	from	from	ADP
cuesj-1229	119	10	a	a	DET
cuesj-1229	119	11	teaching	teaching	NOUN
cuesj-1229	119	12	hospital	hospital	NOUN
cuesj-1229	119	13	in	in	ADP
cuesj-1229	119	14	northwest	northwest	PROPN
cuesj-1229	119	15	china	china	PROPN
cuesj-1229	119	16	.	.	PUNCT
cuesj-1229	120	1	bmc	bmc	ADJ
cuesj-1229	120	2	pregnancy	pregnancy	NOUN
cuesj-1229	120	3	childbirth	childbirth	NOUN
cuesj-1229	120	4	,	,	PUNCT
cuesj-1229	120	5	vol	vol	NOUN
cuesj-1229	120	6	.	.	PROPN
cuesj-1229	121	1	19	19	NUM
cuesj-1229	121	2	,	,	PUNCT
cuesj-1229	121	3	no	no	INTJ
cuesj-1229	121	4	.	.	NOUN
cuesj-1229	121	5	1	1	NUM
cuesj-1229	121	6	,	,	PUNCT
cuesj-1229	121	7	p.	p.	NOUN
cuesj-1229	121	8	484	484	NUM
cuesj-1229	121	9	,	,	PUNCT
cuesj-1229	121	10	2019	2019	NUM
cuesj-1229	121	11	.	.	PUNCT
cuesj-1229	122	1	4	4	X
cuesj-1229	122	2	.	.	PUNCT
cuesj-1229	122	3	j.	j.	PROPN
cuesj-1229	122	4	m.	m.	PROPN
cuesj-1229	122	5	warnecke	warnecke	PROPN
cuesj-1229	122	6	,	,	PUNCT
cuesj-1229	122	7	m.	m.	NOUN
cuesj-1229	122	8	pollmann	pollmann	PROPN
cuesj-1229	122	9	,	,	PUNCT
cuesj-1229	122	10	v.	v.	ADP
cuesj-1229	122	11	borchardt	borchardt	ADJ
cuesj-1229	122	12	-	-	PUNCT
cuesj-1229	122	13	lohölter	lohölter	NOUN
cuesj-1229	122	14	,	,	PUNCT
cuesj-1229	122	15	a.	a.	NOUN
cuesj-1229	122	16	moreirasoto	moreirasoto	PROPN
cuesj-1229	122	17	,	,	PUNCT
cuesj-1229	122	18	s.	s.	PROPN
cuesj-1229	122	19	kaya	kaya	PROPN
cuesj-1229	122	20	,	,	PUNCT
cuesj-1229	122	21	a.	a.	PROPN
cuesj-1229	122	22	g.	g.	PROPN
cuesj-1229	122	23	sener	sener	PROPN
cuesj-1229	122	24	,	,	PUNCT
cuesj-1229	122	25	e.	e.	PROPN
cuesj-1229	122	26	gómez	gómez	PROPN
cuesj-1229	122	27	-	-	PUNCT
cuesj-1229	122	28	guzmán	guzmán	NOUN
cuesj-1229	122	29	,	,	PUNCT
cuesj-1229	122	30	l.	l.	PROPN
cuesj-1229	122	31	figueroahernández	figueroahernández	PROPN
cuesj-1229	122	32	,	,	PUNCT
cuesj-1229	122	33	w.	w.	PROPN
cuesj-1229	122	34	li	li	PROPN
cuesj-1229	122	35	,	,	PUNCT
cuesj-1229	122	36	f.	f.	PROPN
cuesj-1229	122	37	li	li	PROPN
cuesj-1229	122	38	,	,	PUNCT
cuesj-1229	122	39	k.	k.	PROPN
cuesj-1229	122	40	buska	buska	PROPN
cuesj-1229	122	41	,	,	PUNCT
cuesj-1229	122	42	k.	k.	PROPN
cuesj-1229	122	43	zakaszewska	zakaszewska	PROPN
cuesj-1229	122	44	,	,	PUNCT
cuesj-1229	122	45	k.	k.	PROPN
cuesj-1229	122	46	ziolkowska	ziolkowska	PROPN
cuesj-1229	122	47	,	,	PUNCT
cuesj-1229	122	48	j.	j.	PROPN
cuesj-1229	122	49	janz	janz	PROPN
cuesj-1229	122	50	,	,	PUNCT
cuesj-1229	122	51	a.	a.	PROPN
cuesj-1229	122	52	ott	ott	PROPN
cuesj-1229	122	53	,	,	PUNCT
cuesj-1229	122	54	t.	t.	PROPN
cuesj-1229	122	55	scheper	scheper	NOUN
cuesj-1229	122	56	and	and	CCONJ
cuesj-1229	122	57	w.	w.	PROPN
cuesj-1229	122	58	meyer	meyer	PROPN
cuesj-1229	122	59	.	.	PUNCT
cuesj-1229	123	1	seroprevalences	seroprevalence	NOUN
cuesj-1229	123	2	of	of	ADP
cuesj-1229	123	3	antibodies	antibody	NOUN
cuesj-1229	123	4	against	against	ADP
cuesj-1229	123	5	torch	torch	NOUN
cuesj-1229	123	6	infectious	infectious	ADJ
cuesj-1229	123	7	pathogens	pathogen	NOUN
cuesj-1229	123	8	in	in	ADP
cuesj-1229	123	9	women	woman	NOUN
cuesj-1229	123	10	of	of	ADP
cuesj-1229	123	11	childbearing	childbeare	VERB
cuesj-1229	123	12	age	age	NOUN
cuesj-1229	123	13	residing	reside	VERB
cuesj-1229	123	14	in	in	ADP
cuesj-1229	123	15	brazil	brazil	PROPN
cuesj-1229	123	16	,	,	PUNCT
cuesj-1229	123	17	mexico	mexico	PROPN
cuesj-1229	123	18	,	,	PUNCT
cuesj-1229	123	19	germany	germany	PROPN
cuesj-1229	123	20	,	,	PUNCT
cuesj-1229	123	21	poland	poland	PROPN
cuesj-1229	123	22	,	,	PUNCT
cuesj-1229	123	23	turkey	turkey	PROPN
cuesj-1229	123	24	and	and	CCONJ
cuesj-1229	123	25	china	china	PROPN
cuesj-1229	123	26	.	.	PUNCT
cuesj-1229	124	1	epidemiology	epidemiology	NOUN
cuesj-1229	124	2	and	and	CCONJ
cuesj-1229	124	3	infection	infection	NOUN
cuesj-1229	124	4	,	,	PUNCT
cuesj-1229	124	5	vol	vol	NOUN
cuesj-1229	124	6	.	.	NOUN
cuesj-1229	124	7	148	148	NUM
cuesj-1229	124	8	,	,	PUNCT
cuesj-1229	124	9	p.	p.	NOUN
cuesj-1229	124	10	e271	e271	NUM
cuesj-1229	124	11	,	,	PUNCT
cuesj-1229	124	12	2020	2020	NUM
cuesj-1229	124	13	.	.	PUNCT
cuesj-1229	125	1	5	5	NUM
cuesj-1229	125	2	.	.	PUNCT
cuesj-1229	125	3	a.	a.	PROPN
cuesj-1229	125	4	jaan	jaan	PROPN
cuesj-1229	125	5	and	and	CCONJ
cuesj-1229	125	6	m.	m.	NOUN
cuesj-1229	125	7	rajnik	rajnik	PROPN
cuesj-1229	125	8	.	.	PUNCT
cuesj-1229	126	1	torch	torch	NOUN
cuesj-1229	126	2	complex	complex	NOUN
cuesj-1229	126	3	.	.	PUNCT
cuesj-1229	127	1	in	in	ADP
cuesj-1229	127	2	:	:	PUNCT
cuesj-1229	127	3	statpearls	statpearl	NOUN
cuesj-1229	127	4	.	.	PUNCT
cuesj-1229	128	1	statpearls	statpearls	PROPN
cuesj-1229	128	2	publishing	publishing	NOUN
cuesj-1229	128	3	,	,	PUNCT
cuesj-1229	128	4	treasure	treasure	NOUN
cuesj-1229	128	5	island	island	NOUN
cuesj-1229	128	6	,	,	PUNCT
cuesj-1229	128	7	fl	fl	PROPN
cuesj-1229	128	8	,	,	PUNCT
cuesj-1229	128	9	2023	2023	NUM
cuesj-1229	128	10	.	.	PUNCT
cuesj-1229	129	1	available	available	ADJ
cuesj-1229	129	2	:	:	PUNCT
cuesj-1229	130	1	https://www	https://www	PROPN
cuesj-1229	130	2	.	.	PUNCT
cuesj-1229	130	3	statpearls.com/xyz123	statpearls.com/xyz123	PROPN
cuesj-1229	130	4	.	.	PUNCT
cuesj-1229	131	1	[	[	X
cuesj-1229	131	2	last	last	ADV
cuesj-1229	131	3	accessed	access	VERB
cuesj-1229	131	4	on	on	ADP
cuesj-1229	131	5	jul	jul	PROPN
cuesj-1229	131	6	17	17	NUM
cuesj-1229	131	7	,	,	PUNCT
cuesj-1229	131	8	2023	2023	NUM
cuesj-1229	131	9	]	]	PUNCT
cuesj-1229	131	10	.	.	PUNCT
cuesj-1229	132	1	6	6	X
cuesj-1229	132	2	.	.	PUNCT
cuesj-1229	132	3	p.	p.	NOUN
cuesj-1229	132	4	batra	batra	PROPN
cuesj-1229	132	5	,	,	PUNCT
cuesj-1229	132	6	m.	m.	NOUN
cuesj-1229	132	7	batra	batra	PROPN
cuesj-1229	132	8	and	and	CCONJ
cuesj-1229	132	9	s.	s.	PROPN
cuesj-1229	132	10	singh	singh	PROPN
cuesj-1229	132	11	.	.	PUNCT
cuesj-1229	133	1	epidemiology	epidemiology	NOUN
cuesj-1229	133	2	of	of	ADP
cuesj-1229	133	3	torch	torch	NOUN
cuesj-1229	133	4	infections	infection	NOUN
cuesj-1229	133	5	and	and	CCONJ
cuesj-1229	133	6	understanding	understand	VERB
cuesj-1229	133	7	the	the	DET
cuesj-1229	133	8	serology	serology	NOUN
cuesj-1229	133	9	in	in	ADP
cuesj-1229	133	10	their	their	PRON
cuesj-1229	133	11	diagnosis	diagnosis	NOUN
cuesj-1229	133	12	.	.	PUNCT
cuesj-1229	134	1	journal	journal	NOUN
cuesj-1229	134	2	of	of	ADP
cuesj-1229	134	3	fetal	fetal	ADJ
cuesj-1229	134	4	medicine	medicine	NOUN
cuesj-1229	134	5	,	,	PUNCT
cuesj-1229	134	6	vol	vol	NOUN
cuesj-1229	134	7	.	.	PROPN
cuesj-1229	134	8	7	7	NUM
cuesj-1229	134	9	,	,	PUNCT
cuesj-1229	134	10	pp	pp	ADJ
cuesj-1229	134	11	.	.	PUNCT
cuesj-1229	135	1	25	25	NUM
cuesj-1229	135	2	-	-	SYM
cuesj-1229	135	3	29	29	NUM
cuesj-1229	135	4	,	,	PUNCT
cuesj-1229	135	5	2020	2020	NUM
cuesj-1229	135	6	.	.	PUNCT
cuesj-1229	136	1	7	7	X
cuesj-1229	136	2	.	.	X
cuesj-1229	136	3	y.	y.	PROPN
cuesj-1229	136	4	liu	liu	PROPN
cuesj-1229	136	5	,	,	PUNCT
cuesj-1229	136	6	y.	y.	PROPN
cuesj-1229	136	7	wu	wu	PROPN
cuesj-1229	136	8	,	,	PUNCT
cuesj-1229	136	9	f.	f.	PROPN
cuesj-1229	136	10	wang	wang	PROPN
cuesj-1229	136	11	,	,	PUNCT
cuesj-1229	136	12	s.	s.	PROPN
cuesj-1229	136	13	wang	wang	PROPN
cuesj-1229	136	14	,	,	PUNCT
cuesj-1229	136	15	w.	w.	PROPN
cuesj-1229	136	16	zhao	zhao	PROPN
cuesj-1229	136	17	,	,	PUNCT
cuesj-1229	136	18	l.	l.	PROPN
cuesj-1229	136	19	chen	chen	PROPN
cuesj-1229	136	20	,	,	PUNCT
cuesj-1229	136	21	s.	s.	PROPN
cuesj-1229	136	22	tu	tu	PROPN
cuesj-1229	136	23	,	,	PUNCT
cuesj-1229	136	24	y.	y.	PROPN
cuesj-1229	136	25	qian	qian	PROPN
cuesj-1229	136	26	,	,	PUNCT
cuesj-1229	136	27	y.	y.	PROPN
cuesj-1229	136	28	liao	liao	PROPN
cuesj-1229	136	29	,	,	PUNCT
cuesj-1229	136	30	y.	y.	PROPN
cuesj-1229	136	31	huang	huang	PROPN
cuesj-1229	136	32	,	,	PUNCT
cuesj-1229	136	33	r.	r.	PROPN
cuesj-1229	136	34	zhang	zhang	PROPN
cuesj-1229	136	35	,	,	PUNCT
cuesj-1229	136	36	g.	g.	PROPN
cuesj-1229	136	37	xu	xu	PROPN
cuesj-1229	136	38	and	and	CCONJ
cuesj-1229	136	39	d.	d.	PROPN
cuesj-1229	136	40	zhang	zhang	PROPN
cuesj-1229	136	41	.	.	PUNCT
cuesj-1229	137	1	the	the	DET
cuesj-1229	137	2	association	association	NOUN
cuesj-1229	137	3	between	between	ADP
cuesj-1229	137	4	previous	previous	ADJ
cuesj-1229	137	5	torch	torch	NOUN
cuesj-1229	137	6	infections	infection	NOUN
cuesj-1229	137	7	and	and	CCONJ
cuesj-1229	137	8	pregnancy	pregnancy	NOUN
cuesj-1229	137	9	and	and	CCONJ
cuesj-1229	137	10	neonatal	neonatal	ADJ
cuesj-1229	137	11	outcomes	outcome	NOUN
cuesj-1229	137	12	in	in	ADP
cuesj-1229	137	13	ivf	ivf	NOUN
cuesj-1229	137	14	/	/	SYM
cuesj-1229	137	15	icsi	icsi	NOUN
cuesj-1229	137	16	-	-	PUNCT
cuesj-1229	137	17	et	et	NOUN
cuesj-1229	137	18	:	:	PUNCT
cuesj-1229	137	19	a	a	DET
cuesj-1229	137	20	retrospective	retrospective	ADJ
cuesj-1229	137	21	cohort	cohort	NOUN
cuesj-1229	137	22	study	study	NOUN
cuesj-1229	137	23	.	.	PUNCT
cuesj-1229	138	1	frontiers	frontier	NOUN
cuesj-1229	138	2	in	in	ADP
cuesj-1229	138	3	endocrinology	endocrinology	NOUN
cuesj-1229	138	4	(	(	PUNCT
cuesj-1229	138	5	lausanne	lausanne	PROPN
cuesj-1229	138	6	)	)	PUNCT
cuesj-1229	138	7	,	,	PUNCT
cuesj-1229	138	8	vol	vol	NOUN
cuesj-1229	138	9	.	.	PROPN
cuesj-1229	138	10	11	11	NUM
cuesj-1229	138	11	,	,	PUNCT
cuesj-1229	138	12	p.	p.	NOUN
cuesj-1229	138	13	466	466	NUM
cuesj-1229	138	14	,	,	PUNCT
cuesj-1229	138	15	2020	2020	NUM
cuesj-1229	138	16	.	.	PUNCT
cuesj-1229	139	1	8	8	NUM
cuesj-1229	139	2	.	.	PUNCT
cuesj-1229	139	3	l.	l.	PROPN
cuesj-1229	139	4	zhang	zhang	PROPN
cuesj-1229	139	5	,	,	PUNCT
cuesj-1229	139	6	x.	x.	PROPN
cuesj-1229	139	7	wang	wang	PROPN
cuesj-1229	139	8	,	,	PUNCT
cuesj-1229	139	9	m.	m.	PROPN
cuesj-1229	139	10	liu	liu	PROPN
cuesj-1229	139	11	,	,	PUNCT
cuesj-1229	139	12	g.	g.	PROPN
cuesj-1229	139	13	feng	feng	PROPN
cuesj-1229	139	14	,	,	PUNCT
cuesj-1229	139	15	y.	y.	PROPN
cuesj-1229	139	16	zeng	zeng	PROPN
cuesj-1229	139	17	,	,	PUNCT
cuesj-1229	139	18	r.	r.	PROPN
cuesj-1229	139	19	wang	wang	PROPN
cuesj-1229	139	20	and	and	CCONJ
cuesj-1229	139	21	z.	z.	PROPN
cuesj-1229	139	22	xie	xie	PROPN
cuesj-1229	139	23	.	.	PUNCT
cuesj-1229	140	1	the	the	DET
cuesj-1229	140	2	epidemiology	epidemiology	NOUN
cuesj-1229	140	3	and	and	CCONJ
cuesj-1229	140	4	disease	disease	NOUN
cuesj-1229	140	5	burden	burden	NOUN
cuesj-1229	140	6	of	of	ADP
cuesj-1229	140	7	congenital	congenital	ADJ
cuesj-1229	140	8	torch	torch	NOUN
cuesj-1229	140	9	infections	infection	NOUN
cuesj-1229	140	10	among	among	ADP
cuesj-1229	140	11	hospitalized	hospitalize	VERB
cuesj-1229	140	12	children	child	NOUN
cuesj-1229	140	13	in	in	ADP
cuesj-1229	140	14	china	china	PROPN
cuesj-1229	140	15	:	:	PUNCT
cuesj-1229	140	16	a	a	DET
cuesj-1229	140	17	national	national	ADJ
cuesj-1229	140	18	cross	cross	ADJ
cuesj-1229	140	19	-	-	ADJ
cuesj-1229	140	20	sectional	sectional	ADJ
cuesj-1229	140	21	study	study	NOUN
cuesj-1229	140	22	.	.	PUNCT
cuesj-1229	141	1	plos	plos	PROPN
cuesj-1229	141	2	neglected	neglect	VERB
cuesj-1229	141	3	tropical	tropical	ADJ
cuesj-1229	141	4	diseases	disease	NOUN
cuesj-1229	141	5	,	,	PUNCT
cuesj-1229	141	6	vol	vol	NOUN
cuesj-1229	141	7	.	.	PROPN
cuesj-1229	142	1	16	16	NUM
cuesj-1229	142	2	,	,	PUNCT
cuesj-1229	142	3	no	no	INTJ
cuesj-1229	142	4	.	.	NOUN
cuesj-1229	142	5	10	10	NUM
cuesj-1229	142	6	,	,	PUNCT
cuesj-1229	142	7	p.	p.	PROPN
cuesj-1229	142	8	e0010861	e0010861	PROPN
cuesj-1229	142	9	,	,	PUNCT
cuesj-1229	142	10	2022	2022	NUM
cuesj-1229	142	11	.	.	PUNCT
cuesj-1229	143	1	9	9	NUM
cuesj-1229	143	2	.	.	PUNCT
cuesj-1229	143	3	j.	j.	PROPN
cuesj-1229	143	4	j.	j.	PROPN
cuesj-1229	143	5	bigna	bigna	PROPN
cuesj-1229	143	6	,	,	PUNCT
cuesj-1229	143	7	j.	j.	PROPN
cuesj-1229	143	8	n.	n.	PROPN
cuesj-1229	143	9	tochie	tochie	PROPN
cuesj-1229	143	10	,	,	PUNCT
cuesj-1229	143	11	d.	d.	PROPN
cuesj-1229	143	12	n.	n.	PROPN
cuesj-1229	143	13	tounouga	tounouga	PROPN
cuesj-1229	143	14	,	,	PUNCT
cuesj-1229	143	15	a.	a.	NOUN
cuesj-1229	143	16	o.	o.	PROPN
cuesj-1229	143	17	bekolo	bekolo	PROPN
cuesj-1229	143	18	,	,	PUNCT
cuesj-1229	143	19	n.	n.	PROPN
cuesj-1229	143	20	s.	s.	PROPN
cuesj-1229	143	21	ymele	ymele	PROPN
cuesj-1229	143	22	,	,	PUNCT
cuesj-1229	143	23	e.	e.	PROPN
cuesj-1229	143	24	l.	l.	PROPN
cuesj-1229	143	25	youda	youda	PROPN
cuesj-1229	143	26	and	and	CCONJ
cuesj-1229	143	27	j.	j.	PROPN
cuesj-1229	143	28	r.	r.	PROPN
cuesj-1229	143	29	nansseu	nansseu	PROPN
cuesj-1229	143	30	.	.	PUNCT
cuesj-1229	144	1	global	global	ADJ
cuesj-1229	144	2	,	,	PUNCT
cuesj-1229	144	3	regional	regional	ADJ
cuesj-1229	144	4	,	,	PUNCT
cuesj-1229	144	5	and	and	CCONJ
cuesj-1229	144	6	country	country	NOUN
cuesj-1229	144	7	seroprevalence	seroprevalence	NOUN
cuesj-1229	144	8	of	of	ADP
cuesj-1229	144	9	toxoplasma	toxoplasma	NOUN
cuesj-1229	144	10	gondii	gondii	NOUN
cuesj-1229	144	11	in	in	ADP
cuesj-1229	144	12	pregnant	pregnant	ADJ
cuesj-1229	144	13	women	woman	NOUN
cuesj-1229	144	14	:	:	PUNCT
cuesj-1229	144	15	a	a	DET
cuesj-1229	144	16	systematic	systematic	ADJ
cuesj-1229	144	17	review	review	NOUN
cuesj-1229	144	18	,	,	PUNCT
cuesj-1229	144	19	modelling	modelling	NOUN
cuesj-1229	144	20	and	and	CCONJ
cuesj-1229	144	21	meta	meta	ADJ
cuesj-1229	144	22	-	-	PUNCT
cuesj-1229	144	23	analysis	analysis	NOUN
cuesj-1229	144	24	.	.	PUNCT
cuesj-1229	145	1	scientific	scientific	ADJ
cuesj-1229	145	2	reports	report	NOUN
cuesj-1229	145	3	,	,	PUNCT
cuesj-1229	145	4	vol	vol	NOUN
cuesj-1229	145	5	.	.	PROPN
cuesj-1229	146	1	10	10	NUM
cuesj-1229	146	2	,	,	PUNCT
cuesj-1229	146	3	no	no	INTJ
cuesj-1229	146	4	.	.	NOUN
cuesj-1229	146	5	1	1	NUM
cuesj-1229	146	6	,	,	PUNCT
cuesj-1229	146	7	p.	p.	NOUN
cuesj-1229	146	8	12102	12102	NUM
cuesj-1229	146	9	,	,	PUNCT
cuesj-1229	146	10	2020	2020	NUM
cuesj-1229	146	11	.	.	PUNCT
cuesj-1229	147	1	10	10	NUM
cuesj-1229	147	2	.	.	PUNCT
cuesj-1229	147	3	y.	y.	PROPN
cuesj-1229	147	4	wang	wang	PROPN
cuesj-1229	147	5	,	,	PUNCT
cuesj-1229	147	6	s.	s.	PROPN
cuesj-1229	147	7	li	li	PROPN
cuesj-1229	147	8	,	,	PUNCT
cuesj-1229	147	9	n.	n.	PROPN
cuesj-1229	147	10	ma	ma	PROPN
cuesj-1229	147	11	,	,	PUNCT
cuesj-1229	147	12	q.	q.	PROPN
cuesj-1229	147	13	zhang	zhang	PROPN
cuesj-1229	147	14	,	,	PUNCT
cuesj-1229	147	15	h.	h.	PROPN
cuesj-1229	147	16	wang	wang	PROPN
cuesj-1229	147	17	,	,	PUNCT
cuesj-1229	147	18	j.	j.	PROPN
cuesj-1229	147	19	cui	cui	PROPN
cuesj-1229	147	20	and	and	CCONJ
cuesj-1229	147	21	s.	s.	PROPN
cuesj-1229	147	22	wang	wang	PROPN
cuesj-1229	147	23	.	.	PUNCT
cuesj-1229	148	1	the	the	DET
cuesj-1229	148	2	association	association	NOUN
cuesj-1229	148	3	of	of	ADP
cuesj-1229	148	4	torch	torch	NOUN
cuesj-1229	148	5	infection	infection	NOUN
cuesj-1229	148	6	and	and	CCONJ
cuesj-1229	148	7	congenital	congenital	ADJ
cuesj-1229	148	8	malformations	malformation	NOUN
cuesj-1229	148	9	:	:	PUNCT
cuesj-1229	148	10	a	a	DET
cuesj-1229	148	11	prospective	prospective	ADJ
cuesj-1229	148	12	study	study	NOUN
cuesj-1229	148	13	in	in	ADP
cuesj-1229	148	14	china	china	PROPN
cuesj-1229	148	15	.	.	PUNCT
cuesj-1229	149	1	european	european	PROPN
cuesj-1229	149	2	journal	journal	PROPN
cuesj-1229	149	3	of	of	ADP
cuesj-1229	149	4	obstetrics	obstetric	NOUN
cuesj-1229	149	5	and	and	CCONJ
cuesj-1229	149	6	gynecology	gynecology	NOUN
cuesj-1229	149	7	and	and	CCONJ
cuesj-1229	149	8	reproductive	reproductive	ADJ
cuesj-1229	149	9	biology	biology	NOUN
cuesj-1229	149	10	,	,	PUNCT
cuesj-1229	149	11	vol	vol	NOUN
cuesj-1229	149	12	.	.	PROPN
cuesj-1229	149	13	240	240	NUM
cuesj-1229	149	14	,	,	PUNCT
cuesj-1229	149	15	pp	pp	ADJ
cuesj-1229	149	16	.	.	PUNCT
cuesj-1229	150	1	336	336	NUM
cuesj-1229	150	2	-	-	SYM
cuesj-1229	150	3	340	340	NUM
cuesj-1229	150	4	,	,	PUNCT
cuesj-1229	150	5	2019	2019	NUM
cuesj-1229	150	6	.	.	PUNCT
cuesj-1229	151	1	11	11	NUM
cuesj-1229	151	2	.	.	PUNCT
cuesj-1229	152	1	s.	s.	PROPN
cuesj-1229	152	2	k.	k.	PROPN
cuesj-1229	152	3	matta	matta	PROPN
cuesj-1229	152	4	,	,	PUNCT
cuesj-1229	152	5	n.	n.	PROPN
cuesj-1229	152	6	rinkenberger	rinkenberger	PROPN
cuesj-1229	152	7	,	,	PUNCT
cuesj-1229	152	8	i.	i.	PROPN
cuesj-1229	152	9	r.	r.	PROPN
cuesj-1229	152	10	dunay	dunay	PROPN
cuesj-1229	152	11	and	and	CCONJ
cuesj-1229	152	12	l.	l.	PROPN
cuesj-1229	152	13	d.	d.	PROPN
cuesj-1229	152	14	sibley	sibley	PROPN
cuesj-1229	152	15	.	.	PUNCT
cuesj-1229	153	1	toxoplasma	toxoplasma	NOUN
cuesj-1229	153	2	gondii	gondii	NOUN
cuesj-1229	153	3	infection	infection	NOUN
cuesj-1229	153	4	and	and	CCONJ
cuesj-1229	153	5	its	its	PRON
cuesj-1229	153	6	implications	implication	NOUN
cuesj-1229	153	7	within	within	ADP
cuesj-1229	153	8	the	the	DET
cuesj-1229	153	9	central	central	ADJ
cuesj-1229	153	10	nervous	nervous	ADJ
cuesj-1229	153	11	system	system	NOUN
cuesj-1229	153	12	.	.	PUNCT
cuesj-1229	154	1	nature	nature	NOUN
cuesj-1229	154	2	reviews	review	VERB
cuesj-1229	154	3	microbiology	microbiology	NOUN
cuesj-1229	154	4	,	,	PUNCT
cuesj-1229	154	5	vol	vol	NOUN
cuesj-1229	154	6	.	.	PROPN
cuesj-1229	154	7	19	19	NUM
cuesj-1229	154	8	,	,	PUNCT
cuesj-1229	154	9	no	no	INTJ
cuesj-1229	154	10	.	.	NOUN
cuesj-1229	154	11	7	7	NUM
cuesj-1229	154	12	,	,	PUNCT
cuesj-1229	154	13	pp	pp	ADJ
cuesj-1229	154	14	.	.	PUNCT
cuesj-1229	154	15	467	467	NUM
cuesj-1229	154	16	-	-	SYM
cuesj-1229	154	17	480	480	NUM
cuesj-1229	154	18	,	,	PUNCT
cuesj-1229	154	19	2021	2021	NUM
cuesj-1229	154	20	.	.	PUNCT
cuesj-1229	155	1	12	12	NUM
cuesj-1229	155	2	.	.	PUNCT
cuesj-1229	155	3	l.	l.	PROPN
cuesj-1229	155	4	bollani	bollani	PROPN
cuesj-1229	155	5	,	,	PUNCT
cuesj-1229	155	6	c.	c.	PROPN
cuesj-1229	155	7	auriti	auriti	PROPN
cuesj-1229	155	8	,	,	PUNCT
cuesj-1229	155	9	c.	c.	PROPN
cuesj-1229	155	10	achille	achille	PROPN
cuesj-1229	155	11	,	,	PUNCT
cuesj-1229	155	12	f.	f.	PROPN
cuesj-1229	155	13	garofoli	garofoli	PROPN
cuesj-1229	155	14	,	,	PUNCT
cuesj-1229	155	15	d.	d.	PROPN
cuesj-1229	155	16	u.	u.	PROPN
cuesj-1229	155	17	de	de	PROPN
cuesj-1229	155	18	rose	rise	VERB
cuesj-1229	155	19	,	,	PUNCT
cuesj-1229	155	20	v.	v.	CCONJ
cuesj-1229	155	21	meroni	meroni	NOUN
cuesj-1229	155	22	and	and	CCONJ
cuesj-1229	155	23	c.	c.	PROPN
cuesj-1229	155	24	tzialla	tzialla	PROPN
cuesj-1229	155	25	.	.	PUNCT
cuesj-1229	156	1	congenital	congenital	ADJ
cuesj-1229	156	2	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	156	3	:	:	PUNCT
cuesj-1229	156	4	the	the	DET
cuesj-1229	156	5	state	state	NOUN
cuesj-1229	156	6	of	of	ADP
cuesj-1229	156	7	the	the	DET
cuesj-1229	156	8	art	art	NOUN
cuesj-1229	156	9	.	.	PUNCT
cuesj-1229	157	1	frontiers	frontier	NOUN
cuesj-1229	157	2	in	in	ADP
cuesj-1229	157	3	pediatrics	pediatric	NOUN
cuesj-1229	157	4	,	,	PUNCT
cuesj-1229	157	5	vol	vol	NOUN
cuesj-1229	157	6	.	.	PROPN
cuesj-1229	157	7	10	10	NUM
cuesj-1229	157	8	,	,	PUNCT
cuesj-1229	157	9	p.	p.	NOUN
cuesj-1229	157	10	894573	894573	NUM
cuesj-1229	157	11	,	,	PUNCT
cuesj-1229	157	12	2022	2022	NUM
cuesj-1229	157	13	.	.	PUNCT
cuesj-1229	158	1	13	13	NUM
cuesj-1229	158	2	.	.	PUNCT
cuesj-1229	159	1	j.	j.	PROPN
cuesj-1229	159	2	p.	p.	PROPN
cuesj-1229	159	3	dubey	dubey	PROPN
cuesj-1229	159	4	,	,	PUNCT
cuesj-1229	159	5	f.	f.	PROPN
cuesj-1229	159	6	h.	h.	PROPN
cuesj-1229	159	7	a.	a.	PROPN
cuesj-1229	159	8	murata	murata	PROPN
cuesj-1229	159	9	,	,	PUNCT
cuesj-1229	159	10	c.	c.	PROPN
cuesj-1229	159	11	k.	k.	PROPN
cuesj-1229	159	12	cerqueira	cerqueira	PROPN
cuesj-1229	159	13	-	-	PUNCT
cuesj-1229	159	14	cézar	cézar	NOUN
cuesj-1229	159	15	,	,	PUNCT
cuesj-1229	159	16	o.	o.	PROPN
cuesj-1229	159	17	c.	c.	PROPN
cuesj-1229	159	18	h.	h.	PROPN
cuesj-1229	159	19	kwok	kwok	PROPN
cuesj-1229	159	20	and	and	CCONJ
cuesj-1229	159	21	i.	i.	PROPN
cuesj-1229	159	22	villena	villena	PROPN
cuesj-1229	159	23	.	.	PUNCT
cuesj-1229	160	1	congenital	congenital	ADJ
cuesj-1229	160	2	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	160	3	in	in	ADP
cuesj-1229	160	4	humans	human	NOUN
cuesj-1229	160	5	:	:	PUNCT
cuesj-1229	160	6	an	an	DET
cuesj-1229	160	7	update	update	NOUN
cuesj-1229	160	8	of	of	ADP
cuesj-1229	160	9	worldwide	worldwide	ADJ
cuesj-1229	160	10	rate	rate	NOUN
cuesj-1229	160	11	of	of	ADP
cuesj-1229	160	12	congenital	congenital	ADJ
cuesj-1229	160	13	infections	infection	NOUN
cuesj-1229	160	14	.	.	PUNCT
cuesj-1229	161	1	parasitology	parasitology	NOUN
cuesj-1229	161	2	,	,	PUNCT
cuesj-1229	161	3	vol	vol	NOUN
cuesj-1229	161	4	.	.	NOUN
cuesj-1229	161	5	148	148	NUM
cuesj-1229	161	6	,	,	PUNCT
cuesj-1229	161	7	no	no	INTJ
cuesj-1229	161	8	.	.	NOUN
cuesj-1229	161	9	12	12	NUM
cuesj-1229	161	10	,	,	PUNCT
cuesj-1229	161	11	pp	pp	ADJ
cuesj-1229	161	12	.	.	PUNCT
cuesj-1229	162	1	1406	1406	NUM
cuesj-1229	162	2	-	-	SYM
cuesj-1229	162	3	1416	1416	NUM
cuesj-1229	162	4	,	,	PUNCT
cuesj-1229	162	5	2021	2021	NUM
cuesj-1229	162	6	.	.	PUNCT
cuesj-1229	163	1	14	14	NUM
cuesj-1229	163	2	.	.	PUNCT
cuesj-1229	163	3	m.	m.	NOUN
cuesj-1229	163	4	deganich	deganich	PROPN
cuesj-1229	163	5	,	,	PUNCT
cuesj-1229	163	6	c.	c.	PROPN
cuesj-1229	163	7	boudreaux	boudreaux	PROPN
cuesj-1229	163	8	and	and	CCONJ
cuesj-1229	163	9	i.	i.	PROPN
cuesj-1229	163	10	benmerzouga	benmerzouga	PROPN
cuesj-1229	163	11	.	.	PUNCT
cuesj-1229	164	1	toxoplasmosis	toxoplasmosis	PROPN
cuesj-1229	164	2	infection	infection	NOUN
cuesj-1229	164	3	during	during	ADP
cuesj-1229	164	4	pregnancy	pregnancy	NOUN
cuesj-1229	164	5	.	.	PUNCT
cuesj-1229	165	1	tropical	tropical	ADJ
cuesj-1229	165	2	medicine	medicine	NOUN
cuesj-1229	165	3	and	and	CCONJ
cuesj-1229	165	4	infectious	infectious	ADJ
cuesj-1229	165	5	disease	disease	NOUN
cuesj-1229	165	6	,	,	PUNCT
cuesj-1229	165	7	vol	vol	NOUN
cuesj-1229	165	8	.	.	PROPN
cuesj-1229	165	9	8	8	NUM
cuesj-1229	165	10	,	,	PUNCT
cuesj-1229	165	11	no	no	INTJ
cuesj-1229	165	12	.	.	NOUN
cuesj-1229	165	13	1	1	NUM
cuesj-1229	165	14	,	,	PUNCT
cuesj-1229	165	15	p.	p.	NOUN
cuesj-1229	165	16	3	3	NUM
cuesj-1229	165	17	,	,	PUNCT
cuesj-1229	165	18	2022	2022	NUM
cuesj-1229	165	19	.	.	PUNCT
cuesj-1229	166	1	15	15	NUM
cuesj-1229	166	2	.	.	PUNCT
cuesj-1229	166	3	g.	g.	PROPN
cuesj-1229	166	4	c.	c.	PROPN
cuesj-1229	166	5	milne	milne	PROPN
cuesj-1229	166	6	,	,	PUNCT
cuesj-1229	166	7	j.	j.	PROPN
cuesj-1229	166	8	p.	p.	PROPN
cuesj-1229	166	9	webster	webster	PROPN
cuesj-1229	166	10	and	and	CCONJ
cuesj-1229	166	11	m.	m.	PROPN
cuesj-1229	166	12	walker	walker	PROPN
cuesj-1229	166	13	.	.	PROPN
cuesj-1229	166	14	is	be	AUX
cuesj-1229	166	15	the	the	DET
cuesj-1229	166	16	incidence	incidence	NOUN
cuesj-1229	166	17	of	of	ADP
cuesj-1229	166	18	congenital	congenital	ADJ
cuesj-1229	166	19	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	166	20	declining	decline	VERB
cuesj-1229	166	21	?	?	PUNCT
cuesj-1229	166	22	”	"	PUNCT
cuesj-1229	166	23	trends	trend	NOUN
cuesj-1229	166	24	in	in	ADP
cuesj-1229	166	25	parasitology	parasitology	NOUN
cuesj-1229	166	26	,	,	PUNCT
cuesj-1229	166	27	vol	vol	NOUN
cuesj-1229	166	28	.	.	PROPN
cuesj-1229	166	29	39	39	NUM
cuesj-1229	166	30	,	,	PUNCT
cuesj-1229	166	31	pp	pp	ADJ
cuesj-1229	166	32	.	.	PUNCT
cuesj-1229	167	1	26	26	NUM
cuesj-1229	167	2	-	-	SYM
cuesj-1229	167	3	37	37	NUM
cuesj-1229	167	4	,	,	PUNCT
cuesj-1229	167	5	2023	2023	NUM
cuesj-1229	167	6	.	.	PUNCT
cuesj-1229	168	1	16	16	NUM
cuesj-1229	168	2	.	.	PUNCT
cuesj-1229	169	1	k.	k.	PROPN
cuesj-1229	169	2	k.	k.	PROPN
cuesj-1229	169	3	leung	leung	PROPN
cuesj-1229	169	4	,	,	PUNCT
cuesj-1229	169	5	k.	k.	PROPN
cuesj-1229	169	6	l.	l.	PROPN
cuesj-1229	169	7	hon	hon	PROPN
cuesj-1229	169	8	,	,	PUNCT
cuesj-1229	169	9	a.	a.	PROPN
cuesj-1229	169	10	yeung	yeung	PROPN
cuesj-1229	169	11	,	,	PUNCT
cuesj-1229	169	12	a.	a.	PROPN
cuesj-1229	169	13	k.	k.	PROPN
cuesj-1229	169	14	leung	leung	PROPN
cuesj-1229	169	15	and	and	CCONJ
cuesj-1229	169	16	e.	e.	PROPN
cuesj-1229	169	17	man	man	PROPN
cuesj-1229	169	18	.	.	PUNCT
cuesj-1229	170	1	congenital	congenital	ADJ
cuesj-1229	170	2	infections	infection	NOUN
cuesj-1229	170	3	in	in	ADP
cuesj-1229	170	4	hong	hong	PROPN
cuesj-1229	170	5	kong	kong	PROPN
cuesj-1229	170	6	:	:	PUNCT
cuesj-1229	170	7	an	an	DET
cuesj-1229	170	8	overview	overview	NOUN
cuesj-1229	170	9	of	of	ADP
cuesj-1229	170	10	torch	torch	NOUN
cuesj-1229	170	11	.	.	PUNCT
cuesj-1229	171	1	hong	hong	PROPN
cuesj-1229	171	2	kong	kong	PROPN
cuesj-1229	171	3	medical	medical	PROPN
cuesj-1229	171	4	journal	journal	PROPN
cuesj-1229	171	5	,	,	PUNCT
cuesj-1229	171	6	vol	vol	NOUN
cuesj-1229	171	7	.	.	PROPN
cuesj-1229	171	8	26	26	NUM
cuesj-1229	171	9	,	,	PUNCT
cuesj-1229	171	10	no	no	INTJ
cuesj-1229	171	11	.	.	NOUN
cuesj-1229	171	12	2	2	NUM
cuesj-1229	171	13	,	,	PUNCT
cuesj-1229	171	14	p.	p.	NOUN
cuesj-1229	171	15	127	127	NUM
cuesj-1229	171	16	,	,	PUNCT
cuesj-1229	171	17	2020	2020	NUM
cuesj-1229	171	18	.	.	PUNCT
cuesj-1229	171	19	17	17	NUM
cuesj-1229	171	20	.	.	PUNCT
cuesj-1229	171	21	a.	a.	PROPN
cuesj-1229	171	22	r.	r.	PROPN
cuesj-1229	171	23	mawson	mawson	PROPN
cuesj-1229	171	24	and	and	CCONJ
cuesj-1229	171	25	a.	a.	PROPN
cuesj-1229	171	26	m.	m.	PROPN
cuesj-1229	171	27	croft	croft	PROPN
cuesj-1229	171	28	.	.	PUNCT
cuesj-1229	172	1	rubella	rubella	NOUN
cuesj-1229	172	2	virus	virus	NOUN
cuesj-1229	172	3	infection	infection	NOUN
cuesj-1229	172	4	,	,	PUNCT
cuesj-1229	172	5	the	the	DET
cuesj-1229	172	6	congenital	congenital	ADJ
cuesj-1229	172	7	rubella	rubella	NOUN
cuesj-1229	172	8	syndrome	syndrome	NOUN
cuesj-1229	172	9	,	,	PUNCT
cuesj-1229	172	10	and	and	CCONJ
cuesj-1229	172	11	the	the	DET
cuesj-1229	172	12	link	link	NOUN
cuesj-1229	172	13	to	to	ADP
cuesj-1229	172	14	autism	autism	NOUN
cuesj-1229	172	15	.	.	PUNCT
cuesj-1229	173	1	international	international	ADJ
cuesj-1229	173	2	journal	journal	PROPN
cuesj-1229	173	3	of	of	ADP
cuesj-1229	173	4	environmental	environmental	ADJ
cuesj-1229	173	5	research	research	NOUN
cuesj-1229	173	6	and	and	CCONJ
cuesj-1229	173	7	public	public	ADJ
cuesj-1229	173	8	health	health	NOUN
cuesj-1229	173	9	,	,	PUNCT
cuesj-1229	173	10	vol	vol	NOUN
cuesj-1229	173	11	.	.	PROPN
cuesj-1229	173	12	16	16	NUM
cuesj-1229	173	13	,	,	PUNCT
cuesj-1229	173	14	no	no	INTJ
cuesj-1229	173	15	.	.	NOUN
cuesj-1229	173	16	19	19	NUM
cuesj-1229	173	17	,	,	PUNCT
cuesj-1229	173	18	p.	p.	NOUN
cuesj-1229	173	19	3543	3543	NUM
cuesj-1229	173	20	,	,	PUNCT
cuesj-1229	173	21	2019	2019	NUM
cuesj-1229	173	22	.	.	PUNCT
cuesj-1229	174	1	18	18	NUM
cuesj-1229	174	2	.	.	PUNCT
cuesj-1229	174	3	m.	m.	NOUN
cuesj-1229	174	4	leruez	leruez	PROPN
cuesj-1229	174	5	-	-	PUNCT
cuesj-1229	174	6	ville	ville	PROPN
cuesj-1229	174	7	,	,	PUNCT
cuesj-1229	174	8	i.	i.	PROPN
cuesj-1229	174	9	foulon	foulon	PROPN
cuesj-1229	174	10	,	,	PUNCT
cuesj-1229	174	11	r.	r.	PROPN
cuesj-1229	174	12	pass	pass	PROPN
cuesj-1229	174	13	and	and	CCONJ
cuesj-1229	174	14	y.	y.	PROPN
cuesj-1229	174	15	ville	ville	PROPN
cuesj-1229	174	16	.	.	PUNCT
cuesj-1229	175	1	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	175	2	infection	infection	NOUN
cuesj-1229	175	3	during	during	ADP
cuesj-1229	175	4	pregnancy	pregnancy	NOUN
cuesj-1229	175	5	:	:	PUNCT
cuesj-1229	175	6	state	state	NOUN
cuesj-1229	175	7	of	of	ADP
cuesj-1229	175	8	the	the	DET
cuesj-1229	175	9	science	science	NOUN
cuesj-1229	175	10	.	.	PUNCT
cuesj-1229	176	1	american	american	ADJ
cuesj-1229	176	2	journal	journal	PROPN
cuesj-1229	176	3	of	of	ADP
cuesj-1229	176	4	obstetrics	obstetric	NOUN
cuesj-1229	176	5	and	and	CCONJ
cuesj-1229	176	6	gynecology	gynecology	NOUN
cuesj-1229	176	7	,	,	PUNCT
cuesj-1229	176	8	vol	vol	NOUN
cuesj-1229	176	9	.	.	PROPN
cuesj-1229	176	10	223	223	NUM
cuesj-1229	176	11	,	,	PUNCT
cuesj-1229	176	12	no	no	INTJ
cuesj-1229	176	13	.	.	NOUN
cuesj-1229	176	14	3	3	NUM
cuesj-1229	176	15	,	,	PUNCT
cuesj-1229	176	16	pp	pp	ADJ
cuesj-1229	176	17	.	.	PUNCT
cuesj-1229	176	18	330349	330349	NUM
cuesj-1229	176	19	,	,	PUNCT
cuesj-1229	176	20	2020	2020	NUM
cuesj-1229	176	21	.	.	PUNCT
cuesj-1229	177	1	19	19	NUM
cuesj-1229	177	2	.	.	PUNCT
cuesj-1229	177	3	m.	m.	PROPN
cuesj-1229	177	4	l.	l.	PROPN
cuesj-1229	177	5	dietrich	dietrich	PROPN
cuesj-1229	177	6	and	and	CCONJ
cuesj-1229	177	7	j.	j.	PROPN
cuesj-1229	177	8	s.	s.	PROPN
cuesj-1229	177	9	schieffelin	schieffelin	PROPN
cuesj-1229	177	10	.	.	PUNCT
cuesj-1229	178	1	congenital	congenital	ADJ
cuesj-1229	178	2	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	178	3	infection	infection	NOUN
cuesj-1229	178	4	.	.	PUNCT
cuesj-1229	179	1	ochsner	ochsner	PROPN
cuesj-1229	179	2	journal	journal	PROPN
cuesj-1229	179	3	,	,	PUNCT
cuesj-1229	179	4	vol	vol	NOUN
cuesj-1229	179	5	.	.	PROPN
cuesj-1229	179	6	19	19	NUM
cuesj-1229	179	7	,	,	PUNCT
cuesj-1229	179	8	no	no	INTJ
cuesj-1229	179	9	.	.	NOUN
cuesj-1229	179	10	2	2	NUM
cuesj-1229	179	11	,	,	PUNCT
cuesj-1229	179	12	pp	pp	ADJ
cuesj-1229	179	13	.	.	PUNCT
cuesj-1229	180	1	123	123	NUM
cuesj-1229	180	2	-	-	SYM
cuesj-1229	180	3	130	130	NUM
cuesj-1229	180	4	,	,	PUNCT
cuesj-1229	180	5	2019	2019	NUM
cuesj-1229	180	6	.	.	PUNCT
cuesj-1229	181	1	20	20	NUM
cuesj-1229	181	2	.	.	PUNCT
cuesj-1229	182	1	t.	t.	PROPN
cuesj-1229	182	2	e.	e.	PROPN
cuesj-1229	182	3	deftereou	deftereou	PROPN
cuesj-1229	182	4	,	,	PUNCT
cuesj-1229	182	5	a.	a.	NOUN
cuesj-1229	182	6	trypidi	trypidi	PROPN
cuesj-1229	182	7	,	,	PUNCT
cuesj-1229	182	8	c.	c.	PROPN
cuesj-1229	182	9	a.	a.	NOUN
cuesj-1229	182	10	alexiadi	alexiadi	PROPN
cuesj-1229	182	11	,	,	PUNCT
cuesj-1229	182	12	p.	p.	PROPN
cuesj-1229	182	13	theotokis	theotokis	PROPN
cuesj-1229	182	14	,	,	PUNCT
cuesj-1229	182	15	m.	m.	PROPN
cuesj-1229	182	16	e.	e.	PROPN
cuesj-1229	182	17	manthou	manthou	PROPN
cuesj-1229	182	18	,	,	PUNCT
cuesj-1229	182	19	s.	s.	PROPN
cuesj-1229	182	20	meditskou	meditskou	PROPN
cuesj-1229	182	21	,	,	PUNCT
cuesj-1229	182	22	m.	m.	NOUN
cuesj-1229	182	23	simopoulou	simopoulou	NOUN
cuesj-1229	182	24	and	and	CCONJ
cuesj-1229	182	25	m.	m.	PROPN
cuesj-1229	182	26	lambropoulou	lambropoulou	PROPN
cuesj-1229	182	27	.	.	PUNCT
cuesj-1229	183	1	congenital	congenital	ADJ
cuesj-1229	183	2	herpes	herpe	NOUN
cuesj-1229	183	3	simplex	simplex	NOUN
cuesj-1229	183	4	virus	virus	NOUN
cuesj-1229	183	5	:	:	PUNCT
cuesj-1229	183	6	a	a	DET
cuesj-1229	183	7	histopathological	histopathological	ADJ
cuesj-1229	183	8	view	view	NOUN
cuesj-1229	183	9	of	of	ADP
cuesj-1229	183	10	the	the	DET
cuesj-1229	183	11	placenta	placenta	PROPN
cuesj-1229	183	12	.	.	PUNCT
cuesj-1229	184	1	cureus	cureus	NOUN
cuesj-1229	184	2	,	,	PUNCT
cuesj-1229	184	3	vol	vol	NOUN
cuesj-1229	184	4	.	.	PROPN
cuesj-1229	184	5	14	14	NUM
cuesj-1229	184	6	,	,	PUNCT
cuesj-1229	184	7	no	no	INTJ
cuesj-1229	184	8	.	.	NOUN
cuesj-1229	184	9	9	9	NUM
cuesj-1229	184	10	,	,	PUNCT
cuesj-1229	184	11	p.	p.	NOUN
cuesj-1229	184	12	e29101	e29101	PROPN
cuesj-1229	184	13	,	,	PUNCT
cuesj-1229	184	14	2022	2022	NUM
cuesj-1229	184	15	.	.	PUNCT
cuesj-1229	185	1	21	21	NUM
cuesj-1229	185	2	.	.	PUNCT
cuesj-1229	185	3	f.	f.	PROPN
cuesj-1229	185	4	e.	e.	PROPN
cuesj-1229	185	5	fuchs	fuchs	PROPN
cuesj-1229	185	6	,	,	PUNCT
cuesj-1229	185	7	m.	m.	NOUN
cuesj-1229	185	8	pauly	pauly	PROPN
cuesj-1229	185	9	,	,	PUNCT
cuesj-1229	185	10	a.	a.	NOUN
cuesj-1229	185	11	p.	p.	NOUN
cuesj-1229	185	12	black	black	PROPN
cuesj-1229	185	13	and	and	CCONJ
cuesj-1229	185	14	j.	j.	PROPN
cuesj-1229	185	15	m.	m.	PROPN
cuesj-1229	185	16	hübschen	hübschen	PROPN
cuesj-1229	185	17	.	.	PUNCT
cuesj-1229	186	1	seroprevalence	seroprevalence	NOUN
cuesj-1229	186	2	of	of	ADP
cuesj-1229	186	3	torch	torch	NOUN
cuesj-1229	186	4	pathogens	pathogen	NOUN
cuesj-1229	186	5	in	in	ADP
cuesj-1229	186	6	southeast	southeast	PROPN
cuesj-1229	186	7	asia	asia	PROPN
cuesj-1229	186	8	.	.	PUNCT
cuesj-1229	187	1	microorganisms	microorganism	NOUN
cuesj-1229	187	2	,	,	PUNCT
cuesj-1229	187	3	vol	vol	NOUN
cuesj-1229	187	4	.	.	NOUN
cuesj-1229	187	5	9	9	NUM
cuesj-1229	187	6	,	,	PUNCT
cuesj-1229	187	7	p.	p.	NOUN
cuesj-1229	187	8	574	574	NUM
cuesj-1229	187	9	,	,	PUNCT
cuesj-1229	187	10	2021	2021	NUM
cuesj-1229	187	11	.	.	PUNCT
cuesj-1229	188	1	22	22	NUM
cuesj-1229	188	2	.	.	PUNCT
cuesj-1229	189	1	k.	k.	PROPN
cuesj-1229	189	2	m.	m.	PROPN
cuesj-1229	189	3	adams	adams	PROPN
cuesj-1229	189	4	waldorf	waldorf	PROPN
cuesj-1229	189	5	and	and	CCONJ
cuesj-1229	189	6	r.	r.	PROPN
cuesj-1229	189	7	m.	m.	PROPN
cuesj-1229	189	8	mcadams	mcadams	PROPN
cuesj-1229	189	9	.	.	PUNCT
cuesj-1229	190	1	influence	influence	NOUN
cuesj-1229	190	2	of	of	ADP
cuesj-1229	190	3	infection	infection	NOUN
cuesj-1229	190	4	juma	juma	PROPN
cuesj-1229	190	5	,	,	PUNCT
cuesj-1229	190	6	et	et	PROPN
cuesj-1229	190	7	al	al	PROPN
cuesj-1229	190	8	.	.	PROPN
cuesj-1229	190	9	:	:	PUNCT
cuesj-1229	191	1	epidemiological	epidemiological	ADJ
cuesj-1229	191	2	insights	insight	NOUN
cuesj-1229	191	3	into	into	ADP
cuesj-1229	191	4	torch	torch	NOUN
cuesj-1229	191	5	30	30	NUM
cuesj-1229	191	6	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-1229	191	7	cuesj	cuesj	ADJ
cuesj-1229	191	8	2024	2024	NUM
cuesj-1229	191	9	,	,	PUNCT
cuesj-1229	191	10	8	8	NUM
cuesj-1229	191	11	(	(	PUNCT
cuesj-1229	191	12	2	2	NUM
cuesj-1229	191	13	):	):	PUNCT
cuesj-1229	191	14	26	26	NUM
cuesj-1229	191	15	-	-	SYM
cuesj-1229	191	16	30	30	NUM
cuesj-1229	191	17	during	during	ADP
cuesj-1229	191	18	pregnancy	pregnancy	NOUN
cuesj-1229	191	19	on	on	ADP
cuesj-1229	191	20	fetal	fetal	ADJ
cuesj-1229	191	21	development	development	NOUN
cuesj-1229	191	22	.	.	PUNCT
cuesj-1229	192	1	reproduction	reproduction	NOUN
cuesj-1229	192	2	,	,	PUNCT
cuesj-1229	192	3	vol	vol	NOUN
cuesj-1229	192	4	.	.	PROPN
cuesj-1229	192	5	146	146	NUM
cuesj-1229	192	6	,	,	PUNCT
cuesj-1229	192	7	pp	pp	ADJ
cuesj-1229	192	8	.	.	PUNCT
cuesj-1229	193	1	r151	r151	PROPN
cuesj-1229	193	2	-	-	PUNCT
cuesj-1229	193	3	r162	r162	PROPN
cuesj-1229	193	4	,	,	PUNCT
cuesj-1229	193	5	2013	2013	NUM
cuesj-1229	193	6	.	.	PUNCT
cuesj-1229	194	1	23	23	NUM
cuesj-1229	194	2	.	.	PUNCT
cuesj-1229	195	1	e.	e.	PROPN
cuesj-1229	195	2	a.	a.	PROPN
cuesj-1229	195	3	marcu	marcu	PROPN
cuesj-1229	195	4	,	,	PUNCT
cuesj-1229	195	5	s.	s.	PROPN
cuesj-1229	195	6	n.	n.	PROPN
cuesj-1229	195	7	dinescu	dinescu	PROPN
cuesj-1229	195	8	,	,	PUNCT
cuesj-1229	195	9	v.	v.	ADP
cuesj-1229	195	10	pădureanu	pădureanu	NOUN
cuesj-1229	195	11	,	,	PUNCT
cuesj-1229	195	12	f.	f.	PROPN
cuesj-1229	195	13	dumitrescu	dumitrescu	PROPN
cuesj-1229	195	14	and	and	CCONJ
cuesj-1229	195	15	r.	r.	PROPN
cuesj-1229	195	16	diaconu	diaconu	NOUN
cuesj-1229	195	17	.	.	PUNCT
cuesj-1229	196	1	perinatal	perinatal	ADJ
cuesj-1229	196	2	exposure	exposure	NOUN
cuesj-1229	196	3	to	to	ADP
cuesj-1229	196	4	hiv	hiv	PROPN
cuesj-1229	196	5	infection	infection	NOUN
cuesj-1229	196	6	:	:	PUNCT
cuesj-1229	196	7	the	the	DET
cuesj-1229	196	8	experience	experience	NOUN
cuesj-1229	196	9	of	of	ADP
cuesj-1229	196	10	craiova	craiova	PROPN
cuesj-1229	196	11	regional	regional	PROPN
cuesj-1229	196	12	centre	centre	PROPN
cuesj-1229	196	13	,	,	PUNCT
cuesj-1229	196	14	romania	romania	PROPN
cuesj-1229	196	15	.	.	PUNCT
cuesj-1229	197	1	healthcare	healthcare	PROPN
cuesj-1229	197	2	(	(	PUNCT
cuesj-1229	197	3	basel	basel	PROPN
cuesj-1229	197	4	)	)	PUNCT
cuesj-1229	197	5	,	,	PUNCT
cuesj-1229	197	6	vol	vol	NOUN
cuesj-1229	197	7	.	.	PROPN
cuesj-1229	197	8	10	10	NUM
cuesj-1229	197	9	,	,	PUNCT
cuesj-1229	197	10	p.	p.	NOUN
cuesj-1229	197	11	308	308	NUM
cuesj-1229	197	12	,	,	PUNCT
cuesj-1229	197	13	2022	2022	NUM
cuesj-1229	197	14	.	.	PUNCT
cuesj-1229	198	1	24	24	NUM
cuesj-1229	198	2	.	.	PUNCT
cuesj-1229	198	3	s.	s.	PROPN
cuesj-1229	198	4	c.	c.	PROPN
cuesj-1229	198	5	cambrea	cambrea	PROPN
cuesj-1229	198	6	,	,	PUNCT
cuesj-1229	198	7	e.	e.	PROPN
cuesj-1229	198	8	a.	a.	PROPN
cuesj-1229	198	9	marcu	marcu	PROPN
cuesj-1229	198	10	,	,	PUNCT
cuesj-1229	198	11	e.	e.	PROPN
cuesj-1229	198	12	cucli	cucli	PROPN
cuesj-1229	198	13	,	,	PUNCT
cuesj-1229	198	14	d.	d.	PROPN
cuesj-1229	198	15	badiu	badiu	PROPN
cuesj-1229	198	16	,	,	PUNCT
cuesj-1229	198	17	r.	r.	PROPN
cuesj-1229	198	18	penciu	penciu	PROPN
cuesj-1229	198	19	,	,	PUNCT
cuesj-1229	198	20	c.	c.	PROPN
cuesj-1229	198	21	l.	l.	PROPN
cuesj-1229	198	22	petcu	petcu	PROPN
cuesj-1229	198	23	,	,	PUNCT
cuesj-1229	198	24	e.	e.	PROPN
cuesj-1229	198	25	dumea	dumea	PROPN
cuesj-1229	198	26	,	,	PUNCT
cuesj-1229	198	27	s.	s.	PROPN
cuesj-1229	198	28	halichidis	halichidis	PROPN
cuesj-1229	198	29	,	,	PUNCT
cuesj-1229	198	30	l.	l.	PROPN
cuesj-1229	198	31	pazara	pazara	PROPN
cuesj-1229	198	32	,	,	PUNCT
cuesj-1229	198	33	c.	c.	PROPN
cuesj-1229	198	34	m.	m.	PROPN
cuesj-1229	198	35	mihai	mihai	PROPN
cuesj-1229	198	36	and	and	CCONJ
cuesj-1229	198	37	f.	f.	PROPN
cuesj-1229	198	38	dumitrescu	dumitrescu	PROPN
cuesj-1229	198	39	.	.	PUNCT
cuesj-1229	199	1	clinical	clinical	ADJ
cuesj-1229	199	2	and	and	CCONJ
cuesj-1229	199	3	biological	biological	ADJ
cuesj-1229	199	4	risk	risk	NOUN
cuesj-1229	199	5	factors	factor	NOUN
cuesj-1229	199	6	associated	associate	VERB
cuesj-1229	199	7	with	with	ADP
cuesj-1229	199	8	increased	increase	VERB
cuesj-1229	199	9	mother	mother	NOUN
cuesj-1229	199	10	-	-	PUNCT
cuesj-1229	199	11	to	to	ADP
cuesj-1229	199	12	-	-	PUNCT
cuesj-1229	199	13	child	child	NOUN
cuesj-1229	199	14	transmission	transmission	NOUN
cuesj-1229	199	15	of	of	ADP
cuesj-1229	199	16	hiv	hiv	PROPN
cuesj-1229	199	17	in	in	ADP
cuesj-1229	199	18	two	two	NUM
cuesj-1229	199	19	southeast	southeast	ADJ
cuesj-1229	199	20	hiv	hiv	PROPN
cuesj-1229	199	21	-	-	PUNCT
cuesj-1229	199	22	aids	aids	PROPN
cuesj-1229	199	23	regional	regional	ADJ
cuesj-1229	199	24	centers	center	NOUN
cuesj-1229	199	25	in	in	ADP
cuesj-1229	199	26	romania	romania	PROPN
cuesj-1229	199	27	.	.	PUNCT
cuesj-1229	200	1	medicina	medicina	PROPN
cuesj-1229	200	2	(	(	PUNCT
cuesj-1229	200	3	kaunas	kaunas	PROPN
cuesj-1229	200	4	)	)	PUNCT
cuesj-1229	200	5	,	,	PUNCT
cuesj-1229	200	6	vol	vol	NOUN
cuesj-1229	200	7	.	.	PROPN
cuesj-1229	200	8	58	58	NUM
cuesj-1229	200	9	,	,	PUNCT
cuesj-1229	200	10	p.	p.	NOUN
cuesj-1229	200	11	275	275	NUM
cuesj-1229	200	12	,	,	PUNCT
cuesj-1229	200	13	2022	2022	NUM
cuesj-1229	200	14	.	.	PUNCT
cuesj-1229	201	1	25	25	NUM
cuesj-1229	201	2	.	.	PUNCT
cuesj-1229	201	3	a.	a.	PROPN
cuesj-1229	201	4	m.	m.	PROPN
cuesj-1229	201	5	al	al	PROPN
cuesj-1229	201	6	-	-	PUNCT
cuesj-1229	201	7	hakami	hakami	PROPN
cuesj-1229	201	8	,	,	PUNCT
cuesj-1229	201	9	e.	e.	PROPN
cuesj-1229	201	10	paul	paul	PROPN
cuesj-1229	201	11	,	,	PUNCT
cuesj-1229	201	12	f.	f.	PROPN
cuesj-1229	201	13	al	al	PROPN
cuesj-1229	201	14	-	-	PUNCT
cuesj-1229	201	15	abed	abed	PROPN
cuesj-1229	201	16	,	,	PUNCT
cuesj-1229	201	17	a.	a.	NOUN
cuesj-1229	201	18	a	a	DET
cuesj-1229	201	19	alzoani	alzoani	PROPN
cuesj-1229	201	20	,	,	PUNCT
cuesj-1229	201	21	a.	a.	NOUN
cuesj-1229	201	22	a.	a.	NOUN
cuesj-1229	201	23	shati	shati	PROPN
cuesj-1229	201	24	,	,	PUNCT
cuesj-1229	201	25	m.	m.	PROPN
cuesj-1229	201	26	i.	i.	PROPN
cuesj-1229	201	27	assiri	assiri	PROPN
cuesj-1229	201	28	,	,	PUNCT
cuesj-1229	201	29	a.	a.	PROPN
cuesj-1229	201	30	a.	a.	PROPN
cuesj-1229	201	31	qasim	qasim	PROPN
cuesj-1229	201	32	,	,	PUNCT
cuesj-1229	201	33	f.	f.	PROPN
cuesj-1229	201	34	riaz	riaz	PROPN
cuesj-1229	201	35	,	,	PUNCT
cuesj-1229	201	36	r.	r.	PROPN
cuesj-1229	201	37	a.	a.	PROPN
cuesj-1229	201	38	moosa	moosa	PROPN
cuesj-1229	201	39	and	and	CCONJ
cuesj-1229	201	40	h.	h.	PROPN
cuesj-1229	201	41	c.	c.	PROPN
cuesj-1229	201	42	chandramoorthy	chandramoorthy	PROPN
cuesj-1229	201	43	.	.	PUNCT
cuesj-1229	202	1	prevalence	prevalence	NOUN
cuesj-1229	202	2	of	of	ADP
cuesj-1229	202	3	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	202	4	,	,	PUNCT
cuesj-1229	202	5	rubella	rubella	NOUN
cuesj-1229	202	6	,	,	PUNCT
cuesj-1229	202	7	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	202	8	,	,	PUNCT
cuesj-1229	202	9	and	and	CCONJ
cuesj-1229	202	10	herpes	herpe	NOUN
cuesj-1229	202	11	(	(	PUNCT
cuesj-1229	202	12	torch	torch	NOUN
cuesj-1229	202	13	)	)	PUNCT
cuesj-1229	202	14	infections	infection	NOUN
cuesj-1229	202	15	among	among	ADP
cuesj-1229	202	16	women	woman	NOUN
cuesj-1229	202	17	attending	attend	VERB
cuesj-1229	202	18	the	the	DET
cuesj-1229	202	19	antenatal	antenatal	PROPN
cuesj-1229	202	20	care	care	NOUN
cuesj-1229	202	21	clinic	clinic	NOUN
cuesj-1229	202	22	,	,	PUNCT
cuesj-1229	202	23	maternity	maternity	NOUN
cuesj-1229	202	24	hospital	hospital	NOUN
cuesj-1229	202	25	in	in	ADP
cuesj-1229	202	26	abha	abha	NOUN
cuesj-1229	202	27	,	,	PUNCT
cuesj-1229	202	28	southwestern	southwestern	ADJ
cuesj-1229	202	29	saudi	saudi	PROPN
cuesj-1229	202	30	arabia	arabia	PROPN
cuesj-1229	202	31	.	.	PUNCT
cuesj-1229	203	1	saudi	saudi	ADJ
cuesj-1229	203	2	medical	medical	ADJ
cuesj-1229	203	3	journal	journal	PROPN
cuesj-1229	203	4	,	,	PUNCT
cuesj-1229	203	5	vol	vol	NOUN
cuesj-1229	203	6	.	.	PROPN
cuesj-1229	203	7	41	41	NUM
cuesj-1229	203	8	,	,	PUNCT
cuesj-1229	203	9	no	no	INTJ
cuesj-1229	203	10	.	.	NOUN
cuesj-1229	203	11	7	7	NUM
cuesj-1229	203	12	,	,	PUNCT
cuesj-1229	203	13	pp	pp	ADJ
cuesj-1229	203	14	.	.	PUNCT
cuesj-1229	204	1	757	757	NUM
cuesj-1229	204	2	-	-	SYM
cuesj-1229	204	3	762	762	NUM
cuesj-1229	204	4	,	,	PUNCT
cuesj-1229	204	5	2020	2020	NUM
cuesj-1229	204	6	.	.	PUNCT
cuesj-1229	205	1	26	26	NUM
cuesj-1229	205	2	.	.	PUNCT
cuesj-1229	205	3	x.	x.	PROPN
cuesj-1229	205	4	qin	qin	PROPN
cuesj-1229	205	5	,	,	PUNCT
cuesj-1229	205	6	s.	s.	PROPN
cuesj-1229	205	7	zhang	zhang	PROPN
cuesj-1229	205	8	,	,	PUNCT
cuesj-1229	205	9	h.	h.	PROPN
cuesj-1229	205	10	liu	liu	PROPN
cuesj-1229	205	11	,	,	PUNCT
cuesj-1229	205	12	g.	g.	PROPN
cuesj-1229	205	13	cheng	cheng	PROPN
cuesj-1229	205	14	,	,	PUNCT
cuesj-1229	205	15	y.	y.	PROPN
cuesj-1229	205	16	liu	liu	PROPN
cuesj-1229	205	17	,	,	PUNCT
cuesj-1229	205	18	m.	m.	PROPN
cuesj-1229	205	19	hu	hu	PROPN
cuesj-1229	205	20	,	,	PUNCT
cuesj-1229	205	21	n.	n.	PROPN
cuesj-1229	205	22	liu	liu	PROPN
cuesj-1229	205	23	and	and	CCONJ
cuesj-1229	205	24	m.	m.	PROPN
cuesj-1229	205	25	zhang	zhang	PROPN
cuesj-1229	205	26	.	.	PUNCT
cuesj-1229	206	1	seroepidemiology	seroepidemiology	PROPN
cuesj-1229	206	2	of	of	ADP
cuesj-1229	206	3	torch	torch	NOUN
cuesj-1229	206	4	infections	infection	NOUN
cuesj-1229	206	5	among	among	ADP
cuesj-1229	206	6	1.7	1.7	NUM
cuesj-1229	206	7	million	million	NUM
cuesj-1229	206	8	women	woman	NOUN
cuesj-1229	206	9	of	of	ADP
cuesj-1229	206	10	childbearing	childbeare	VERB
cuesj-1229	206	11	age	age	NOUN
cuesj-1229	206	12	in	in	ADP
cuesj-1229	206	13	rural	rural	ADJ
cuesj-1229	206	14	china	china	PROPN
cuesj-1229	206	15	:	:	PUNCT
cuesj-1229	206	16	a	a	DET
cuesj-1229	206	17	populationbased	populationbase	VERB
cuesj-1229	206	18	cross	cross	ADJ
cuesj-1229	206	19	-	-	ADJ
cuesj-1229	206	20	sectional	sectional	ADJ
cuesj-1229	206	21	study	study	NOUN
cuesj-1229	206	22	.	.	PUNCT
cuesj-1229	207	1	american	american	PROPN
cuesj-1229	207	2	journal	journal	PROPN
cuesj-1229	207	3	of	of	ADP
cuesj-1229	207	4	tropical	tropical	ADJ
cuesj-1229	207	5	medicine	medicine	NOUN
cuesj-1229	207	6	and	and	CCONJ
cuesj-1229	207	7	hygiene	hygiene	NOUN
cuesj-1229	207	8	,	,	PUNCT
cuesj-1229	207	9	vol	vol	NOUN
cuesj-1229	207	10	.	.	PROPN
cuesj-1229	207	11	105	105	NUM
cuesj-1229	207	12	,	,	PUNCT
cuesj-1229	207	13	no	no	INTJ
cuesj-1229	207	14	.	.	NOUN
cuesj-1229	207	15	5	5	NUM
cuesj-1229	207	16	,	,	PUNCT
cuesj-1229	207	17	pp	pp	ADJ
cuesj-1229	207	18	.	.	PUNCT
cuesj-1229	208	1	1202	1202	NUM
cuesj-1229	208	2	-	-	SYM
cuesj-1229	208	3	1209	1209	NUM
cuesj-1229	208	4	,	,	PUNCT
cuesj-1229	208	5	2021	2021	NUM
cuesj-1229	208	6	.	.	PUNCT
cuesj-1229	209	1	27	27	NUM
cuesj-1229	209	2	.	.	PUNCT
cuesj-1229	210	1	g.	g.	PROPN
cuesj-1229	210	2	pappas	pappas	PROPN
cuesj-1229	210	3	,	,	PUNCT
cuesj-1229	210	4	n.	n.	PROPN
cuesj-1229	210	5	roussos	roussos	PROPN
cuesj-1229	210	6	and	and	CCONJ
cuesj-1229	210	7	m.	m.	PROPN
cuesj-1229	210	8	e.	e.	PROPN
cuesj-1229	210	9	falagas	falagas	PROPN
cuesj-1229	210	10	.	.	PUNCT
cuesj-1229	211	1	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	211	2	snapshots	snapshot	NOUN
cuesj-1229	211	3	:	:	PUNCT
cuesj-1229	211	4	global	global	ADJ
cuesj-1229	211	5	status	status	NOUN
cuesj-1229	211	6	of	of	ADP
cuesj-1229	211	7	toxoplasma	toxoplasma	NOUN
cuesj-1229	211	8	gondii	gondii	NOUN
cuesj-1229	211	9	seroprevalence	seroprevalence	NOUN
cuesj-1229	211	10	and	and	CCONJ
cuesj-1229	211	11	implications	implication	NOUN
cuesj-1229	211	12	for	for	ADP
cuesj-1229	211	13	pregnancy	pregnancy	NOUN
cuesj-1229	211	14	and	and	CCONJ
cuesj-1229	211	15	congenital	congenital	ADJ
cuesj-1229	211	16	toxoplasmosis	toxoplasmosis	NOUN
cuesj-1229	211	17	.	.	PUNCT
cuesj-1229	212	1	international	international	ADJ
cuesj-1229	212	2	journal	journal	PROPN
cuesj-1229	212	3	for	for	ADP
cuesj-1229	212	4	parasitology	parasitology	NOUN
cuesj-1229	212	5	,	,	PUNCT
cuesj-1229	212	6	vol	vol	NOUN
cuesj-1229	212	7	.	.	PROPN
cuesj-1229	212	8	39	39	NUM
cuesj-1229	212	9	,	,	PUNCT
cuesj-1229	212	10	no	no	INTJ
cuesj-1229	212	11	.	.	NOUN
cuesj-1229	212	12	12	12	NUM
cuesj-1229	212	13	,	,	PUNCT
cuesj-1229	212	14	pp	pp	ADJ
cuesj-1229	212	15	.	.	PUNCT
cuesj-1229	212	16	13851394	13851394	NUM
cuesj-1229	212	17	,	,	PUNCT
cuesj-1229	212	18	2009	2009	NUM
cuesj-1229	212	19	.	.	PUNCT
cuesj-1229	213	1	28	28	NUM
cuesj-1229	213	2	.	.	PUNCT
cuesj-1229	214	1	s.	s.	PROPN
cuesj-1229	214	2	wang	wang	PROPN
cuesj-1229	214	3	,	,	PUNCT
cuesj-1229	214	4	t.	t.	PROPN
cuesj-1229	214	5	wang	wang	PROPN
cuesj-1229	214	6	,	,	PUNCT
cuesj-1229	214	7	w.	w.	PROPN
cuesj-1229	214	8	zhang	zhang	PROPN
cuesj-1229	214	9	,	,	PUNCT
cuesj-1229	214	10	x.	x.	PROPN
cuesj-1229	214	11	liu	liu	PROPN
cuesj-1229	214	12	,	,	PUNCT
cuesj-1229	214	13	x.	x.	PROPN
cuesj-1229	214	14	wang	wang	PROPN
cuesj-1229	214	15	,	,	PUNCT
cuesj-1229	214	16	h.	h.	PROPN
cuesj-1229	214	17	wang	wang	PROPN
cuesj-1229	214	18	,	,	PUNCT
cuesj-1229	214	19	x.	x.	PROPN
cuesj-1229	215	1	he	he	PRON
cuesj-1229	215	2	,	,	PUNCT
cuesj-1229	215	3	s.	s.	PROPN
cuesj-1229	215	4	zhang	zhang	PROPN
cuesj-1229	215	5	,	,	PUNCT
cuesj-1229	215	6	s.	s.	PROPN
cuesj-1229	215	7	xu	xu	PROPN
cuesj-1229	215	8	,	,	PUNCT
cuesj-1229	215	9	y.	y.	PROPN
cuesj-1229	215	10	yu	yu	PROPN
cuesj-1229	215	11	,	,	PUNCT
cuesj-1229	215	12	x.	x.	PROPN
cuesj-1229	215	13	jia	jia	PROPN
cuesj-1229	215	14	,	,	PUNCT
cuesj-1229	215	15	m.	m.	PROPN
cuesj-1229	215	16	wang	wang	PROPN
cuesj-1229	215	17	,	,	PUNCT
cuesj-1229	215	18	a.	a.	PROPN
cuesj-1229	215	19	xu	xu	PROPN
cuesj-1229	215	20	,	,	PUNCT
cuesj-1229	215	21	w.	w.	PROPN
cuesj-1229	215	22	ma	ma	PROPN
cuesj-1229	215	23	,	,	PUNCT
cuesj-1229	215	24	m.	m.	PROPN
cuesj-1229	215	25	m.	m.	PROPN
cuesj-1229	215	26	amin	amin	PROPN
cuesj-1229	215	27	,	,	PUNCT
cuesj-1229	215	28	s.	s.	PROPN
cuesj-1229	215	29	r.	r.	PROPN
cuesj-1229	215	30	bialek	bialek	PROPN
cuesj-1229	215	31	,	,	PUNCT
cuesj-1229	215	32	s.	s.	PROPN
cuesj-1229	215	33	c.	c.	PROPN
cuesj-1229	215	34	dollard	dollard	PROPN
cuesj-1229	215	35	and	and	CCONJ
cuesj-1229	215	36	c.	c.	PROPN
cuesj-1229	215	37	wang	wang	PROPN
cuesj-1229	215	38	.	.	PUNCT
cuesj-1229	216	1	cohort	cohort	PROPN
cuesj-1229	216	2	study	study	NOUN
cuesj-1229	216	3	on	on	ADP
cuesj-1229	216	4	maternal	maternal	ADJ
cuesj-1229	216	5	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	216	6	seroprevalence	seroprevalence	NOUN
cuesj-1229	216	7	and	and	CCONJ
cuesj-1229	216	8	prevalence	prevalence	NOUN
cuesj-1229	216	9	and	and	CCONJ
cuesj-1229	216	10	clinical	clinical	ADJ
cuesj-1229	216	11	manifestations	manifestation	NOUN
cuesj-1229	216	12	of	of	ADP
cuesj-1229	216	13	congenital	congenital	ADJ
cuesj-1229	216	14	infection	infection	NOUN
cuesj-1229	216	15	in	in	ADP
cuesj-1229	216	16	china	china	PROPN
cuesj-1229	216	17	.	.	PUNCT
cuesj-1229	217	1	medicine	medicine	NOUN
cuesj-1229	217	2	(	(	PUNCT
cuesj-1229	217	3	baltimore	baltimore	PROPN
cuesj-1229	217	4	)	)	PUNCT
cuesj-1229	217	5	,	,	PUNCT
cuesj-1229	217	6	vol	vol	NOUN
cuesj-1229	217	7	.	.	PROPN
cuesj-1229	217	8	96	96	NUM
cuesj-1229	217	9	,	,	PUNCT
cuesj-1229	217	10	p.	p.	NOUN
cuesj-1229	217	11	e6007	e6007	NOUN
cuesj-1229	217	12	,	,	PUNCT
cuesj-1229	217	13	2017	2017	NUM
cuesj-1229	217	14	.	.	PUNCT
cuesj-1229	217	15	29	29	NUM
cuesj-1229	217	16	.	.	PUNCT
cuesj-1229	218	1	m.	m.	PROPN
cuesj-1229	218	2	zuhair	zuhair	PROPN
cuesj-1229	218	3	,	,	PUNCT
cuesj-1229	218	4	g.	g.	PROPN
cuesj-1229	218	5	s.	s.	PROPN
cuesj-1229	218	6	a.	a.	PROPN
cuesj-1229	218	7	smit	smit	PROPN
cuesj-1229	218	8	,	,	PUNCT
cuesj-1229	218	9	g.	g.	PROPN
cuesj-1229	218	10	wallis	wallis	PROPN
cuesj-1229	218	11	,	,	PUNCT
cuesj-1229	218	12	f.	f.	PROPN
cuesj-1229	218	13	jabbar	jabbar	PROPN
cuesj-1229	218	14	,	,	PUNCT
cuesj-1229	218	15	c.	c.	PROPN
cuesj-1229	218	16	smith	smith	PROPN
cuesj-1229	218	17	,	,	PUNCT
cuesj-1229	218	18	b.	b.	PROPN
cuesj-1229	218	19	devleesschauwer	devleesschauwer	PROPN
cuesj-1229	218	20	and	and	CCONJ
cuesj-1229	218	21	p.	p.	PROPN
cuesj-1229	218	22	griffiths	griffiths	PROPN
cuesj-1229	218	23	.	.	PUNCT
cuesj-1229	219	1	estimation	estimation	NOUN
cuesj-1229	219	2	of	of	ADP
cuesj-1229	219	3	the	the	DET
cuesj-1229	219	4	worldwide	worldwide	ADJ
cuesj-1229	219	5	seroprevalence	seroprevalence	NOUN
cuesj-1229	219	6	of	of	ADP
cuesj-1229	219	7	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	219	8	:	:	PUNCT
cuesj-1229	219	9	a	a	DET
cuesj-1229	219	10	systematic	systematic	ADJ
cuesj-1229	219	11	review	review	NOUN
cuesj-1229	219	12	and	and	CCONJ
cuesj-1229	219	13	meta	meta	ADJ
cuesj-1229	219	14	-	-	PUNCT
cuesj-1229	219	15	analysis	analysis	NOUN
cuesj-1229	219	16	.	.	PUNCT
cuesj-1229	220	1	reviews	review	NOUN
cuesj-1229	220	2	in	in	ADP
cuesj-1229	220	3	medical	medical	ADJ
cuesj-1229	220	4	virology	virology	NOUN
cuesj-1229	220	5	,	,	PUNCT
cuesj-1229	220	6	vol	vol	NOUN
cuesj-1229	220	7	.	.	PROPN
cuesj-1229	220	8	29	29	NUM
cuesj-1229	220	9	,	,	PUNCT
cuesj-1229	220	10	p.	p.	NOUN
cuesj-1229	220	11	e2034	e2034	NOUN
cuesj-1229	220	12	,	,	PUNCT
cuesj-1229	220	13	2019	2019	NUM
cuesj-1229	220	14	.	.	PUNCT
cuesj-1229	221	1	30	30	NUM
cuesj-1229	221	2	.	.	PUNCT
cuesj-1229	222	1	q.	q.	PROPN
cuesj-1229	222	2	zhou	zhou	PROPN
cuesj-1229	222	3	,	,	PUNCT
cuesj-1229	222	4	q.	q.	PROPN
cuesj-1229	222	5	wang	wang	PROPN
cuesj-1229	222	6	,	,	PUNCT
cuesj-1229	222	7	h.	h.	PROPN
cuesj-1229	222	8	shen	shen	PROPN
cuesj-1229	222	9	,	,	PUNCT
cuesj-1229	222	10	y.	y.	PROPN
cuesj-1229	222	11	zhang	zhang	PROPN
cuesj-1229	222	12	,	,	PUNCT
cuesj-1229	222	13	s.	s.	PROPN
cuesj-1229	222	14	zhang	zhang	PROPN
cuesj-1229	222	15	,	,	PUNCT
cuesj-1229	222	16	x.	x.	PROPN
cuesj-1229	222	17	li	li	PROPN
cuesj-1229	222	18	and	and	CCONJ
cuesj-1229	222	19	g.	g.	PROPN
cuesj-1229	222	20	acharya	acharya	PROPN
cuesj-1229	222	21	.	.	PUNCT
cuesj-1229	223	1	seroepidemiological	seroepidemiological	ADJ
cuesj-1229	223	2	map	map	NOUN
cuesj-1229	223	3	of	of	ADP
cuesj-1229	223	4	toxoplasma	toxoplasma	NOUN
cuesj-1229	223	5	gondii	gondii	NOUN
cuesj-1229	223	6	infection	infection	NOUN
cuesj-1229	223	7	and	and	CCONJ
cuesj-1229	223	8	associated	associate	VERB
cuesj-1229	223	9	risk	risk	NOUN
cuesj-1229	223	10	factors	factor	NOUN
cuesj-1229	223	11	in	in	ADP
cuesj-1229	223	12	preconception	preconception	NOUN
cuesj-1229	223	13	period	period	NOUN
cuesj-1229	223	14	in	in	ADP
cuesj-1229	223	15	china	china	PROPN
cuesj-1229	223	16	:	:	PUNCT
cuesj-1229	223	17	a	a	DET
cuesj-1229	223	18	nationwide	nationwide	ADJ
cuesj-1229	223	19	cross	cross	ADJ
cuesj-1229	223	20	-	-	ADJ
cuesj-1229	223	21	sectional	sectional	ADJ
cuesj-1229	223	22	study	study	NOUN
cuesj-1229	223	23	.	.	PUNCT
cuesj-1229	224	1	journal	journal	NOUN
cuesj-1229	224	2	of	of	ADP
cuesj-1229	224	3	obstetrics	obstetric	NOUN
cuesj-1229	224	4	and	and	CCONJ
cuesj-1229	224	5	gynaecology	gynaecology	NOUN
cuesj-1229	224	6	research	research	NOUN
cuesj-1229	224	7	,	,	PUNCT
cuesj-1229	224	8	vol	vol	NOUN
cuesj-1229	224	9	.	.	PROPN
cuesj-1229	224	10	44	44	NUM
cuesj-1229	224	11	,	,	PUNCT
cuesj-1229	224	12	pp	pp	ADJ
cuesj-1229	224	13	.	.	PUNCT
cuesj-1229	225	1	1134	1134	NUM
cuesj-1229	225	2	-	-	SYM
cuesj-1229	225	3	1139	1139	NUM
cuesj-1229	225	4	,	,	PUNCT
cuesj-1229	225	5	2018	2018	NUM
cuesj-1229	225	6	.	.	PUNCT
cuesj-1229	226	1	31	31	NUM
cuesj-1229	226	2	.	.	PUNCT
cuesj-1229	226	3	q.	q.	PROPN
cuesj-1229	226	4	zhou	zhou	PROPN
cuesj-1229	226	5	,	,	PUNCT
cuesj-1229	226	6	q.	q.	PROPN
cuesj-1229	226	7	wang	wang	PROPN
cuesj-1229	226	8	,	,	PUNCT
cuesj-1229	226	9	h.	h.	PROPN
cuesj-1229	226	10	shen	shen	PROPN
cuesj-1229	226	11	,	,	PUNCT
cuesj-1229	226	12	y.	y.	PROPN
cuesj-1229	226	13	zhang	zhang	PROPN
cuesj-1229	226	14	,	,	PUNCT
cuesj-1229	226	15	s.	s.	PROPN
cuesj-1229	226	16	zhang	zhang	PROPN
cuesj-1229	226	17	,	,	PUNCT
cuesj-1229	226	18	x.	x.	PROPN
cuesj-1229	226	19	li	li	PROPN
cuesj-1229	226	20	and	and	CCONJ
cuesj-1229	226	21	g.	g.	PROPN
cuesj-1229	226	22	acharya	acharya	PROPN
cuesj-1229	226	23	.	.	PUNCT
cuesj-1229	227	1	seroprevalence	seroprevalence	NOUN
cuesj-1229	227	2	of	of	ADP
cuesj-1229	227	3	cytomegalovirus	cytomegalovirus	NOUN
cuesj-1229	227	4	and	and	CCONJ
cuesj-1229	227	5	associated	associated	ADJ
cuesj-1229	227	6	factors	factor	NOUN
cuesj-1229	227	7	among	among	ADP
cuesj-1229	227	8	preconception	preconception	NOUN
cuesj-1229	227	9	women	woman	NOUN
cuesj-1229	227	10	:	:	PUNCT
cuesj-1229	227	11	a	a	DET
cuesj-1229	227	12	cross	cross	ADJ
cuesj-1229	227	13	-	-	ADJ
cuesj-1229	227	14	sectional	sectional	ADJ
cuesj-1229	227	15	nationwide	nationwide	ADJ
cuesj-1229	227	16	study	study	NOUN
cuesj-1229	227	17	in	in	ADP
cuesj-1229	227	18	china	china	PROPN
cuesj-1229	227	19	.	.	PUNCT
cuesj-1229	228	1	frontiers	frontier	NOUN
cuesj-1229	228	2	in	in	ADP
cuesj-1229	228	3	public	public	ADJ
cuesj-1229	228	4	health	health	NOUN
cuesj-1229	228	5	,	,	PUNCT
cuesj-1229	228	6	vol	vol	NOUN
cuesj-1229	228	7	.	.	NOUN
cuesj-1229	228	8	9	9	NUM
cuesj-1229	228	9	,	,	PUNCT
cuesj-1229	228	10	p.	p.	NOUN
cuesj-1229	228	11	631411	631411	NUM
cuesj-1229	228	12	,	,	PUNCT
cuesj-1229	228	13	2021	2021	NUM
cuesj-1229	228	14	.	.	PUNCT
cuesj-1229	229	1	32	32	NUM
cuesj-1229	229	2	.	.	PUNCT
cuesj-1229	230	1	q.	q.	PROPN
cuesj-1229	230	2	zhou	zhou	PROPN
cuesj-1229	230	3	,	,	PUNCT
cuesj-1229	230	4	q.	q.	PROPN
cuesj-1229	230	5	wang	wang	PROPN
cuesj-1229	230	6	,	,	PUNCT
cuesj-1229	230	7	h.	h.	PROPN
cuesj-1229	230	8	shen	shen	PROPN
cuesj-1229	230	9	,	,	PUNCT
cuesj-1229	230	10	y.	y.	PROPN
cuesj-1229	230	11	zhang	zhang	PROPN
cuesj-1229	230	12	,	,	PUNCT
cuesj-1229	230	13	s.	s.	PROPN
cuesj-1229	230	14	zhang	zhang	PROPN
cuesj-1229	230	15	,	,	PUNCT
cuesj-1229	230	16	x.	x.	PROPN
cuesj-1229	230	17	li	li	PROPN
cuesj-1229	230	18	and	and	CCONJ
cuesj-1229	230	19	g.	g.	PROPN
cuesj-1229	230	20	acharya	acharya	PROPN
cuesj-1229	230	21	.	.	PUNCT
cuesj-1229	231	1	rubella	rubella	NOUN
cuesj-1229	231	2	virus	virus	NOUN
cuesj-1229	231	3	immunization	immunization	NOUN
cuesj-1229	231	4	status	status	NOUN
cuesj-1229	231	5	in	in	ADP
cuesj-1229	231	6	preconception	preconception	NOUN
cuesj-1229	231	7	period	period	NOUN
cuesj-1229	231	8	among	among	ADP
cuesj-1229	231	9	chinese	chinese	ADJ
cuesj-1229	231	10	women	woman	NOUN
cuesj-1229	231	11	of	of	ADP
cuesj-1229	231	12	reproductive	reproductive	ADJ
cuesj-1229	231	13	age	age	NOUN
cuesj-1229	231	14	:	:	PUNCT
cuesj-1229	231	15	a	a	DET
cuesj-1229	231	16	nationwide	nationwide	ADJ
cuesj-1229	231	17	,	,	PUNCT
cuesj-1229	231	18	cross	cross	ADJ
cuesj-1229	231	19	-	-	ADJ
cuesj-1229	231	20	sectional	sectional	ADJ
cuesj-1229	231	21	study	study	NOUN
cuesj-1229	231	22	.	.	PUNCT
cuesj-1229	232	1	vaccine	vaccine	NOUN
cuesj-1229	232	2	,	,	PUNCT
cuesj-1229	232	3	vol	vol	NOUN
cuesj-1229	232	4	.	.	PROPN
cuesj-1229	232	5	35	35	NUM
cuesj-1229	232	6	,	,	PUNCT
cuesj-1229	232	7	pp	pp	ADJ
cuesj-1229	232	8	.	.	PUNCT
cuesj-1229	233	1	3076	3076	NUM
cuesj-1229	233	2	-	-	SYM
cuesj-1229	233	3	3081	3081	NUM
cuesj-1229	233	4	,	,	PUNCT
cuesj-1229	233	5	2017	2017	NUM
cuesj-1229	233	6	.	.	PUNCT
cuesj-1229	234	1	33	33	NUM
cuesj-1229	234	2	.	.	PUNCT
cuesj-1229	235	1	t.	t.	PROPN
cuesj-1229	235	2	vilibic	vilibic	PROPN
cuesj-1229	235	3	-	-	PUNCT
cuesj-1229	235	4	cavlek	cavlek	NOUN
cuesj-1229	235	5	,	,	PUNCT
cuesj-1229	235	6	s.	s.	PROPN
cuesj-1229	235	7	ljubin	ljubin	PROPN
cuesj-1229	235	8	-	-	PUNCT
cuesj-1229	235	9	sternak	sternak	NOUN
cuesj-1229	235	10	,	,	PUNCT
cuesj-1229	235	11	m.	m.	NOUN
cuesj-1229	235	12	ban	ban	NOUN
cuesj-1229	235	13	,	,	PUNCT
cuesj-1229	235	14	b.	b.	PROPN
cuesj-1229	235	15	kolaric	kolaric	PROPN
cuesj-1229	235	16	,	,	PUNCT
cuesj-1229	235	17	m.	m.	NOUN
cuesj-1229	235	18	sviben	sviben	PROPN
cuesj-1229	235	19	and	and	CCONJ
cuesj-1229	235	20	g.	g.	PROPN
cuesj-1229	235	21	mlinaric	mlinaric	PROPN
cuesj-1229	235	22	-	-	PUNCT
cuesj-1229	235	23	galinovic	galinovic	ADJ
cuesj-1229	235	24	.	.	PUNCT
cuesj-1229	236	1	seroprevalence	seroprevalence	NOUN
cuesj-1229	236	2	of	of	ADP
cuesj-1229	236	3	torch	torch	NOUN
cuesj-1229	236	4	infections	infection	NOUN
cuesj-1229	236	5	in	in	ADP
cuesj-1229	236	6	women	woman	NOUN
cuesj-1229	236	7	of	of	ADP
cuesj-1229	236	8	childbearing	childbeare	VERB
cuesj-1229	236	9	age	age	NOUN
cuesj-1229	236	10	in	in	ADP
cuesj-1229	236	11	croatia	croatia	PROPN
cuesj-1229	236	12	.	.	PUNCT
cuesj-1229	237	1	journal	journal	PROPN
cuesj-1229	237	2	of	of	ADP
cuesj-1229	237	3	maternalfetal	maternalfetal	ADJ
cuesj-1229	237	4	and	and	CCONJ
cuesj-1229	237	5	neonatal	neonatal	ADJ
cuesj-1229	237	6	medicine	medicine	NOUN
cuesj-1229	237	7	,	,	PUNCT
cuesj-1229	237	8	vol	vol	NOUN
cuesj-1229	237	9	.	.	PROPN
cuesj-1229	237	10	24	24	NUM
cuesj-1229	237	11	,	,	PUNCT
cuesj-1229	237	12	no	no	INTJ
cuesj-1229	237	13	.	.	NOUN
cuesj-1229	237	14	2	2	NUM
cuesj-1229	237	15	,	,	PUNCT
cuesj-1229	237	16	pp	pp	ADJ
cuesj-1229	237	17	.	.	PUNCT
cuesj-1229	238	1	280	280	NUM
cuesj-1229	238	2	-	-	SYM
cuesj-1229	238	3	283	283	NUM
cuesj-1229	238	4	,	,	PUNCT
cuesj-1229	238	5	feb	feb	PROPN
cuesj-1229	238	6	.	.	PROPN
cuesj-1229	238	7	2011	2011	NUM
cuesj-1229	238	8	.	.	PUNCT
cuesj-1229	239	1	34	34	NUM
cuesj-1229	239	2	.	.	PUNCT
cuesj-1229	239	3	c.	c.	PROPN
cuesj-1229	239	4	l.	l.	PROPN
cuesj-1229	239	5	radoi	radoi	PROPN
cuesj-1229	239	6	,	,	PUNCT
cuesj-1229	239	7	o.	o.	PROPN
cuesj-1229	239	8	zlatian	zlatian	PROPN
cuesj-1229	239	9	,	,	PUNCT
cuesj-1229	239	10	m.	m.	NOUN
cuesj-1229	239	11	balasoiu	balasoiu	PROPN
cuesj-1229	239	12	,	,	PUNCT
cuesj-1229	239	13	l.	l.	PROPN
cuesj-1229	239	14	giubelan	giubelan	PROPN
cuesj-1229	239	15	,	,	PUNCT
cuesj-1229	239	16	a.	a.	PROPN
cuesj-1229	239	17	c.	c.	PROPN
cuesj-1229	239	18	stoian	stoian	PROPN
cuesj-1229	239	19	,	,	PUNCT
cuesj-1229	239	20	l.	l.	PROPN
cuesj-1229	239	21	dragonu	dragonu	PROPN
cuesj-1229	239	22	,	,	PUNCT
cuesj-1229	239	23	a.	a.	PROPN
cuesj-1229	239	24	neacsu	neacsu	PROPN
cuesj-1229	239	25	and	and	CCONJ
cuesj-1229	239	26	d.	d.	PROPN
cuesj-1229	239	27	g.	g.	PROPN
cuesj-1229	239	28	iliescu	iliescu	PROPN
cuesj-1229	239	29	.	.	PUNCT
cuesj-1229	240	1	seroprevalence	seroprevalence	NOUN
cuesj-1229	240	2	of	of	ADP
cuesj-1229	240	3	infections	infection	NOUN
cuesj-1229	240	4	with	with	ADP
cuesj-1229	240	5	torch	torch	NOUN
cuesj-1229	240	6	agents	agent	NOUN
cuesj-1229	240	7	in	in	ADP
cuesj-1229	240	8	romania	romania	PROPN
cuesj-1229	240	9	:	:	PUNCT
cuesj-1229	240	10	a	a	DET
cuesj-1229	240	11	systematic	systematic	ADJ
cuesj-1229	240	12	review	review	NOUN
cuesj-1229	240	13	.	.	PUNCT
cuesj-1229	241	1	microorganisms	microorganism	NOUN
cuesj-1229	241	2	,	,	PUNCT
cuesj-1229	241	3	vol	vol	NOUN
cuesj-1229	241	4	.	.	PROPN
cuesj-1229	241	5	11	11	NUM
cuesj-1229	241	6	,	,	PUNCT
cuesj-1229	241	7	no	no	INTJ
cuesj-1229	241	8	.	.	NOUN
cuesj-1229	241	9	8	8	NUM
cuesj-1229	241	10	,	,	PUNCT
cuesj-1229	241	11	p.	p.	NOUN
cuesj-1229	241	12	2120	2120	NUM
cuesj-1229	241	13	,	,	PUNCT
cuesj-1229	241	14	2023	2023	NUM
cuesj-1229	241	15	.	.	PUNCT
cuesj-1229	242	1	35	35	NUM
cuesj-1229	242	2	.	.	PUNCT
cuesj-1229	242	3	l.	l.	PROPN
cuesj-1229	242	4	d.	d.	PROPN
cuesj-1229	242	5	samatova	samatova	PROPN
cuesj-1229	242	6	,	,	PUNCT
cuesj-1229	242	7	a.	a.	PROPN
cuesj-1229	242	8	b.	b.	PROPN
cuesj-1229	242	9	saidov	saidov	PROPN
cuesj-1229	242	10	,	,	PUNCT
cuesj-1229	242	11	s.	s.	PROPN
cuesj-1229	242	12	d.	d.	PROPN
cuesj-1229	242	13	bobozhonova	bobozhonova	PROPN
cuesj-1229	242	14	,	,	PUNCT
cuesj-1229	242	15	and	and	CCONJ
cuesj-1229	242	16	k.	k.	PROPN
cuesj-1229	242	17	r.	r.	PROPN
cuesj-1229	242	18	kuchkarova	kuchkarova	PROPN
cuesj-1229	242	19	.	.	PUNCT
cuesj-1229	243	1	frequency	frequency	NOUN
cuesj-1229	243	2	of	of	ADP
cuesj-1229	243	3	torch	torch	NOUN
cuesj-1229	243	4	infection	infection	NOUN
cuesj-1229	243	5	among	among	ADP
cuesj-1229	243	6	the	the	DET
cuesj-1229	243	7	donor	donor	NOUN
cuesj-1229	243	8	population	population	NOUN
cuesj-1229	243	9	in	in	ADP
cuesj-1229	243	10	the	the	DET
cuesj-1229	243	11	republican	republican	ADJ
cuesj-1229	243	12	center	center	NOUN
cuesj-1229	243	13	for	for	ADP
cuesj-1229	243	14	blood	blood	NOUN
cuesj-1229	243	15	transfusion	transfusion	NOUN
cuesj-1229	243	16	.	.	PUNCT
cuesj-1229	244	1	e3s	e3s	PROPN
cuesj-1229	244	2	web	web	NOUN
cuesj-1229	244	3	of	of	ADP
cuesj-1229	244	4	conferences	conference	NOUN
cuesj-1229	244	5	,	,	PUNCT
cuesj-1229	244	6	vol	vol	NOUN
cuesj-1229	244	7	.	.	PROPN
cuesj-1229	244	8	381	381	NUM
cuesj-1229	244	9	,	,	PUNCT
cuesj-1229	244	10	p.	p.	NOUN
cuesj-1229	244	11	01095	01095	NUM
cuesj-1229	244	12	,	,	PUNCT
cuesj-1229	244	13	2023	2023	NUM
cuesj-1229	244	14	.	.	PUNCT
cuesj-1229	245	1	36	36	NUM
cuesj-1229	245	2	.	.	PUNCT
cuesj-1229	246	1	e.	e.	PROPN
cuesj-1229	246	2	ç	ç	PROPN
cuesj-1229	246	3	.	.	PUNCT
cuesj-1229	246	4	tanriverdi	tanriverdi	PROPN
cuesj-1229	246	5	,	,	PUNCT
cuesj-1229	246	6	l.	l.	PROPN
cuesj-1229	246	7	dikbaş	dikbaş	PROPN
cuesj-1229	246	8	,	,	PUNCT
cuesj-1229	246	9	a.	a.	PROPN
cuesj-1229	246	10	l.	l.	PROPN
cuesj-1229	246	11	a.	a.	PROPN
cuesj-1229	246	12	y.	y.	PROPN
cuesj-1229	246	13	handan	handan	PROPN
cuesj-1229	246	14	,	,	PUNCT
cuesj-1229	246	15	b.	b.	PROPN
cuesj-1229	246	16	g.	g.	PROPN
cuesj-1229	246	17	kadioğlu	kadioğlu	PROPN
cuesj-1229	246	18	and	and	CCONJ
cuesj-1229	246	19	z.	z.	PROPN
cuesj-1229	246	20	özkurt	özkurt	PROPN
cuesj-1229	246	21	.	.	PUNCT
cuesj-1229	247	1	seroprevalance	seroprevalance	NOUN
cuesj-1229	247	2	of	of	ADP
cuesj-1229	247	3	rubella	rubella	NOUN
cuesj-1229	247	4	antibodies	antibodie	VERB
cuesj-1229	247	5	among	among	ADP
cuesj-1229	247	6	pregnant	pregnant	ADJ
cuesj-1229	247	7	women	woman	NOUN
cuesj-1229	247	8	in	in	ADP
cuesj-1229	247	9	a	a	DET
cuesj-1229	247	10	regional	regional	ADJ
cuesj-1229	247	11	maternity	maternity	NOUN
cuesj-1229	247	12	hospital	hospital	NOUN
cuesj-1229	247	13	in	in	ADP
cuesj-1229	247	14	eastern	eastern	ADJ
cuesj-1229	247	15	turkey	turkey	NOUN
cuesj-1229	247	16	.	.	PUNCT
cuesj-1229	248	1	mediterranean	mediterranean	PROPN
cuesj-1229	248	2	journal	journal	PROPN
cuesj-1229	248	3	of	of	ADP
cuesj-1229	248	4	infection	infection	NOUN
cuesj-1229	248	5	microbes	microbe	NOUN
cuesj-1229	248	6	and	and	CCONJ
cuesj-1229	248	7	antimicrobials	antimicrobial	NOUN
cuesj-1229	248	8	,	,	PUNCT
cuesj-1229	248	9	vol	vol	NOUN
cuesj-1229	248	10	.	.	PROPN
cuesj-1229	248	11	7	7	NUM
cuesj-1229	248	12	,	,	PUNCT
cuesj-1229	248	13	p.	p.	NOUN
cuesj-1229	248	14	4	4	NUM
cuesj-1229	248	15	,	,	PUNCT
cuesj-1229	248	16	2018	2018	NUM
cuesj-1229	248	17	.	.	PUNCT
cuesj-1229	249	1	37	37	NUM
cuesj-1229	249	2	.	.	PUNCT
cuesj-1229	250	1	s.	s.	PROPN
cuesj-1229	250	2	calimeri	calimeri	PROPN
cuesj-1229	250	3	,	,	PUNCT
cuesj-1229	250	4	a.	a.	NOUN
cuesj-1229	250	5	capua	capua	PROPN
cuesj-1229	250	6	,	,	PUNCT
cuesj-1229	250	7	v.	v.	ADP
cuesj-1229	250	8	la	la	X
cuesj-1229	250	9	fauci	fauci	PROPN
cuesj-1229	250	10	,	,	PUNCT
cuesj-1229	250	11	r.	r.	PROPN
cuesj-1229	250	12	squeri	squeri	PROPN
cuesj-1229	250	13	,	,	PUNCT
cuesj-1229	250	14	o.	o.	PROPN
cuesj-1229	250	15	c.	c.	PROPN
cuesj-1229	250	16	grillo	grillo	PROPN
cuesj-1229	250	17	and	and	CCONJ
cuesj-1229	250	18	d.	d.	PROPN
cuesj-1229	250	19	l.	l.	PROPN
cuesj-1229	250	20	giudice	giudice	PROPN
cuesj-1229	250	21	.	.	PUNCT
cuesj-1229	251	1	prevalence	prevalence	NOUN
cuesj-1229	251	2	of	of	ADP
cuesj-1229	251	3	serum	serum	NOUN
cuesj-1229	251	4	anti	anti	ADJ
cuesj-1229	251	5	-	-	ADJ
cuesj-1229	251	6	rubella	rubella	ADJ
cuesj-1229	251	7	virus	virus	NOUN
cuesj-1229	251	8	antibodies	antibodie	VERB
cuesj-1229	251	9	among	among	ADP
cuesj-1229	251	10	pregnant	pregnant	ADJ
cuesj-1229	251	11	women	woman	NOUN
cuesj-1229	251	12	in	in	ADP
cuesj-1229	251	13	southern	southern	PROPN
cuesj-1229	251	14	italy	italy	PROPN
cuesj-1229	251	15	.	.	PUNCT
cuesj-1229	252	1	international	international	ADJ
cuesj-1229	252	2	journal	journal	PROPN
cuesj-1229	252	3	of	of	ADP
cuesj-1229	252	4	gynecology	gynecology	NOUN
cuesj-1229	252	5	and	and	CCONJ
cuesj-1229	252	6	obstetrics	obstetric	NOUN
cuesj-1229	252	7	,	,	PUNCT
cuesj-1229	252	8	vol	vol	NOUN
cuesj-1229	252	9	.	.	PROPN
cuesj-1229	252	10	116	116	NUM
cuesj-1229	252	11	,	,	PUNCT
cuesj-1229	252	12	no	no	INTJ
cuesj-1229	252	13	.	.	NOUN
cuesj-1229	252	14	3	3	NUM
cuesj-1229	252	15	,	,	PUNCT
cuesj-1229	252	16	pp	pp	ADJ
cuesj-1229	252	17	.	.	PUNCT
cuesj-1229	253	1	211	211	NUM
cuesj-1229	253	2	-	-	SYM
cuesj-1229	253	3	213	213	NUM
cuesj-1229	253	4	,	,	PUNCT
cuesj-1229	253	5	2012	2012	NUM
cuesj-1229	253	6	.	.	PUNCT
cuesj-1229	254	1	38	38	NUM
cuesj-1229	254	2	.	.	PUNCT
cuesj-1229	255	1	m.	m.	PROPN
cuesj-1229	255	2	d.	d.	PROPN
cuesj-1229	255	3	amina	amina	PROPN
cuesj-1229	255	4	,	,	PUNCT
cuesj-1229	255	5	s.	s.	PROPN
cuesj-1229	255	6	oladapo	oladapo	PROPN
cuesj-1229	255	7	,	,	PUNCT
cuesj-1229	255	8	s.	s.	PROPN
cuesj-1229	255	9	habib	habib	PROPN
cuesj-1229	255	10	,	,	PUNCT
cuesj-1229	255	11	o.	o.	PROPN
cuesj-1229	255	12	adebola	adebola	PROPN
cuesj-1229	255	13	,	,	PUNCT
cuesj-1229	255	14	k.	k.	PROPN
cuesj-1229	255	15	bimbo	bimbo	PROPN
cuesj-1229	255	16	and	and	CCONJ
cuesj-1229	255	17	a.	a.	PROPN
cuesj-1229	255	18	daniel	daniel	PROPN
cuesj-1229	255	19	.	.	PUNCT
cuesj-1229	256	1	prevalence	prevalence	NOUN
cuesj-1229	256	2	of	of	ADP
cuesj-1229	256	3	rubella	rubella	NOUN
cuesj-1229	256	4	igg	igg	PROPN
cuesj-1229	256	5	antibodies	antibodie	VERB
cuesj-1229	256	6	among	among	ADP
cuesj-1229	256	7	pregnant	pregnant	ADJ
cuesj-1229	256	8	women	woman	NOUN
cuesj-1229	256	9	in	in	ADP
cuesj-1229	256	10	zaria	zaria	PROPN
cuesj-1229	256	11	,	,	PUNCT
cuesj-1229	256	12	nigeria	nigeria	PROPN
cuesj-1229	256	13	.	.	PUNCT
cuesj-1229	257	1	international	international	ADJ
cuesj-1229	257	2	health	health	NOUN
cuesj-1229	257	3	,	,	PUNCT
cuesj-1229	257	4	vol	vol	NOUN
cuesj-1229	257	5	.	.	PROPN
cuesj-1229	257	6	2	2	NUM
cuesj-1229	257	7	,	,	PUNCT
cuesj-1229	257	8	no	no	INTJ
cuesj-1229	257	9	.	.	NOUN
cuesj-1229	257	10	2	2	NUM
cuesj-1229	257	11	,	,	PUNCT
cuesj-1229	257	12	pp	pp	ADJ
cuesj-1229	257	13	.	.	PUNCT
cuesj-1229	258	1	156	156	NUM
cuesj-1229	258	2	-	-	SYM
cuesj-1229	258	3	159	159	NUM
cuesj-1229	258	4	,	,	PUNCT
cuesj-1229	258	5	2010	2010	NUM
cuesj-1229	258	6	.	.	PUNCT
cuesj-1229	259	1	39	39	NUM
cuesj-1229	259	2	.	.	PUNCT
cuesj-1229	260	1	a.	a.	PROPN
cuesj-1229	260	2	s.	s.	PROPN
cuesj-1229	260	3	m.	m.	PROPN
cuesj-1229	260	4	juma	juma	PROPN
cuesj-1229	260	5	,	,	PUNCT
cuesj-1229	260	6	m.	m.	PROPN
cuesj-1229	260	7	h.	h.	PROPN
cuesj-1229	260	8	ubeid	ubeid	PROPN
cuesj-1229	260	9	and	and	CCONJ
cuesj-1229	260	10	t.	t.	PROPN
cuesj-1229	260	11	s.	s.	PROPN
cuesj-1229	260	12	salih	salih	PROPN
cuesj-1229	260	13	.	.	PUNCT
cuesj-1229	261	1	anti	anti	PROPN
cuesj-1229	261	2	-	-	ADJ
cuesj-1229	261	3	toxoplasma	toxoplasma	ADJ
cuesj-1229	261	4	,	,	PUNCT
cuesj-1229	261	5	anti	anti	ADJ
cuesj-1229	261	6	-	-	NOUN
cuesj-1229	261	7	rubella	rubella	NOUN
cuesj-1229	261	8	and	and	CCONJ
cuesj-1229	261	9	anti	anti	ADJ
cuesj-1229	261	10	-	-	ADJ
cuesj-1229	261	11	cmv	cmv	ADJ
cuesj-1229	261	12	antibodies	antibody	NOUN
cuesj-1229	261	13	in	in	ADP
cuesj-1229	261	14	dumpsite	dumpsite	ADJ
cuesj-1229	261	15	workers	worker	NOUN
cuesj-1229	261	16	of	of	ADP
cuesj-1229	261	17	erbil	erbil	PROPN
cuesj-1229	261	18	governorate	governorate	PROPN
cuesj-1229	261	19	.	.	PUNCT
cuesj-1229	262	1	cihan	cihan	VERB
cuesj-1229	262	2	university	university	NOUN
cuesj-1229	262	3	-	-	PUNCT
cuesj-1229	262	4	erbil	erbil	PROPN
cuesj-1229	262	5	scientific	scientific	ADJ
cuesj-1229	262	6	journal	journal	NOUN
cuesj-1229	262	7	,	,	PUNCT
cuesj-1229	262	8	vol	vol	NOUN
cuesj-1229	262	9	.	.	PROPN
cuesj-1229	263	1	3	3	NUM
cuesj-1229	263	2	,	,	PUNCT
cuesj-1229	263	3	no	no	INTJ
cuesj-1229	263	4	.	.	NOUN
cuesj-1229	263	5	1	1	NUM
cuesj-1229	263	6	,	,	PUNCT
cuesj-1229	263	7	pp	pp	ADJ
cuesj-1229	263	8	.	.	PUNCT
cuesj-1229	264	1	85	85	NUM
cuesj-1229	264	2	-	-	SYM
cuesj-1229	264	3	89	89	NUM
cuesj-1229	264	4	,	,	PUNCT
cuesj-1229	264	5	2019	2019	NUM
cuesj-1229	264	6	.	.	PUNCT
cuesj-1229	265	1	40	40	NUM
cuesj-1229	265	2	.	.	PUNCT
cuesj-1229	266	1	t.	t.	PROPN
cuesj-1229	266	2	s.	s.	PROPN
cuesj-1229	266	3	salih	salih	PROPN
cuesj-1229	266	4	,	,	PUNCT
cuesj-1229	266	5	a.	a.	PROPN
cuesj-1229	266	6	s.	s.	PROPN
cuesj-1229	266	7	m.	m.	PROPN
cuesj-1229	266	8	juma	juma	PROPN
cuesj-1229	266	9	and	and	CCONJ
cuesj-1229	266	10	m.	m.	PROPN
cuesj-1229	266	11	h.	h.	PROPN
cuesj-1229	266	12	ubeid	ubeid	PROPN
cuesj-1229	266	13	.	.	PUNCT
cuesj-1229	267	1	occupational	occupational	ADJ
cuesj-1229	267	2	exposures	exposure	NOUN
cuesj-1229	267	3	and	and	CCONJ
cuesj-1229	267	4	associated	associated	ADJ
cuesj-1229	267	5	health	health	NOUN
cuesj-1229	267	6	effects	effect	NOUN
cuesj-1229	267	7	among	among	ADP
cuesj-1229	267	8	dumpsite	dumpsite	ADJ
cuesj-1229	267	9	workers	worker	NOUN
cuesj-1229	267	10	:	:	PUNCT
cuesj-1229	267	11	a	a	DET
cuesj-1229	267	12	case	case	NOUN
cuesj-1229	267	13	study	study	NOUN
cuesj-1229	267	14	of	of	ADP
cuesj-1229	267	15	kani	kani	PROPN
cuesj-1229	267	16	qirzhala	qirzhala	PROPN
cuesj-1229	267	17	landfill	landfill	PROPN
cuesj-1229	267	18	site	site	PROPN
cuesj-1229	267	19	,	,	PUNCT
cuesj-1229	267	20	erbil	erbil	PROPN
cuesj-1229	267	21	,	,	PUNCT
cuesj-1229	267	22	iraq	iraq	PROPN
cuesj-1229	267	23	.	.	PUNCT
cuesj-1229	268	1	cihan	cihan	VERB
cuesj-1229	268	2	universityerbil	universityerbil	ADJ
cuesj-1229	268	3	scientific	scientific	ADJ
cuesj-1229	268	4	journal	journal	NOUN
cuesj-1229	268	5	,	,	PUNCT
cuesj-1229	268	6	vol	vol	NOUN
cuesj-1229	268	7	.	.	PROPN
cuesj-1229	268	8	5	5	NUM
cuesj-1229	268	9	,	,	PUNCT
cuesj-1229	268	10	no	no	INTJ
cuesj-1229	268	11	.	.	NOUN
cuesj-1229	268	12	2	2	NUM
cuesj-1229	268	13	,	,	PUNCT
cuesj-1229	268	14	pp	pp	ADJ
cuesj-1229	268	15	.	.	PUNCT
cuesj-1229	269	1	1	1	NUM
cuesj-1229	269	2	-	-	SYM
cuesj-1229	269	3	5	5	NUM
cuesj-1229	269	4	,	,	PUNCT
cuesj-1229	269	5	2021	2021	NUM
cuesj-1229	269	6	.	.	PUNCT
cuesj-1229	270	1	41	41	NUM
cuesj-1229	270	2	.	.	PUNCT
cuesj-1229	270	3	m.	m.	NOUN
cuesj-1229	270	4	h.	h.	PROPN
cuesj-1229	270	5	ubeid	ubeid	PROPN
cuesj-1229	270	6	,	,	PUNCT
cuesj-1229	270	7	t.	t.	PROPN
cuesj-1229	270	8	s.	s.	PROPN
cuesj-1229	270	9	salih	salih	PROPN
cuesj-1229	270	10	and	and	CCONJ
cuesj-1229	270	11	a.	a.	PROPN
cuesj-1229	270	12	s.	s.	PROPN
cuesj-1229	270	13	m.	m.	PROPN
cuesj-1229	270	14	juma	juma	PROPN
cuesj-1229	270	15	.	.	PUNCT
cuesj-1229	271	1	hiv	hiv	PROPN
cuesj-1229	271	2	,	,	PUNCT
cuesj-1229	271	3	hbs	hbs	PROPN
cuesj-1229	271	4	and	and	CCONJ
cuesj-1229	271	5	hcv	hcv	NOUN
cuesj-1229	271	6	in	in	ADP
cuesj-1229	271	7	dump	dump	NOUN
cuesj-1229	271	8	site	site	NOUN
cuesj-1229	271	9	workers	worker	NOUN
cuesj-1229	271	10	of	of	ADP
cuesj-1229	271	11	erbil	erbil	PROPN
cuesj-1229	271	12	governorate	governorate	PROPN
cuesj-1229	271	13	.	.	PUNCT
cuesj-1229	272	1	cihan	cihan	VERB
cuesj-1229	272	2	university	university	NOUN
cuesj-1229	272	3	-	-	PUNCT
cuesj-1229	272	4	erbil	erbil	PROPN
cuesj-1229	272	5	scientific	scientific	ADJ
cuesj-1229	272	6	journal	journal	NOUN
cuesj-1229	272	7	,	,	PUNCT
cuesj-1229	272	8	vol	vol	NOUN
cuesj-1229	272	9	.	.	PROPN
cuesj-1229	272	10	5	5	NUM
cuesj-1229	272	11	,	,	PUNCT
cuesj-1229	272	12	no	no	INTJ
cuesj-1229	272	13	.	.	NOUN
cuesj-1229	272	14	2	2	NUM
cuesj-1229	272	15	,	,	PUNCT
cuesj-1229	272	16	pp	pp	ADJ
cuesj-1229	272	17	.	.	PUNCT
cuesj-1229	273	1	20	20	NUM
cuesj-1229	273	2	-	-	SYM
cuesj-1229	273	3	23	23	NUM
cuesj-1229	273	4	,	,	PUNCT
cuesj-1229	273	5	2021	2021	NUM
cuesj-1229	273	6	.	.	PUNCT